Attenuated influenza viruses and vaccines

Information

  • Patent Grant
  • 11549101
  • Patent Number
    11,549,101
  • Date Filed
    Monday, June 10, 2019
    5 years ago
  • Date Issued
    Tuesday, January 10, 2023
    a year ago
Abstract
This invention provides highly attenuated influenza viruses and vaccines. The attenuated viruses and vaccines proliferate well and have high safety factors. The attenuated viruses providing protective immunity from challenge by virus of the same subtype, as well as cross protection against heterologous viruses.
Description
FIELD OF THE INVENTION

This invention provides highly attenuated influenza viruses and vaccines. The attenuated viruses and vaccines proliferate well and have high safety factors. The attenuated viruses providing protective immunity from challenge by virus of the same subtype, as well as cross protection against heterologous viruses.


BACKGROUND OF THE INVENTION

Influenza is a human disease that leads every year to >30,000 deaths in the US and several hundred thousand deaths globally (1). Major neutralization antigenic proteins, hemagglutinin (HA) and neuraminidase (NA) on the virion surface, provide protecting immunity, but undergo yearly genetic variation by point mutations (genetic drift). This renders the viruses resistant to population immunity and set the stage for seasonal epidemics. Further, influenza virus may acquire a new antigenic make-up (reassortment of heterologous genes, referred to as genetic shift) leading to pandemics. Because the flu is seasonal and variable, new vaccines must be produced every year. This is made more complex since more than one type or strain of influenza virus co-circulates in any flu season, a phenomenon demanding that more than one new vaccine may have to be developed every year.


Currently, only two major types of vaccines are licensed, the intramuscularly administered inactivated vaccines (“Flu shot”), and the live attenuated vaccine (LAIV), given intra-nasally (“FluMist®”). The efficacy of the two vaccines is suboptimal. The injectable inactivated vaccines that requires a large quantity of starting material (the equivalent of approximately 1010 plaque-forming units, PFU, per dose), are incapable of inducing significant cell-mediated immunity, which is being recognized as an important determinant of protection (4). Moreover, the overall efficacy of the inactivated vaccine in the U.S. adult population aged 18-65 years is only 59% (5). The LAIV “FluMist,” on the other hand, induces both humoral and cellular immunity but it is restricted in use to people 2 to 49 yr of age (6, 7). Moreover, recurrent administration of LAIV, which always uses the same attenuating viral backbone, could result in tolerance in repeat recipients (8).


Influenza viruses that have been classified as type A, B, and C, are enveloped, negative-strand RNA viruses of Orthomyxoviridae of which subtypes of type A are the major culprit of human disease (3). The viruses transcribe and replicate their multipartite genome in the cell nucleus, each segment encoding one or two polypeptides. Of these the most important antigenic molecules are the glycoproteins hemagglutinin (HA) and neuraminidase (NA).


SUMMARY OF THE INVENTION

A long-held dogma posits that strong presentation to the immune system of the dominant influenza virus glycoprotein antigens hemagglutinin (HA) and neuraminidase (NA) is paramount for inducing protective immunity against influenza virus infection. It has now been discovered that attenuated viruses in which expression of the two dominant influenza virus glycoprotein antigens, HA and NA, is reduced, are highly effective in providing long lasting protective immunity against lethal wild type challenge and cross protection against diverse subtypes. Further, the viruses have exceptional safety profiles. Accordingly, the invention provides an attenuated influenza virus in which expression of hemagglutinin (HA) and neuraminidase (NA) is reduced. In certain embodiments, HA and NA are the only the only virus proteins having reduced expression. In other embodiments of the invention, the expression of one or more other virus proteins may also be reduced, such as, for example, PA, PB1, PB2, NP, NS, Ml, or M2. In certain embodiments, when the expression of a virus proteins other than HA and NA is reduced, the reduction is small compared to the reduction of HA and NA. According to the invention, reduction in expression of virus proteins of the invention is accomplished by changes in protein encoding sequence, for example by lowering the codon pair bias of the protein-encoding sequence, substituting rare codons, modifying G+C content, modifying CG and/or TA (or UA) dinucleotide content, or combinations. Reduced expression can also be accomplished by modifications to the regulatory sequences of the proteins.


In one such embodiment, reducing the codon-pair bias comprises identifying a codon pair in the parent protein-encoding sequence having a codon-pair score that can be reduced, and reducing the codon-pair bias by substituting the codon pair with a codon pair that has a lower codon-pair score. In another such embodiment, reducing the codon-pair bias comprises rearranging the codons of a parent protein-encoding sequence. In certain embodiments, the reduced-expression HA protein-encoding sequence and the reduced-expression NA protein-encoding sequence individually have a codon pair bias less than −0.1, or less than −0.2, or less than −0.3, or less than −0.4. Codon pair bias of a protein-encoding sequence (i.e., an open reading frame) is calculated as described in Coleman et al., 2000 (ref 12) and herein.


In an embodiment of the invention, expression of one or both of the HA protein-encoding sequence and the NA protein-encoding sequence is reduced by replacing one or more codons with synonymous codons that are less frequent in the host.


The invention further provides an influenza vaccine composition for inducing a protective immune response in a subject, wherein the vaccine composition comprises virus in which expression of HA is reduced and expression of NA is reduced. In certain embodiments, only expression of HA and NA is reduced. In some embodiments, expression of another virus protein is also reduced.


The invention also provides a method of eliciting a protective immune response in a subject comprising administering to the subject a prophylactically or therapeutically effective dose of a vaccine composition comprising an attenuated influenza virus, wherein expression of HA is reduced and expression of NA is reduced. In certain embodiments, only expression of HA and NA is reduced. In some embodiments, expression of another virus protein is also reduced. In an embodiment of the invention, an immune response is elicited that is effective against influenza of the same subtype as the attenuated virus of the vaccine. In another embodiment, an immune response is elicited that is effective against a heterologous influenza virus.


The invention also provides a method of making an attenuated influenza virus genome comprising a) obtaining the nucleotide sequence encoding the hemagglutinin protein of an influenza virus and the nucleotide sequence encoding the neuraminidase protein of an influenza virus, b) recoding the hemagglutinin-encoding nucleotide sequence to reduce expression and recoding the neuraminidase-encoding nucleotide sequence to reduce expression, and substituting the recoded nucleotide sequences into an influenza virus genome to make an attenuated influenza virus genome. In certain embodiments, only expression of HA and NA is reduced. In some embodiments, expression of another virus protein is also reduced.





DESCRIPTION OF THE FIGURES


FIGS. 1A-1D. Construction of variants having reduced codon pair bias and phenotypes in tissue cultures. (FIG. 1A) NAMin and HAMin were designed (leaving 120-200 nt long wt sequences at 5′ and 3′ ends) and constructed by chemical synthesis. They were then used to replace by reverse genetics (13) one or two corresponding genes of wt PR8. The number of synonymous mutations is shown. (FIG. 1B) Recovered viruses were analyzed for plaque size phenotypes on MDCK monolayers. (FIG. 1C) Growth kinetics of wt PR8 and reduced codon-pair bias variants were analyzed on MDCK cells after infections at an MOI of 0.01. Every three hours post-infection, cell supernatants were collected and analyzed for virus titers by plaque assays. (FIG. 1D) Growth kinetics of wt PR8 and (NA+HA)Min virus in A549 cells. Cells were infected at an MOI of 1.



FIGS. 2A-2B. Protein expression and mRNA levels in (NA+HA)Min-infected in tissue culture cells. MDCK cells were infected with (NA+HA)Min or wt PR8 at a MOI of 5. (FIG. 2A) Western blot analyses were performed to determine the viral protein expression the infected cells at 3 h and 6 h p.i. (FIG. 2B) Northern blot analyses were performed to determine mRNA levels of HA, NA, PB1 and GAPDH in (NA+HA)Min or wt PR8-infected MDCK cells. At 3, 6, and 9 h p.i., cytoplasmic mRNA were collected and analyzed. For HAMin and HAWT transcript probes, the same 150 nt that recognized the common 3′ end of the respective genes was used. Similarly, the probes for NAMin and NAWT have the same 150 nt sequence corresponding to the common 3′ end of the NA genes.



FIGS. 3A-3F. Virus phenotypes in infected mice. (FIGS. 3A and 3B) Measurement of the median lethal dose (LD50). Groups of five male Balb/C mice were intranasally infected with the (NA+HA)Min variant at 104, 105, or 106 PFU and the relative body weight and survival rate were monitored for 14 days p.i. Mice that lost 25% of their body weight were euthanized. LD50 was calculated based on the method of Reed-Muench (24). (FIGS. 3C and 3D) Measurement of the median protective dose (PD50). Groups of five male Balb/C mice were vaccinated with 102, 101, or 100 PFU of (NA+HA)Min on day 0. On day 28 post vaccination, all mice were challenged with 105 PFU wt PR8 virus. The relative body weight and survival rate after challenge were monitored. PD50 was calculated based on the method of Reed-Muench (24). (FIGS. 3E and 3F) Safe and effective vaccine range of the (NA+HA)Min (open box) and wt PR8 virus (gray zone) were plotted. Any vaccine dose within this region warranted survival of the animals, and also completely protected them from lethal homogeneous challenge. Error bars represent SD.



FIGS. 4A-4B. Virus titers in lungs of infected mice. (FIG. 4A) Groups of three male Balb/C mice were infected with 104 PFU of wt PR8 or (NA+HA)Min. On day 1, 3, 5, 7, 9 and 11 p.i., the mice were euthanized and their lungs harvested and homogenized. Viral titers in the homogenates were determined by plaque assays on MDCK cells. * All wt PR8-infected mice were dead on day 5. ‡ The virus titers in (NA+HA)Min-infected mice after day 9 were undetectable (less than 4 PFU). (FIG. 4B) Comparison of virus titers in lungs of three mice each infected with wt PR8 or (NA+HA)Min at a dose from 101 to 104 PFU. The lungs of the animals were harvest on day 3, and plaque assays were performed to determine virus titers. Error bars represent SD.



FIGS. 5A-5D. Cross protection against H3N2 virus infections in (NA+HA)Min(H1N1)-vaccinated mice. Groups of five Balb/c mice were vaccinated with (NA+HA)Min at different doses. On day 28 post vaccination, mice were challenged with (FIGS. 5A and 5B) 100 LD50 heterologous viruses A/Aichi/2/1968 (H3N2) virus (=1.5×104 PFU). Survival rate and relative body weights were monitored for 14 days. All mice vaccinated with at least 103 PFU of (NA+HA)Min(H1N1) survived the lethal challenge. The cross protection PD50 against H3N2 Aichi virus calculated is 237 PFU. (FIGS. 5C and 5D) Mice vaccinated with (NA+HA)Min virus were also challenged with 100 LD50 A/Victoria/3/75 (H3N2) virus (=3.2×104 PFU). Survival rate and relative body weights were monitored for 14 days. All mice vaccinated with at least 103 PFU of (NA+HA)Min(H1N1) survived the lethal challenge. The cross protection PD50 against H3N2 Victoria virus calculated is 147 PFU based on the method of Reed-Muench (24). Error bars represent SD.



FIG. 6. Hemagglutination inhibition (HAI) assay with serum of vaccinated mice. Mice were infected at different doses with PR8 or (NA+HA)Min. Serum was collected on day 28 p.i. and antibody titers were determined by hemagglutination inhibition assays, as described in Material and Methods. Mice were then challenged with 105 PFU wt PR8 and survival rates were monitored. Gray labeled dots indicated mice that did not survive.



FIGS. 7A-7D. LD50 and PD50 values of NAMin in mice. (FIGS. 7A and 7B) Groups of five male Balb/c mice were infected intranasally with different doses of NAMin variant. The relative body weight and survival rate were monitored for 14 days. The LD50 calculated was 2.4×105 PFU. (C and D) Groups of five males were vaccinated with different dose of NAMin variant, 28 days p.i., mice were challenged with 105 PFU wt influenza A/PR/8/34 (PR8). The relative body weight and survival rate were monitored for 14 days. Error bars represent SD.



FIGS. 8A-8B. Long term protection of (NA+HA)Min-vaccinated mice. Groups of five Balb/c mice (5-6 weeks) were infected intranasally with (NA+HA)Min at different doses. After seven months, mice were challenged with 105 PFU wt PR8. Their body weight and survival rate were monitored for 14 days. Error bars represent SD.



FIGS. 9A-9D. Composition of (NA+HA)Min virus. WT and (NA+HA)Min virus were purified by sucrose gradient. Equivalent amounts of PFUs were compared to determine the relative amounts of the indicated virus proteins. (FIG. 9A) Commassie stain. (FIGS. 9B and 9C) silver stain. (FIG. 9D) Western blot.



FIGS. 10A-10B. Expression of virus proteins and mRNAs in MDCK cells infected with WT influenza or (NA+HA)Min. (FIG. 10A) 35S labeled proteins in infected MDCK cells. (FIG. 10B) Northern analysis of viral mRNAs expressed in infected MDCK.



FIG. 11. Passive immunization with Serum from PR8-(NA+HA)Min vaccinated mice protects naïve mice from homologous WT PR8 challenge. FIG. 11 shows mice passively immunized with PR8-(NA+HA)Min sera survived and remained healthy upon challenge with WT virus.



FIGS. 12A-12B. Passive immunization with serum from PR8-(NA+HA)Min (H1N1) vaccinated mice protects naïve mice from heterologous challenge with an H3N2 virus. FIG. 11 shows mice passively immunized with PR8-(NA+HA)Min sera maintained weight (Panel A) and had improved survival (Panel B) when challenged with H3N2 virus.



FIGS. 13A-13B. Assessment of cross protection against H3N2 viruses conferred by immunization with PR8-(NA+HA)Min. (FIG. 13A) Inhibition of hemagglutination by sera from PR8-(NA+HA)Min immunized mice. (FIG. 13B) Neutralization of virus infection of MDCK cells by sera from PR8-(NA+HA)Min immunized mice.



FIG. 14. Growth of WT and PR8-(NA+HA)Min virus in MDCK cells and MDCK cells transfected to express α-2,6-sialyltransferase.



FIG. 15. T cell responses in lungs of Balb/C mice 7 days post-infection. Cell numbers are expressed as total cell count in lung (left panels) or percentage of CD45+ cells (right panels).



FIG. 16. B cell responses in lungs of Balb/C mice 7 days post-infection. Cell numbers are expressed as total cell count in lung (upper panel) or percentage of CD45+ cells (lower panels).



FIG. 17. T cell responses in spleens of Balb/C mice 7 days post-infection.



FIG. 18. T cell responses in spleens of Balb/C mice 7 days post-infection.



FIGS. 19A-19I. Immune cell infiltration of lung tissue 3 days post-infection. (FIG. 19A) CD45+ leukocytes, (FIG. 19B) CD45+ Ly6Ghigh polymorphonuclear leukocytes (PMN), (FIG. 19C) CD45+CD11c+ I-Ad+ F4/80 dendritic cells, (FIG. 19D) CD45+ NKp46+ natural killer cells, (FIG. 19E) CD45+CD11b+Ly6ChighLy6G inflammatory monocytes, (FIG. 19F) CD45+ I-Ad+ F4/80+ macrophages, (G) CD45+CD3+CD4+ T helper cells, (FIG. 19H) CD45+ CD19+ B cells, and (FIG. 19I) CD45+CD19+IgM+ B cells.





DETAILED DESCRIPTION

The present invention relates to the production of attenuated influenza viruses that can be used to protect against viral infection and disease. A basic premise in flu vaccination is adequate delivery of HA and NA to vaccine recipients assuming that a very high dose (“Flu shot”) or a dose corresponding to live viral infection (“FluMist”) of these traditionally dominant antigenic polypeptides alone are sufficient for adequate vaccine efficacy. Those expectations aside, the present invention benefits from a contrary approach. The invention provides attenuated influenza viruses in which expression of HA and NA is reduced, which have excellent growth properties useful to vaccine production, yet possess an extraordinary safety profile and enhanced protective characteristics. The attenuated viruses proliferate nearly as well as wild type virus, have highly attenuated phenotypes, as revealed by LD50 values, are unusually effective in providing protective immunity against challenge by influenza virus of the same subtype, and also provide protective immunity against challenge by influenza virus of other subtypes.


In certain attenuated viruses of the invention, the expression of one or more other virus proteins may also be reduced, such as, for example, PA, PB1, PB2, NP, NS, M1, or M2. In certain embodiments, when the expression of a virus proteins other than HA and NA is reduced, the reduction is small compared to the reduction of HA and NA.


In certain attenuated influenza viruses of the invention, expression of hemagglutinin (HA) and neuraminidase (NA) is reduced, and expression of other influenza proteins (i.e., NP, M (including M1 and M2), NS, PA, PB1, and PB2 protein is not substantially changed (i.e., substantially reduced or increased). In an embodiment of the invention, expression of NP, PA, PB1, and PB2 is not substantially reduced. That expression of the NP, M (including M1 and M2), NS, PA, PB1, and PB2 protein encoding sequences is not substantially reduced means that in embodiments where there is a small change in expression of one or more of those proteins (e.g., NP, PA, PB1, PB2, M, and or M), the change in expression of those proteins has little or no effect on attenuation. Little or no effect on attenuation includes one or both of the following: 1) Any reduced expression of NP, M (including M1 and M2), NS, PA, PB1, or PB2 does not reduce viral replication or viral infectivity more than 20% when the NP, M (including M1 and M2), NS, PA, PB1, or PB2 is expressed at the reduced level in a test influenza virus in which only the level of that protein is reduced; 2) The level of expression of NP, M (including M1 and M2), NS, PA, PB1, or PB2 is reduced by less than 20% in the attenuated virus in which expression of HA and NA is reduced.


In certain embodiments of the invention, the attenuated influenza viruses of the invention comprise a recoded hemagglutinin (HA) nucleic acid and a recoded neuraminidase (NA) nucleic acid. In certain of these embodiments, another virus protein, such as NP, M (including M1 and M2), NS, PA, PB1, or PB2, is recoded. In others of these embodiments, other protein encoding sequences (i.e., NP, M (including M1 and M2), NS, PA, PB1, and PB2 protein encoding sequences are not recoded. That the NP, M (including M1 and M2), NS, PA, PB1, and PB2 protein encoding sequences are not recoded does not exclude mutations and other variations in those sequences, but only means that any mutations or variations made in those sequences have little or no effect on attenuation. Little or no effect on attenuation includes one or both of the following: 1) The mutations or variations in the NP, M (including M1 and M2), NS, PA, PB1, or PB2 sequence do not reduce viral replication or viral infectivity more than 20% when the variant NP, M (including M1 and M2), NS, PA, PB1, or PB2 nucleic acid sequence is the only variant in a test influenza virus; 2) Mutations or variations in any of the NP, M (including M1 and M2), NS, PA, PB1, or PB2 nucleic acid represent fewer than 10% of the nucleotides in that coding sequence.


The viruses of the invention are highly attenuated. In embodiments of the invention, compared to wild type, the viruses are at least 5,000 fold attenuated, or at least 10,000 fold attenuated, or at least 20,000 fold attenuated, or at least 33,000 fold attenuated, or at least 50,000 fold attenuated, of at least 100,000 fold attenuated in the BALB/c mouse model compared to a wild type virus having proteins of the same sequence but encoded by a different nucleotide sequence.


The attenuated viruses are also highly protective against wild type virus of the same subtype. In embodiments of the invention, the protective dose (PD50) of the viruses is less than 100 PFU, or less than 50 PFU, or less than 20 PFU, or less than 10 PFU, or less than 5 PFU, when measured by a mouse model, such as exemplified herein.


The attenuated viruses of the invention also exhibit a large margin of safety (i.e., the difference between LD50 and PD50), thus have high safety factors, defined herein as the ratio of LD50/PD50. In certain embodiments of the invention, the safety factor is at least 102, or at least 103, or at least 104, or at least 105, or at least 2×105, or at least 5×105, or at least 106, or at least 2×106, or at least 5×106. In certain embodiments, the safety factor is from 102 to 103, or from 103 to 104, or from 104 to 105, or from 105 to 106.


The attenuated viruses of the invention are also highly protective against heterologous viruses. In certain embodiments of the invention, the protective dose (PD50) of an attenuated virus of the invention is less than 1000 PFU, or less than 500 PFU, or less than 200 PFU, or less than 100 PFU, when measured by a mouse model, such as exemplified herein


The recoding of HA and NA protein encoding sequences of the attenuated viruses of the invention can have been made utilizing any algorithm or procedure known in the art or newly devised for recoding a protein encoding sequence. According to the invention, nucleotide substitutions are engineered in multiple locations in the HA and NA coding sequences, wherein the substitutions introduce a plurality of synonymous codons into the genome. In certain embodiments, the synonymous codon substitutions alter codon bias, codon pair bias, the density of infrequent codons or infrequently occurring codon pairs, RNA secondary structure, CG and/or TA (or UA) dinucleotide content, C+G content, translation frameshift sites, translation pause sites, the presence or absence microRNA recognition sequences or any combination thereof, in the genome. The codon substitutions may be engineered in multiple locations distributed throughout the HA and NA coding sequences, or in the multiple locations restricted to a portion of the HA and NA coding sequences. Because of the large number of defects (i.e., nucleotide substitutions) involved, the invention provides a means of producing stably attenuated viruses and live vaccines.


As discussed further below, in some embodiments, a virus coding sequence is recoded by substituting one or more codon with synonymous codons used less frequently in the influenza host (e.g., humans, birds, pigs). In some embodiments, a virus coding sequence is recoded by substituting one or more codons with synonymous codons used less frequently in the influenza virus. In certain embodiments, the number of codons substituted with synonymous codons is at least 5. In some embodiments, at least 10, or at least 20 codons are substituted with synonymous codons.


In some embodiments, virus codon pairs are recoded to reduce (i.e., lower the value of) codon-pair bias. In certain embodiments, codon-pair bias is reduced by identifying a codon pair in an HA or NA coding sequence having a codon-pair score that can be reduced and reducing the codon-pair bias by substituting the codon pair with a codon pair that has a lower codon-pair score. In some embodiments, this substitution of codon pairs takes the form of rearranging existing codons of a sequence. In some such embodiments, a subset of codon pairs is substituted by rearranging a subset of synonymous codons. In other embodiments, codon pairs are substituted by maximizing the number of rearranged synonymous codons. It is noted that while rearrangement of codons leads to codon-pair bias that is reduced (made more negative) for the virus coding sequence overall, and the rearrangement results in a decreased CPS at many locations, there may accompanying CPS increases at other locations, but on average, the codon pair scores, and thus the CPB of the modified sequence, is reduced. In some embodiments, recoding of codons or codon-pairs can take into account altering the G+C content of the HA and NA coding sequences. In some embodiments, recoding of codons or codon-pairs can take into account altering the frequency of CG and/or TA dinucleotides in the HA and NA coding sequences.


In certain embodiments, the recoded (i.e., reduced-expression) HA protein-encoding sequence has a codon pair bias less than −0.1, or less than −0.2, or less than −0.3, or less than −0.4. In certain embodiments, the recoded (i.e., reduced-expression) NA protein-encoding sequence has a codon pair bias less than −0.1, or less than −0.2, or less than −0.3, or less than −0.4. In certain embodiments, the codon pair bias of the recoded HA protein encoding sequence is reduced by at least 0.1, or at least 0.2, or at least 0.3, or at least 0.4, compared to the parent HA protein encoding sequence from which it is derived. In certain embodiments, the codon pair bias of the recoded NA protein encoding sequence is reduced by at least 0.1, or at least 0.2, or at least 0.3, or at least 0.4, compared to the parent NA protein encoding sequence from which it is derived. In certain embodiments, rearrangement of synonymous codons of the HA protein-encoding sequence provides a codon-pair bias reduction of at least 0.1, or at least 0.2, or at least 0.3, or at least 0.4, parent HA protein encoding sequence from which it is derived. In certain embodiments, rearrangement of synonymous codons of the NA protein-encoding sequence provides a codon-pair bias reduction of at least 0.1, or at least 0.2, or at least 0.3, or at least 0.4, parent NA protein encoding sequence from which it is derived.


Usually, these substitutions and alterations are made and reduce expression of the encoded virus proteins without altering the amino acid sequence of the encoded protein. In certain embodiments, the invention also includes alterations in the HA and/or NA coding sequences that result in substitution of non-synonymous codons an amino acid substitutions in the encoded protein, which may or may not be conservative.


Most amino acids are encoded by more than one codon. See the genetic code in Table 1. For instance, alanine is encoded by GCU, GCC, GCA, and GCG. Three amino acids (Leu, Ser, and Arg) are encoded by six different codons, while only Trp and Met have unique codons. “Synonymous” codons are codons that encode the same amino acid. Thus, for example, CUU, CUC, CUA, CUG, UUA, and UUG are synonymous codons that code for Leu. Synonymous codons are not used with equal frequency. In general, the most frequently used codons in a particular organism are those for which the cognate tRNA is abundant, and the use of these codons enhances the rate and/or accuracy of protein translation. Conversely, tRNAs for the rarely used codons are found at relatively low levels, and the use of rare codons is thought to reduce translation rate and/or accuracy.









TABLE 1







Genetic Codea













U
C
A
G


















U
Phe
Ser
Tyr
Cys
U




Phe
Ser
Tyr
Cys
C




Leu
Ser
STOP
STOP
A




Leu
Ser
STOP
Trp
G



C
Leu
Pro
His
Arg
U




Leu
Pro
His
Arg
C




Leu
Pro
Gln
Arg
A




Leu
Pro
Gln
Arg
G



A
Ile
Thr
Asn
Ser
U




Ile
Thr
Asn
Ser
C




Ile
Thr
Lys
Arg
A




Met
Thr
Lys
Arg
G



G
Val
Ala
Asp
Gly
U




Val
Ala
Asp
Gly
C




Val
Ala
Glu
Gly
A




Val
Ala
Glu
Gly
G








aThe first nucleotide in each codon encoding a particular amino acid is shown in the left-most column; the second nucleotide is shown in the top row; and the third nucleotide is shown in the right-most column.







Codon Bias


As used herein, a “rare” codon is one of at least two synonymous codons encoding a particular amino acid that is present in an mRNA at a significantly lower frequency than the most frequently used codon for that amino acid. Thus, the rare codon may be present at about a 2-fold lower frequency than the most frequently used codon. Preferably, the rare codon is present at least a 3-fold, more preferably at least a 5-fold, lower frequency than the most frequently used codon for the amino acid. Conversely, a “frequent” codon is one of at least two synonymous codons encoding a particular amino acid that is present in an mRNA at a significantly higher frequency than the least frequently used codon for that amino acid. The frequent codon may be present at about a 2-fold, preferably at least a 3-fold, more preferably at least a 5-fold, higher frequency than the least frequently used codon for the amino acid. For example, human genes use the leucine codon CTG 40% of the time, but use the synonymous CTA only 7% of the time (see Table 2). Thus, CTG is a frequent codon, whereas CTA is a rare codon. Roughly consistent with these frequencies of usage, there are 6 copies in the genome for the gene for the tRNA recognizing CTG, whereas there are only 2 copies of the gene for the tRNA recognizing CTA. Similarly, human genes use the frequent codons TCT and TCC for serine 18% and 22% of the time, respectively, but the rare codon TCG only 5% of the time. TCT and TCC are read, via wobble, by the same tRNA, which has 10 copies of its gene in the genome, while TCG is read by a tRNA with only 4 copies. It is well known that those mRNAs that are very actively translated are strongly biased to use only the most frequent codons. This includes genes for ribosomal proteins and glycolytic enzymes. On the other hand, mRNAs for relatively non-abundant proteins may use the rare codons.









TABLE 2







Codon usage in Homo sapiens (source:


http://www.kazusa.or.jp/codon/)











Amino Acid
Codon
Number
/1000
Fraction














Gly
GGG
636457.00
16.45
0.25


Gly
GGA
637120.00
16.47
0.25


Gly
GGT
416131.00
10.76
0.16


Gly
GGC
862557.00
22.29
0.34


Glu
GAG
1532589.00
39.61
0.58


Glu
GAA
1116000.00
28.84
0.42


Asp
GAT
842504.00
21.78
0.46


Asp
GAC
973377.00
25.16
0.54


Val
GTG
1091853.00
28.22
0.46


Val
GTA
273515.00
7.07
0.12


Val
GTT
426252.00
11.02
0.18


Val
GTC
562086.00
14.53
0.24


Ala
GCG
286975.00
7.42
0.11


Ala
GCA
614754.00
15.89
0.23


Ala
GCT
715079.00
18.48
0.27


Ala
GCC
1079491.00
27.90
0.40


Arg
AGG
461676.00
11.93
0.21


Arg
AGA
466435.00
12.06
0.21


Ser
AGT
469641.00
12.14
0.15


Ser
AGC
753597.00
19.48
0.24


Lys
AAG
1236148.00
31.95
0.57


Lys
AAA
940312.00
24.30
0.43


Asn
AAT
653566.00
16.89
0.47


Asn
AAC
739007.00
19.10
0.53


Met
ATG
853648.00
22.06
1.00


Ile
ATA
288118.00
7.45
0.17


Ile
ATT
615699.00
15.91
0.36


Ile
ATC
808306.00
20.89
0.47


Thr
ACG
234532.00
6.06
0.11


Thr
ACA
580580.00
15.01
0.28


Thr
ACT
506277.00
13.09
0.25


Thr
ACC
732313.00
18.93
0.36


Trp
TGG
510256.00
13.19
1.00


End
TGA
59528.00
1.54
0.47


Cys
TGT
407020.00
10.52
0.45


Cys
TGC
487907.00
12.61
0.55


End
TAG
30104.00
0.78
0.24


End
TAA
38222.00
0.99
0.30


Tyr
TAT
470083.00
12.15
0.44


Tyr
TAC
592163.00
15.30
0.56


Leu
TTG
498920.00
12.89
0.13


Leu
TTA
294684.00
7.62
0.08


Phe
TTT
676381.00
17.48
0.46


Phe
TTC
789374.00
20.40
0.54


Ser
TCG
171428.00
4.43
0.05


Ser
TCA
471469.00
12.19
0.15


Ser
TCT
585967.00
15.14
0.19


Ser
TCC
684663.00
17.70
0.22


Arg
CGG
443753.00
11.47
0.20


Arg
CGA
239573.00
6.19
0.11


Arg
CGT
176691.00
4.57
0.08


Arg
CGC
405748.00
10.49
0.18


Gln
CAG
1323614.00
34.21
0.74


Gln
CAA
473648.00
12.24
0.26


His
CAT
419726.00
10.85
0.42


His
CAC
583620.00
15.08
0.58


Leu
CTG
1539118.00
39.78
0.40


Leu
CTA
276799.00
7.15
0.07


Leu
CTT
508151.00
13.13
0.13


Leu
CTC
759527.00
19.63
0.20


Pro
CCG
268884.00
6.95
0.11


Pro
CCA
653281.00
16.88
0.28


Pro
CCT
676401.00
17.48
0.29


Pro
CCC
767793.00
19.84
0.32









The propensity for highly expressed genes to use frequent codons is called “codon bias.” A gene for a ribosomal protein might use only the 20 to 25 most frequent of the 61 codons, and have a high codon bias (a codon bias close to 1), while a poorly expressed gene might use all 61 codons, and have little or no codon bias (a codon bias close to 0). It is thought that the frequently used codons are codons where larger amounts of the cognate tRNA are expressed, and that use of these codons allows translation to proceed more rapidly, or more accurately, or both. The PV capsid protein, for example, is very actively translated, and has a high codon bias.


Codon Pair Bias


In addition, a given organism has a preference for the nearest codon neighbor of a given codon A, referred to a bias in codon pair utilization. A change of codon pair bias, without changing the existing codons, can influence the rate of protein synthesis and production of a protein.


Codon pair bias may be illustrated by considering the amino acid pair Ala-Glu, which can be encoded by 8 different codon pairs. If no factors other than the frequency of each individual codon (as shown in Table 2) are responsible for the frequency of the codon pair, the expected frequency of each of the 8 encodings can be calculated by multiplying the frequencies of the two relevant codons. For example, by this calculation the codon pair GCA-GAA would be expected to occur at a frequency of 0.097 out of all Ala-Glu coding pairs (0.23×0.42; based on the frequencies in Table 2). In order to relate the expected (hypothetical) frequency of each codon pair to the actually observed frequency in the human genome the Consensus CDS (CCDS) database of consistently annotated human coding regions, containing a total of 14,795 human genes, was used. This set of genes is the most comprehensive representation of human coding sequences. Using this set of genes the frequencies of codon usage were re-calculated by dividing the number of occurrences of a codon by the number of all synonymous codons coding for the same amino acid. As expected the frequencies correlated closely with previously published ones such as the ones given in Table 2. Slight frequency variations are possibly due to an oversampling effect in the data provided by the codon usage database at Kazusa DNA Research Institute (http://www.kazusa.or.jp/codon/codon.html) where 84949 human coding sequences were included in the calculation (far more than the actual number of human genes). The codon frequencies thus calculated were then used to calculate the expected codon-pair frequencies by first multiplying the frequencies of the two relevant codons with each other (see Table 3 expected frequency), and then multiplying this result with the observed frequency (in the entire CCDS data set) with which the amino acid pair encoded by the codon pair in question occurs. In the example of codon pair GCA-GAA, this second calculation gives an expected frequency of 0.098 (compared to 0.097 in the first calculation using the Kazusa dataset). Finally, the actual codon pair frequencies as observed in a set of 14,795 human genes was determined by counting the total number of occurrences of each codon pair in the set and dividing it by the number of all synonymous coding pairs in the set coding for the same amino acid pair (Table 3; observed frequency). Frequency and observed/expected values for the complete set of 3721 (612) codon pairs, based on the set of 14,795 human genes, are provided herewith as Supplemental Table 1.









TABLE 3







Codon Pair Scores Exemplified by the Amino Acid


Pair Ala-Glu











amino acid
codon
expected
observed
obs/exp


pair
pair
frequency
frequency
ratio














AE
GCAGAA
0.098
0.163
1.65





AE
GCAGAG
0.132
0.198
1.51





AE
GCCGAA
0.171
0.031
0.18





AE
GCCGAG
0.229
0.142
0.62





AE
GCGGAA
0.046
0.027
0.57





AE
GCGGAG
0.062
0.089
1.44





AE
GCTGAA
0.112
0.145
1.29





AE
GCTGAG
0.150
0.206
1.37


Total

1.000
1.000









If the ratio of observed frequency/expected frequency of the codon pair is greater than one the codon pair is said to be overrepresented. If the ratio is smaller than one, it is said to be underrepresented. In the example the codon pair GCA-GAA is overrepresented 1.65 fold while the coding pair GCC-GAA is more than 5-fold underrepresented.


Many other codon pairs show very strong bias; some pairs are under-represented, while other pairs are over-represented. For instance, the codon pairs GCCGAA (AlaGlu) and GATCTG (AspLeu) are three- to six-fold under-represented (the preferred pairs being GCAGAG and GACCTG, respectively), while the codon pairs GCCAAG (AlaLys) and AATGAA (AsnGlu) are about two-fold over-represented. It is noteworthy that codon pair bias has nothing to do with the frequency of pairs of amino acids, nor with the frequency of individual codons. For instance, the under-represented pair GATCTG (AspLeu) happens to use the most frequent Leu codon, (CTG).


As discussed more fully below, codon pair bias takes into account the score for each codon pair in a coding sequence averaged over the entire length of the coding sequence. According to the invention, codon pair bias is determined by






CPB
=




i
=
1

k




CPSi

k
-
1


.






Accordingly, similar codon pair bias for a coding sequence can be obtained, for example, by minimized codon pair scores over a subsequence or moderately diminished codon pair scores over the full length of the coding sequence.


Calculation of Codon Pair Bias.


Every individual codon pair of the possible 3721 non-“STOP” containing codon pairs (e.g., GTT-GCT) carries an assigned “codon pair score,” or “CPS” that is specific for a given “training set” of genes. The CPS of a given codon pair is defined as the log ratio of the observed number of occurances over the number that would have been expected in this set of genes (in this example the human genome). Determining the actual number of occurrences of a particular codon pair (or in other words the likelyhood of a particular amino acid pair being encoded by a particular codon pair) is simply a matter of counting the actual number of occurances of a codon pair in a particular set of coding sequences. Determining the expected number, however, requires additional calculations. The expected number is calculated so as to be independent of both amino acid frequency and codon bias similarly to Gutman and Hatfield. That is, the expected frequency is calculated based on the relative proportion of the number of times an amino acid is encoded by a specific codon. A positive CPS value signifies that the given codon pair is statistically over-represented, and a negative CPS indicates the pair is statistically under-represented in the human genome.


To perform these calculations within the human context, the most recent Consensus CDS (CCDS) database of consistently annotated human coding regions, containing a total of 14,795 genes, was used. This data set provided codon and codon pair, and thus amino acid and amino-acid pair frequencies on a genomic scale.


The paradigm of Federov et al. (2002), was used to further enhanced the approach of Gutman and Hatfield (1989). This allowed calculation of the expected frequency of a given codon pair independent of codon frequency and non-random associations of neighboring codons encoding a particular amino acid pair.







S


(

P
ij

)


=


ln
(



N
O



(

P
ij

)




N
E



(

P
ij

)



)

=

ln
(



N
O



(

P
ij

)




F


(

C
i

)




F


(

C
j

)





N
O



(

X
ij

)




)






In the calculation, Pij is a codon pair occurring with a frequency of NO(Pij) in its synonymous group. Ci and Cj are the two codons comprising Pij, occuring with frequencies F(Ci) and F(Cj) in their synonymous groups respectively. More explicitly, F(Ci) is the frequency that corresponding amino acid Xi is coded by codon Ci throughout all coding regions and F(Ci)=NO(Ci)/NO(Xi), where NO(Ci) and NO(Xi) are the observed number of occurrences of codon Ci and amino acid Xi respectively. F(Cj) is calculated accordingly. Further, NO(Xij) is the number of occurrences of amino acid pair Xij throughout all coding regions. The codon pair bias score S(Pij) of Pij was calculated as the log-odds ratio of the observed frequency No(Pij) over the expected number of occurrences of Ne(Pij).


Using the formula above, it was then determined whether individual codon pairs in individual coding sequences are over- or under-represented when compared to the corresponding genomic Ne(Pij) values that were calculated by using the entire human CCDS data set. This calculation resulted in positive S(Pij) score values for over-represented and negative values for under-represented codon pairs in the human coding regions (FIG. 7).


The “combined” codon pair bias of an individual coding sequence was calculated by averaging all codon pair scores according to the following formula:







S


(

P
ij

)


=




l
=
1

k






S


(
Pij
)



l


k
-
1


.






The codon pair bias of an entire coding region is thus calculated by adding all of the individual codon pair scores comprising the region and dividing this sum by the length of the coding sequence.


Calculation of Codon Pair Bias, Implementation of Algorithm to Alter Codon-Pair Bias.


An algorithm was developed to quantify codon pair bias. Every possible individual codon pair was given a “codon pair score”, or “CPS”. CPS is defined as the natural log of the ratio of the observed over the expected number of occurrences of each codon pair over all human coding regions, where humans represent the host species of the instant vaccine virus to be recoded.






CPS
=

ln
(



F


(
AB
)



o





F


(
A
)


×

F


(
B
)





F


(
X
)


×

F


(
Y
)




×

F


(
XY
)




)





Although the calculation of the observed occurences of a particular codon pair is straightforward (the actual count within the gene set), the expected number of occurrences of a codon pair requires additional calculation. We calculate this expected number to be independent both of amino acid frequency and of codon bias, similar to Gutman and Hatfield. That is, the expected frequency is calculated based on the relative proportion of the number of times an amino acid is encoded by a specific codon. A positive CPS value signifies that the given codon pair is statistically over-represented, and a negative CPS indicates the pair is statistically under-represented in the human genome


Using these calculated CPSs, any coding region can then be rated as using over- or under-represented codon pairs by taking the average of the codon pair scores, thus giving a Codon Pair Bias (CPB) for the entire gene.






CPB
=




i
=
1

k



CPSi

k
-
1







The CPB has been calculated for all annotated human genes using the equations shown and plotted (FIG. 4). Each point in the graph corresponds to the CPB of a single human gene. The peak of the distribution has a positive codon pair bias of 0.07, which is the mean score for all annotated human genes. Also there are very few genes with a negative codon pair bias. Equations established to define and calculate CPB were then used to manipulate this bias.


Algorithm for Reducing Codon-Pair Bias.


Recoding of protein-encoding sequences may be performed with or without the aid of a computer, using, for example, a gradient descent, or simulated annealing, or other minimization routine. An example of the procedure that rearranges codons present in a starting sequence can be represented by the following steps:


1) Obtain wildtype viral genome sequence.


2) Select protein coding sequences to target for attenuated design.


3) Lock down known or conjectured DNA segments with non-coding functions.


4) Select desired codon distribution for remaining amino acids in redesigned proteins.


5) Perform random shuffle of at least two synonymous unlocked codon positions and calculate codon-pair score.


6) Further reduce (or increase) codon-pair score optionally employing a simulated annealing procedure.


7) Inspect resulting design for excessive secondary structure and unwanted restriction site:

    • if yes—>go to step (5) or correct the design by replacing problematic regions with wildtype sequences and go to step (8).
    • 8. Synthesize DNA sequence corresponding to virus design.
    • 9. Create viral construct and assess viral phenotype:


if too attenuated, prepare subclone construct and go to 9; if insufficiently attenuated, go to 2.


Attenuation of viruses by reducing codon pair bias is disclosed in WO 2008/121992 and WO 2011/044561, which are incorporated by reference.


Attenuated Influenza Viruses


According to the invention, viral attenuation is accomplished by reducing expression of HA and NA coding sequences. One way to reduce expression of the coding sequences is by a reduction in codon pair bias, but other methods can also be used, alone or in combination. While codon bias may be changed, adjusting codon pair bias is particularly advantageous. For example, attenuating a virus through codon bias generally requires elimination of common codons, and so the complexity of the nucleotide sequence is reduced. In contrast, codon pair bias reduction or minimization can be accomplished while maintaining far greater sequence diversity, and consequently greater control over nucleic acid secondary structure, annealing temperature, and other physical and biochemical properties.


Codon pair bias of a protein-encoding sequence (i.e., an open reading frame) is calculated as set forth above and described in Coleman et al., 2000 (ref. 12).


Viral attenuation and induction or protective immune responses can be confirmed in ways that are well known to one of ordinary skill in the art, including but not limited to, the methods and assays disclosed herein. Non-limiting examples include plaque assays, growth measurements, reduced lethality in test animals, and protection against subsequent infection with a wild type virus.


In preferred embodiments, the invention provides viruses that are highly attenuated, and induce immunity against a plurality of influenza types and/or subtypes. Such flu varieties include viruses bearing all possible HA-NA combinations. Currently, there are 16 recognized hemagglutinins and nine neuraminidases, each of which has mutational variants. Examples of type A subtypes include, but are not limited to, H10N7, H10N1, H10N2, H10N3, H10N4, H10N5, H10N6, H10N7, H10N8, H10N9, H11N1, H11N2, H11N3, H11N4, H11N6, H11N8, H11N9, H12N1, H12N2, H12N4, H12N5, H12N6, H12N8, H12N9, H13N2, H13N3, H13N6, H13N9, H14N5, H14N6, H15N2, H15N8, H15N9, H16N3, H1N1, H1N2, H1N3, H1N5, H1N6, H1N8, H1N9, H2N1, H2N2, H2N3, H2N4, H2N5, H2N6, H2N7, H2N8, H2N9, H3N1, H3N2, H3N3, H3N4, H3N5, H3N6, H3N8, H3N9, H4N1, H4N2, H4N3, H4N4, H4N5, H4N6, H4N7, H4N8, H4N9, H5N1, H5N2, H5N3, H5N4, H5N6, H5N7, H5N8, H5N9, H6N1, H6N2, H6N3, H6N4, H6N5, H6N6, H6N7, H6N8, H6N9, H7N1, H7N2, H7N3, H7N4, H7N5, H7N7, H7N8, H7N9, H8N2, H8N4, H8N5, H9N1, H9N2, H9N3, H9N4, H9N5, H9N6, H9N7, H9N8, H9N9. Some subtypes of interest include, but are not limited to, H1N1 (one variant of which caused Spanish flu in 1918, another of which is pandemic in 2009), H2N2 (a variant of which caused Asian Flu in 1957), H3N2 (a variant of which caused Hong Kong Flu in 1968, H5N1 (a current pandemic threat), H7N7 (which has unusual zoonotic potential), and H1N2 (endemic in humans and pigs). Examples of attenuated influenza protein coding sequences are provided below.









TABLE 4







Reduced-Expression Influenza A Virus Genes










WT Coding Sequence
Recoded Coding Sequence














SEQ ID


SEQ ID
Recoded



Gene
NO:
CDS
CPB
NO
Codons
CPB










H10N7 (A/northern shoveler/California/HKWF392sm/2007)(Avian)













HA
1
1-1683
0.018
2
1-561
−0.441


NA
3
1-1494
0.009
4
1-498
−0.449







H1N1 (A/New York/3568/2009)(Human)













HA
5
1-1698
0.043
6
1-566
−0.410


NA
7
1-1407
0.005
8
1-469
−0.456







H1N2 (A/New York/211/2003)(Human)













HA
9
1-1695
0.036
10
1-565
−0.421


NA
11
1-1407
0.034
12
1-469
−0.476







H2N2 (A/Albany/22/1957)(Human)













HA
13
1-1686
0.040
14
1-562
−0.422


NA
15
1-1407
0.008
16
1-469
−0.453







H3N2 (A/New York/933/2006)(Human)













HA
17
1-1698
0.027
18
1-566
−0.447


NA
19
1-1407
0.041
20
1-469
−0.463







H5N1 (A/Jiangsu/1/2007)(Human)













HA
21
1-1701
0.017
22
1-567
−0.435


NA
23
1-1347
0.009
24
1-449
−0.407







H7N2 (A/chicken/NJ/294508-12/2004)(Avian)













HA
25
1-1656
0.036
26
1-552
−0.377


NA
27
1-1359
0.013
28
1-453
−0.491







H7N3 (A/Canada/rv504/2004)(Human)













HA
29
1-1701
0.029
30
1-567
−0.405


NA
31
1-1407
0.042
32
1-469
−0.413







H7N7 (A/Netherlands/219/03)(Human)













HA
33
1-1707
0.008
34
1-569
−0.447


NA
35
1-1413
−0.009
36
1-471
−0.423







H9N2 (A/Hong Kong/1073/99)(Human)













HA
37
1-1680
0.021
38
1-560
−0.440


NA
39
1-1401
0.020
40
1-467
−0.453









Vaccine Compositions


The present invention provides a vaccine composition for inducing a protective immune response in a subject comprising any of the attenuated viruses described herein and a pharmaceutically acceptable carrier.


It should be understood that an attenuated virus of the invention, where used to elicit a protective immune response in a subject or to prevent a subject from becoming afflicted with a virus-associated disease, is administered to the subject in the form of a composition additionally comprising a pharmaceutically acceptable carrier. Pharmaceutically acceptable carriers are well known to those skilled in the art and include, but are not limited to, one or more of 0.01-0.1M and preferably 0.05M phosphate buffer, phosphate-buffered saline (PBS), or 0.9% saline. Such carriers also include aqueous or non-aqueous solutions, suspensions, and emulsions. Aqueous carriers include water, alcoholic/aqueous solutions, emulsions or suspensions, saline and buffered media. Examples of non-aqueous solvents are propylene glycol, polyethylene glycol, vegetable oils such as olive oil, and injectable organic esters such as ethyl oleate. Parenteral vehicles include sodium chloride solution, Ringer's dextrose, dextrose and sodium chloride, lactated Ringer's and fixed oils. Intravenous vehicles include fluid and nutrient replenishers, electrolyte replenishers such as those based on Ringer's dextrose, and the like. Solid compositions may comprise nontoxic solid carriers such as, for example, glucose, sucrose, mannitol, sorbitol, lactose, starch, magnesium stearate, cellulose or cellulose derivatives, sodium carbonate and magnesium carbonate. For administration in an aerosol, such as for pulmonary and/or intranasal delivery, an agent or composition is preferably formulated with a nontoxic surfactant, for example, esters or partial esters of C6 to C22 fatty acids or natural glycerides, and a propellant. Additional carriers such as lecithin may be included to facilitate intranasal delivery. Pharmaceutically acceptable carriers can further comprise minor amounts of auxiliary substances such as wetting or emulsifying agents, preservatives and other additives, such as, for example, antimicrobials, antioxidants and chelating agents, which enhance the shelf life and/or effectiveness of the active ingredients. The instant compositions can, as is well known in the art, be formulated so as to provide quick, sustained or delayed release of the active ingredient after administration to a subject.


In various embodiments of the instant vaccine composition, the attenuated virus (i) does not substantially alter the synthesis and processing of viral proteins in an infected cell; (ii) produces similar amounts of virions per infected cell as wt virus; and/or (iii) exhibits substantially lower virion-specific infectivity than wt virus. In further embodiments, the attenuated virus induces a substantially similar immune response in a host animal as the corresponding wt virus.


This invention also provides a modified host cell line specially isolated or engineered to be permissive for an attenuated virus that is inviable in a wild type host cell. Since the attenuated virus cannot grow in normal (wild type) host cells, it is absolutely dependent on the specific helper cell line for growth. This provides a very high level of safety for the generation of virus for vaccine production. Various embodiments of the instant modified cell line permit the growth of an attenuated virus, wherein the genome of said cell line has been altered to increase the number of genes encoding rare tRNAs.


In addition, the present invention provides a method for eliciting a protective immune response in a subject comprising administering to the subject a prophylactically or therapeutically effective dose of any of the vaccine compositions described herein. This invention also provides a method for preventing a subject from becoming afflicted with a virus-associated disease comprising administering to the subject a prophylactically effective dose of any of the instant vaccine compositions. In embodiments of the above methods, the subject has been exposed to a pathogenic virus. “Exposed” to a pathogenic virus means contact with the virus such that infection could result.


The invention further provides a method for delaying the onset, or slowing the rate of progression, of a virus-associated disease in a virus-infected subject comprising administering to the subject a therapeutically effective dose of any of the instant vaccine compositions.


As used herein, “administering” means delivering using any of the various methods and delivery systems known to those skilled in the art. Administering can be performed, for example, intranasally, intraperitoneally, intracerebrally, intravenously, orally, transmucosally, subcutaneously, transdermally, intradermally, intramuscularly, topically, parenterally, via implant, intrathecally, intralymphatically, intralesionally, pericardially, or epidurally. An agent or composition may also be administered in an aerosol, such as for pulmonary and/or intranasal delivery. Administering may be performed, for example, once, a plurality of times, and/or over one or more extended periods.


Eliciting a protective immune response in a subject can be accomplished, for example, by administering a primary dose of a vaccine to a subject, followed after a suitable period of time by one or more subsequent administrations of the vaccine. A suitable period of time between administrations of the vaccine may readily be determined by one skilled in the art, and is usually on the order of several weeks to months. The present invention is not limited, however, to any particular method, route or frequency of administration.


A “subject” means any animal or artificially modified animal. Animals include, but are not limited to, humans, non-human primates, cows, horses, sheep, pigs, dogs, cats, rabbits, ferrets, rodents such as mice, rats and guinea pigs, and birds. Artificially modified animals include, but are not limited to, SCID mice with human immune systems, and CD155tg transgenic mice expressing the human poliovirus receptor CD155. In a preferred embodiment, the subject is a human. Preferred embodiments of birds are domesticated poultry species, including, but not limited to, chickens, turkeys, ducks, and geese.


A “prophylactically effective dose” is any amount of a vaccine that, when administered to a subject prone to viral infection or prone to affliction with a virus-associated disorder, induces in the subject an immune response that protects the subject from becoming infected by the virus or afflicted with the disorder. “Protecting” the subject means either reducing the likelihood of the subject's becoming infected with the virus, or lessening the likelihood of the disorder's onset in the subject, by at least two-fold, preferably at least ten-fold. For example, if a subject has a 1% chance of becoming infected with a virus, a two-fold reduction in the likelihood of the subject becoming infected with the virus would result in the subject having a 0.5% chance of becoming infected with the virus. Most preferably, a “prophylactically effective dose” induces in the subject an immune response that completely prevents the subject from becoming infected by the virus or prevents the onset of the disorder in the subject entirely.


As used herein, a “therapeutically effective dose” is any amount of a vaccine that, when administered to a subject afflicted with a disorder against which the vaccine is effective, induces in the subject an immune response that causes the subject to experience a reduction, remission or regression of the disorder and/or its symptoms. In preferred embodiments, recurrence of the disorder and/or its symptoms is prevented. In other preferred embodiments, the subject is cured of the disorder and/or its symptoms.


Certain embodiments of any of the instant immunization and therapeutic methods further comprise administering to the subject at least one adjuvant. An “adjuvant” shall mean any agent suitable for enhancing the immunogenicity of an antigen and boosting an immune response in a subject. Numerous adjuvants, including particulate adjuvants, suitable for use with both protein- and nucleic acid-based vaccines, and methods of combining adjuvants with antigens, are well known to those skilled in the art. Suitable adjuvants for nucleic acid based vaccines include, but are not limited to, Quil A, imiquimod, resiquimod, and interleukin-12 delivered in purified protein or nucleic acid form. Adjuvants suitable for use with protein immunization include, but are not limited to, alum, Freund's incomplete adjuvant (FIA), saponin, Quil A, and QS-21.


The invention also provides a kit for immunization of a subject with an attenuated virus of the invention. The kit comprises the attenuated virus, a pharmaceutically acceptable carrier, an applicator, and an instructional material for the use thereof. In further embodiments, the attenuated virus may be one or more poliovirus, one or more rhinovirus, one or more influenza virus, etc. More than one virus may be preferred where it is desirable to immunize a host against a number of different isolates of a particular virus. The invention includes other embodiments of kits that are known to those skilled in the art. The instructions can provide any information that is useful for directing the administration of the attenuated viruses.


Throughout this application, various publications, reference texts, textbooks, technical manuals, patents, and patent applications have been referred to. The teachings and disclosures of these publications, patents, patent applications and other documents in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which the present invention pertains. However, the citation of a reference herein should not be construed as an acknowledgement that such reference is prior art to the present invention.


It is to be understood and expected that variations in the principles of invention herein disclosed can be made by one skilled in the art and it is intended that such modifications are to be included within the scope of the present invention. The following Examples further illustrate the invention, but should not be construed to limit the scope of the invention in any way. Detailed descriptions of conventional methods, such as those employed in the construction of recombinant plasmids, transfection of host cells with viral constructs, polymerase chain reaction (PCR), and immunological techniques can be obtained from numerous publications, including Sambrook et al. (1989) and Coligan et al. (1994). All references mentioned herein are incorporated in their entirety by reference into this application. The contents of WO 2008/121992 and WO 2011/044561 are incorporated by reference.


EXAMPLES
Example 1
Construction and Characterization of an HA and NA Codon Pair-Bias Reduced Influenza Virus in Tissue Culture

To achieve attenuation of influenza virus PR8, codon pair bias was reduced (introducing underrepresented codon pairs) in viral genes HA and NA according to computer algorithms (12, 13) and chemical synthesis (14), in order to reduce the expression level of the targeted viral genes.


Cells and viruses. MDCK, A549 and HEK293 T cell lines were maintained in DMEM supplemented with 10% FBS at 37° C. Influenza A/PR/8/34 (PR8) was cultured in MDCK cells.


Variant (NA+HA)Min (618/3188 nt changes), combining the HAMin (SEQ ID NO:53) and NAMin (SEQ ID NO:60) genes, expressed growth and plaque phenotypes in MDCK cells comparable to those of the individual HAMin and NAMin variants (FIG. 1B, C). Similarly, a variant with a codon-pair bias reduced NA gene (NAMin, 265/1413 synonymous mutations; FIG. 1A) also replicated well in MDCK cells (FIG. 1C) and expressed an only slightly smaller plaque size phenotype (FIG. 1B) than wt PR8. In A549 cells the (NA+HA)Min variant was highly attenuated (FIG. 1D), growing to a final titer three to four orders of magnitudes lower than wt PR8. A549 cells retain a complex signaling network that is related to the innate host response (15, 16).


Example 2
Levels of NA mRNA and HA Protein are Reduced in (NA+HA)Min-Infected Cells

The apparent yield of HA polypeptide was examined by western blotting in MDCK cells at 3 h and 6 h post infection (p.i.) with 5 MOI of wt virus or (NA+HA)Min. Remarkably, at 6 h p.i., expression of HA protein was significantly reduced in (NA+HA)Min-infected cells when compared to PR8-infected cells whereas PB1 and NS1 were synthesized to equal levels by viruses (FIG. 2A). Using the levels of PB1 and GAPDH mRNAs as control, the Northern blot analysis of mRNA levels in (NA+HA)Min-infected cells indicated only a slight reduction of HAMin mRNA at 3 h and 6 h (FIG. 2B).


In contrast, Northern blot analyses indicated an extensive reduction of the recoded NAMin mRNA after 6 h and particularly after 9 h p.i. (FIG. 2B). Early in infection (3 h), the level of NAMin mRNA was slightly reduced.


Example 3
Characterization of the Reduced Codon-Pair Bias Variants as Vaccine Candidates in Mice

The growth phenotype and pathogenesis of the (NA+HA)Min variant was examined in an animal model. Groups of five BALB/c mice received (NA+HA)Min at doses of 104, 105 or 106 PFU intra-nasally, and body weight and survival of the animals was monitored continuously for 14 days p.i. (FIG. 3A, B). Morbidity and mortality (weight loss, reduced activity, death) was monitored. The Lethal Dose 50 (LD50) of the wildtype virus and the vaccine candidates was calculated by the method of Reed and Muench (Reed, L. J.; Muench, H., 1938, The American Journal of Hygiene 27: 493-497). Remarkably, the (NA+HA)Min variant did not induce apparent disease after a dose up to 105 PFU. Even at 106 PFU, mice only suffered transient weight loss, but all animals survived. Therefore, the theoretical LD50 of the (NA+HA)Min variant was calculated to be equal or greater than 3.16×106 PFU, which exceeds that of wt PR8 by a factor of at least 100,000 (Table 1).


Whereas the (NA+HA)Min, HAMin, and NAMin variants replicated with nearly equal efficiency and similar kinetics as wt PR8 in MDCK cells (FIG. 1C), the LD50 of the variants were by orders of magnitude different: PR8=32 PFU, HAMin=1.7×103PFU (13), NAMin=2.4×105 PFU (FIG. 7, Table 5), and (NA+HA)Min>3.3×106. By itself, the NAMin gene is about 100-fold more attenuated than the HAMin gene, but reducing expression of NA and NP in the same virus significantly increases attenuation of the virus.









TABLE 5







LD50 and PD50 of Attenuated Virus










LD50
PD50















WT PR8
3.2 × 101
~1



NAMin
2.4 × 105
<32



HAMin
1.7 × 103
n.d.



(NA + HA)Min
>3.3 × 106
2.4










Vaccine candidates should be capable of providing, at low dose, long-term protection from challenge with a lethal dose of wt virus. The dose of (NA+HA)Min required to protect 50% of vaccinated animals from subsequent lethal wild type challenge (defined as “protective dose 50”, PD50) was determined. Groups of five Balb/c mice were vaccinated with a single dose of 100, 101, or 102 PFU of (NA+HA)Min. 28 days after vaccination, the animals were challenged with 105 PFU (3000×LD50) of wt PR8 virus. As with the original infections, we monitored body weight and survival of the animals 14 days after challenge. Remarkably, although (NA+HA)Min was highly attenuated in mice, it was also highly proficient at protecting against lethal challenge with wt virus. As little as 10 PFU of (NA+HA)Min protected all five mice from lethal challenge (FIGS. 3C, 3D). The PD50 value calculated by the method of Reed-Muench was only 2.4 PFU. (Table 5) To our knowledge this is the lowest reported protective dose of an experimental vaccine in a mouse model.


Vaccine safety and protective range was evaluated with various doses of either (NA+HA)Min variant or wt PR8. As shown in FIG. 3E, a zone of five orders of magnitude (from 10 PFU to 106 PFU) can be considered the “region of safety” of (NA+HA)Min vaccination since all mice receiving increasing doses of “vaccine” within this region were protected from lethal challenge with wt virus. In contrast, the safe and effective region for wt PR8 was extremely limited (FIG. 3F).


Example 4
The Growth of (NA+HA)Min is Greatly Reduced in the Lungs of Vaccinated Mice

To determine parameters of the (NA+HA)Min pathogenicity in vivo, groups of BALB/c mice were infected with 104 PFU of wt PR8 or (NA+HA)Min. On day 1, 3, 5, 7, 9 and 11, three mice each from the wt and (NA+HA)Min groups were euthanized, their lungs were homogenized, and virus titers in the homogenates were determined by plaque assays. As expected, wt PR8 replicated well, but even (NA+HA)Min replicated noticeably in lungs of the vaccinated animals. Both PR8 and variant achieved maximum titers around day 3 (FIG. 4A) although there was a ˜100 fold difference in the titers between the two viruses. All wt PR8-infected mice died on day 5, whereas all (NA+HA)Min-infected mice remained healthy. (NA+HA)Min was eventually cleared at 8 to 9 days p.i. (FIG. 4A). When mice were inoculated at different doses, the (NA+HA)Min titers were always 100-1000 fold lower in lungs when compare to those of wt PR8 on day 3 p.i. (FIG. 4B). Strikingly, at a vaccination dose of 10 PFU when (NA+HA)Min barely replicated in the lungs of the animals, it nevertheless provided complete protection against wt PR8 challenge (FIGS. 4B and 3D). Interestingly, the attenuation of (NA+HA)Min in mice correlates with the attenuation of (NA+HA)Min in A549 cells (FIG. 1D).


Example 5
Cross Protection and Long Term Protection Induced by the (NA+HA)Min Variant

The (NA+HA)Min variant of PR8, which belongs to the influenza H1N1 subtype, was further tested for its capacity to cross protect animals against infections with a heterologous influenza virus strain, such as a mouse adapted H3N2 strain (A/Aichi/2/1968) (21). Groups of five BALB/c mice were vaccinated with (NA+HA)Min virus at doses ranging from 102 to 104 PFU and challenged 28 days post vaccination with 100×LD50 doses of A/Aichi/2/1968 (H3N2) virus (1.5×104 PFU). Remarkably, 1000 PFU of (NA+HA)Min were sufficient to protect mice from the heterologous lethal challenge, corresponding to a PD50 value of only 237 PFU (FIGS. 5A, 5B). A similar result was obtained when the vaccinated (NA+HA)Min mice were challenged with a different strain of mouse adapted H3N2, A/Victoria/3/75. Again, as little as 1000 PFU of the H1N1 PR8-(NA+HA)Min variant protected all mice from lethal challenge with 100×LD50 dose (3.2×104 PFU) of A/Victoria/3/75. The PD50 of (NA+HA)Min protecting against A/Victoria/3/75 (H3N2) was only 147 PFU (FIGS. 5C, 5D). Both results indicate that (NA+HA)Min of H1N1 PR8 can induce a robust cross protective immune response in mice against H3N2 subtypes.


(NA+HA)Min-vaccinated animals were tested to determine whether they were protected against challenge after an extended period of time. Groups of five mice were vaccinated with different doses (101 to 105 PFU) of (NA+HA)Min and the animals were challenged seven months later with 105 PFU of wt PR8. All vaccinated animals were completely protected without signs of disease (FIG. 8).


Example 6
The (NA+HA)Min Variant Induces a Robust Antibody Response

The host response to (NA+HA)Min inoculation suggested a strong host response, including adaptive immunity. Groups of five Balb/c mice were vaccinated with varying doses of (NA+HA)Min or wt PR8 (see FIG. 6). Sera were collected on day 28 p.i., and antibody responses were determined by hemagglutination inhibition (HAI) assays performed according to the protocol in the WHO Manual on Animal Influenza Diagosis and Surveillance (23). The mice were challenged with a lethal dose of PR8 (105 PFU). An HAI titer of 40 or more in the serum is generally considered to be protective (22). This level was reached with just 101 PFU of (NA+HA)Min (FIG. 6) and protected vaccinated mice from challenge with 105 PFU wt PR8 virus (FIG. 6).


Example 7
Virus Composition

Both WT and (NA+HA)Min virus were purified by sucrose gradient. 5×107 PFU of both viruses were loaded onto SDS gels followed by Commassie blue stain (0.1% Coomassie blue R250 for 45 min.) (FIG. 9A) or silver stain (Bio-Rad silver stain kit) (FIG. 9B and C) to detect virion protein composition. At the same PFU, WT virions contain more HA1 molecues than the (NA+HA)Min virus, while the latter contains more M1 proteins.


WT and (NA+HA)Min virus were also analyzed by Western blot. 2×107 PFU of WT and (NA+HA)Min viruses were loaded onto SDS-PAGE gels and analyzed for content of PB1, NP, HA2, and M1. At the same PFU of purified virions, the virus preparations have similar amounts of NP and PB1 protein. Purified WT virions, however, have more HA2 protein, while purified (NA+HA)Min virions have more M1 protein. (FIG. 9D).


Example 8
Expression of Virus Proteins and mRNAs in Infected MDCK Cells

HA protein expression was measured by 35S methionine incorporation. MDCK cells were infected with 10 MOI wild type PR8, or (NA+HA)Min virus. At 3 h post infection, cells were starved for 45 min, and then labeled for 30 min. Following cell lysis, equal amounts of cell lysates were resolved by SDS PAGE and labeled proteins were visualized by autoradiography. Expression of the HA protein is notably reduced relative to other viral proteins in (NA+HA)Min virus-infected cells. (FIG. 10A).


Viral mRNA in virus infected MDCK cells nucleus was analyzed by Northern blot. MDCK cells were infected with both WT and (NA+HA)Min viruses at an MOI of 1. At 6 h, and 9 h post infection, cells were lysed using Life Technologies PARIS Kit. Nucleus and cytoplasmic portions were separated and mRNA were extracted from both portions. Northern blotting was performed using isolated mRNAs. The nuclear NP mRNA signals were relatively similar between WT and (NA+HA)Min virus infected cells at all time points. Yet, WT virus infected cells, compared to (NA+HA)Min viruses infected cells, contained more nuclear HA and NA mRNA, and less nuclear PB1 mRNA. (FIG. 10B)


Example 9
Passive Immunization by Serum Transfer from PR8-(NA+HA)Min Vaccinated Mice Protects Naïve Mice from Homologous WT PR8 Challenge

Groups of five Balb/C mice were vaccinated with 104 PFU (NA+HA)Min virus or PBS. 28 days after vaccination mouse sera were collected, and transferred to five naïve Balb/C mice in a volume of 250 ul. 24 h post transfer, mice were challenged with 105 PFU of WT PR8, corresponding to 3000×LD50. All passively immunized mice survived and remained healthy upon challenge, while mock transferred mice died in 8 days. These results suggest that antibodies are the major mediator of immune protection induced by (NA+HA)Min virus vaccination. (FIG. 11).


Example 10
Passive Immunization by Serum Transfer From PR8-(NA+HA)Min Vaccinated Mice Protects Naïve Mice From Heterologous H3N2 Challenge

Groups of five Balb/C mice were infected with 3×105 PFU H1N1-(NA+HA)Min virus or PBS. On day 28, all mice were euthanized and their blood was collected. Sera were prepared on the same day and immediately transferred to groups of five naïve Balb/c mice (i.p injection with 250 μl of sera). 24 h post transfer, mice were challenged with 10×LD50 of H1N1-WT PR8, H3N2 Aichi or H3N2 Victoria viruses. Their body weights (FIG. 12A) and survival rates (FIG. 12B) were monitored for 14 days post infection. 60% of sera transferred mice were protected from lethal H3N2 Aichi challenge, and survival times upon challenge of lethal H3N2 Victoria virus were extended.


Example 11
Cross Protection

Cross protection was investigated by assay of hemagglutination inhibition and neutralization. To determine inhibition of hemagglutination, groups of five Balb/C mice were vaccinated with 102-104 PFU of H1N1-(NA+HA)Min virus. Sera were collected on day 28 p.i. Hemagglutination inhibition assays were performed by incubating the serum with H1N1 PR8, H3N2 Aichi or H3N2 Victoria virues. (FIG. 13A). H1N1-(NA+HA)Min virus infected mice contain abundant anti-H1N1 HA antibodies with a HAI titer from 100-640. The sera, however, do not contain much of the anti-H3N2 HA antibodies, since the HAI titer are 40 regardless of the vaccine dose. This data suggests that survival of (NA+HA)Min virus-vaccinated mice from heterologous challenge (as illustrated in Example 5) is mainly due to immunity not correlated with antibodies, such as cellular immunity.


To test neutralization, MDCK cells were seeded onto 96 well plate on day 0. 2 fold dilutions of sera from vaccinated mice were incubated with 100 TCID50 viruses for 1 h and then added to pre-seeded MDCK cells on day 1. Cells were stained with crystal violet on day 4 to determine neutralization titers.


Groups of five Balb/C mice were vaccinated with 105 PFU of H1N1-(NA+HA)Min virus. Sera were collected on day 28 p.i. Neutralization assays were performed by incubating the sera with H1N1 PR8, H3N2 Aichi or H3N2 Victoria viruses. H1N1-(NA+HA)Min virus infected mice were capable of neutralizing H1N1 PR8 with a neutralization titers above 1200. The sera, interestingly, were also able to neutralize H3N2 viruses. (FIG. 13B).


Example 12
Neuraminidase Encoded by (NA+HA)Min

Viral neuraminidase cleaves terminal sialic acid residues from glycan structures on the surface of an infected cell, which promotes the release of progeny viruses. MDCK cells and MDCK-SIAT1 cells which overexpress overexpressing the α-2,6-Sialyltransferase, were infected with WT or (NA+HA)Min viruses at MOI of 0.01. Virus titers were examined at 48 h p.i. In MDCK-SIAT1 cells, which overexpressed influenza receptor sialic acid, both WT and (NA+HA)Min viruses grew better than MDCK cell lines. (FIG. 14). This indicates that (NA+HA)Min virus comprises neuraminidase molecles encoded by NAMin that cleave sialic acid residues normally.


Example 13
T and B Cell Responses in Lungs and Spleen

T cell responses in lungs. Groups of five Balb/C mice were with 10 PFU of WT (a dose close the LD50 of this virus) or 10 PFU (NA+HA)Min (a dose over 300,000-fold below the LD50 for this virus). On day 7 post infection, mice were euthanized and their lungs were collected for flow cytometry. (NA+HA)Min infected mice showed lower numbers of CD4+T and CD8+T cells than WT-infected mice, since (NA+HA)Min infection is cleared by 7 days, while WT infection is still ongoing. (FIG. 15).


B cell responses in lungs. Groups of five Balb/C mice were infected with 10 PFU of WT or (NA+HA)Min viruses. On day 7 post infection, mice were euthanized and their lungs were collected for flow cytometry. WT infected mice showed higher numbers of B cells than both the (NA+HA)Min viruses and the mock group, indicating the WT viruses were much harder to clear than the other two. Yet, the percentage of CD45+ B cells in (NA+HA)Min virus infected mice were similar, or slightly higher, than the WT PR8 infected mice, which indicates they share similar ability in inducing long term protective antibodies. (FIG. 16)


T cell responses in spleen. Groups of five Balb/C mice were infected with 10 PFU of WT or (NA+HA)Min viruses. On day 7 post infection, mice were euthanized and their spleens were collected for flow cytometry. Both WT and (NA+HA)Min virus infected mice showed higher number of CD4+T and CD8+T cells than the mock group, indicating a strong adaptive immune responses triggered by both viruses. (FIG. 17).


B cell responses in spleen. Groups of five Balb/C mice were infected with 10 PFU of WT or (NA+HA)Min viruses. On day 7 post infection, mice were euthanized and their spleens were collected for flow cytometry. (NA+HA)Min infected mice showed significantly higher numbers of B cells than mock group, indicating (NA+HA)Min virus is highly efficient in inducing protective antibodies. (FIG. 18).


In summary, at 7 days post infection, the response to WT virus in lung tissue involved greater numbers of CD4+T, CD8+T and B cells to clear the viruses than the response to (NA+HA)Min. In spleen, (NA+HA)Min and WT infected mice both showed elevated T and B cells, indicating strong adaptive immune responses. Also, the T cell proportion of cells in spleen responding to infection by (NA+HA)Min was higher than the proportion responding to infection by WT virus. (FIG. 17).


Example 14
Flow Cytometry Analyses of Immune Cells Infiltrating Lung Tissue

Groups of five male Balb/C mice received 104 PFU wild type PR8 (a lethal dose equal to 300-fold the LD50 for this virus), 104 PFU (NA+HA)Min (a safe dose at least 300-fold below the LD50 for this virus), or PBS. Note: A the chosen dose of 104 PFU wild type PR8-infected mice invariably sucumb to the infection between 4 and 9 days. On day 3 post infection, lungs were collected and flow cytometry analyses were performed. FIG. 19 shows the results for various immune cells as follows: (A) CD45+ leukocytes, (B) CD45+ Ly6Ghigh polymorphonuclear leukocytes (PMN), (C) CD45+CD11c+ I-Ad+ F4/80 dendritic cells, (D) CD45+ NKp46+ natural killer cells, (E) CD45+CD11b+Ly6ChighLy6G inflammatory monocytes, (F) CD45+ I-Ad+ F4/80+ macrophages, (G) CD45+CD3+CD4+ T helper cells, (H) CD45+ CD19+ B cells, and (I) CD45+CD19+IgM+ B cells were monitored. Most notably (NA+HA)Min infection induced a significantly higher amount of natural killer cells, implicated in viral clearance, as well as a reduced infiltration of PMN, which are known to be associated with immune induced lung damage following natural influenza virus infection. Thus the marked lack of PMN infiltration during (NA+HA)Min infection may explain the high degree of attenuation (i.e the absence of virus induced disease and pathology) of (NA+HA)Min.


REFERENCES



  • 1. Thompson, W. W., Comanor, L., & Shay, D. K. (2006) Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J. Infect. Dis. 194 Suppl 2:S82-91.

  • 2. Smith, D. J., et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305(5682):371-376.

  • 3. Bouvier, N. M. & Palese, P. (2008) The biology of influenza viruses. Vaccine 26 Suppl. 4:D49-53.

  • 4. Simonsen, L., et al. (2005) Impact of influenza vaccination on seasonal mortality in the U.S. elderly population. Arch. Intern. Med. 165(3):265-272.

  • 5. Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 12(1):36-44.

  • 6. Belshe, R. B., et al. (2007) Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J Med. 356(7):685-696.

  • 7. Hussain, A. I., Cordeiro, M., Sevilla, E., & Liu, J. (2010) Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells. Vaccine 28(22):3848-3855

  • 8. Wang, Z., Tobler, S., Roayaei, J., & Eick, A. (2009) Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA 301(9):945-953.

  • 9. Gutman, G. A. & Hatfield, G. W. (1989) Nonrandom utilization of codon pairs in Escherichia coli. Proc. Natl. Acad. Sci U.S.A. 86(10):3699-3703.

  • 10. Moura, G., et al. (2007) Large scale comparative codon-pair context analysis unveils general rules that fine-tune evolution of mRNA primary structure. PLoS One 2(9):e847.

  • 11. Wang, F. P. & Li, H. (2009) Codon-pair usage and genome evolution. Gene 433(1-2):8-15.

  • 12. Coleman, J. R., et al. (2008) Virus attenuation by genome-scale changes in codon pair bias. Science 320(5884): 1784-1787.

  • 13. Mueller, S., et al. (2010) Live attenuated influenza virus vaccines by computer-aided rational design. Nat Biotechnol 28(7):723-726.

  • 14. Cello, J., Paul, A. V., & Wimmer, E. (2002) Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297(5583):1016-1018.

  • 15. Sutejo, R., et al. (2012) Activation of type I and III interferon signalling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses. PLoS One 7(3):e33732.

  • 16. Dove, B. K., et al. (2012) A quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza A virus using stable isotope labelling with amino acids in cell culture. Proteomics 12(9):1431-1436.

  • 17. Doma, M. K. & Parker, R. (2006) Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation. Nature 440(7083):561-564.

  • 18. Liu, C., Eichelberger, M. C., Compans, R. W., & Air, G. M. (1995) Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 69(2):1099-1106.

  • 19. Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61(2):397-410.

  • 20. Muster, T., et al. (1995) Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J. Virol. 69(11):6678-6686.

  • 21. Koutsonanos, D. G., et al. (2009) Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 4(3):e4773.

  • 22. de Jong, J. C., et al. (2003) Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 115:63-73.

  • 23. WHO (2002) WHO Manual on Animal Influenza Diagnosis and Surveillance. www.who.int/vaccine_research/diseases/influenza/WHO_manual_on_animaldiagnosis_and_surveillance_2002_5.pdf.

  • 24. Reed, L., Muench, M. (1938) A simple method for estimating fifty percent endpoints. Am J. Hyg 27(3):493-497.










SUPPLEMENTAL TABLE 1







Expected and Observed Codon Pair Frequencies and


Codon Pair Scores for 14,795 Human Genes












amino







acid
codon


observed /



pair
pair
expected
observed
expected
CPS















AA
GCGGCG
630.04
2870
4.555
1.516





AA
GCGGCC
2330.20
4032
1.730
0.548





AA
GCTGCT
3727.41
5562
1.492
0.400





AA
GCAGCA
2856.40
4196
1.469
0.385





AA
GCAGCT
3262.97
4711
1.444
0.367





AA
GCTGCA
3262.97
4357
1.335
0.289





AA
GCTGCC
5667.77
7014
1.238
0.213





AA
GCAGCC
4961.56
6033
1.216
0.196





AA
GCAGCG
1341.51
1420
1.059
0.057





AA
GCTGCG
1532.46
1533
1.000
0.000





AA
GCGGCT
1532.46
1472
0.961
−0.040





AA
GCCGCG
2330.20
2042
0.876
−0.132





AA
GCGGCA
1341.51
1142
0.851
−0.161





AA
GCCGCC
8618.21
5141
0.597
−0.517





AA
GCCGCT
5667.77
1378
0.243
−1.414





AA
GCCGCA
4961.56
1122
0.226
−1.487





AC
GCCTGC
2333.61
3975
1.703
0.533





AC
GCCTGT
1965.56
2436
1.239
0.215





AC
GCGTGC
630.96
560
0.888
−0.119





AC
GCTTGT
1292.65
1142
0.883
−0.124





AC
GCATGT
1131.59
881
0.779
−0.250





AC
GCGTGT
531.45
322
0.606
−0.501





AC
GCTTGC
1534.70
894
0.583
−0.540





AC
GCATGC
1343.47
554
0.412
−0.886





AD
GCAGAT
2373.33
4215
1.776
0.574





AD
GCTGAT
2711.15
3887
1.434
0.360





AD
GCTGAC
3062.55
4374
1.428
0.356





AD
GCGGAC
1259.11
1625
1.291
0.255





AD
GCAGAC
2680.95
3395
1.266
0.236





AD
GCGGAT
1114.64
839
0.753
−0.284





AD
GCCGAC
4656.80
2726
0.585
−0.535





AD
GCCGAT
4122.47
920
0.223
−1.500





AE
GCAGAA
3517.48
5814
1.653
0.503





AE
GCAGAG
4703.98
7094
1.508
0.411





AE
GCGGAG
2209.23
3171
1.435
0.361





AE
GCTGAG
5373.53
7362
1.370
0.315





AE
GCTGAA
4018.14
5186
1.291
0.255





AE
GCCGAG
8170.80
5082
0.622
−0.475





AE
GCGGAA
1651.99
949
0.574
−0.554





AE
GCCGAA
6109.85
1097
0.180
−1.717





AF
GCCTTC
4447.90
7382
1.660
0.507





AF
GCATTT
2237.22
2332
1.042
0.041





AF
GCTTTT
2555.66
2580
1.010
0.009





AF
GCCTTT
3886.04
3842
0.989
−0.011





AF
GCTTTC
2925.16
2315
0.791
−0.234





AF
GCGTTC
1202.63
636
0.529
−0.637





AF
GCGTTT
1050.71
518
0.493
−0.707





AF
GCATTC
2560.68
1261
0.492
−0.708





AG
GCGGGC
1369.64
2638
1.926
0.655





AG
GCGGGG
986.17
1738
1.762
0.567





AG
GCTGGG
2398.67
3855
1.607
0.474





AG
GCTGGT
1590.73
2524
1.587
0.462





AG
GCTGGA
2457.02
3783
1.540
0.432





AG
GCAGGA
2150.87
3074
1.429
0.357





AG
GCAGGG
2099.79
2782
1.325
0.281





AG
GCAGGT
1392.52
1748
1.255
0.227





AG
GCTGGC
3331.38
3961
1.189
0.173





AG
GCAGGC
2916.28
3119
1.070
0.067





AG
GCGGGT
654.00
617
0.943
−0.058





AG
GCGGGA
1010.16
793
0.785
−0.242





AG
GCCGGG
3647.33
2240
0.614
−0.488





AG
GCCGGC
5065.58
2977
0.588
−0.532





AG
GCCGGT
2418.80
581
0.240
−1.426





AG
GCCGGA
3736.06
795
0.213
−1.547





AH
GCGCAC
748.29
983
1.314
0.273





AH
GCCCAC
2767.53
3465
1.252
0.225





AH
GCTCAT
1319.86
1471
1.115
0.108





AH
GCACAT
1155.40
1122
0.971
−0.029





AH
GCCCAT
2006.93
1827
0.910
−0.094





AH
GCTCAC
1820.07
1526
0.838
−0.176





AH
GCACAC
1593.29
1312
0.823
−0.194





AH
GCGCAT
542.64
248
0.457
−0.783





AI
GCCATC
3894.51
7798
2.002
0.694





AI
GCCATT
3079.73
3761
1.221
0.200





AI
GCAATA
815.43
924
1.133
0.125





AI
GCAATT
1773.02
1684
0.950
−0.052





AI
GCCATA
1416.41
1257
0.887
−0.119





AI
GCTATT
2025.39
1709
0.844
−0.170





AI
GCTATA
931.50
771
0.828
−0.189





AI
GCTATC
2561.23
1194
0.466
−0.763





AI
GCGATT
832.70
373
0.448
−0.803





AI
GCAATC
2242.09
984
0.439
−0.824





AI
GCGATA
382.97
149
0.389
−0.944





AI
GCGATC
1053.00
404
0.384
−0.958





AK
GCCAAG
5767.01
9818
1.702
0.532





AK
GCAAAA
2563.57
3011
1.175
0.161





AK
GCCAAA
4452.91
4794
1.077
0.074





AK
GCAAAG
3320.10
3044
0.917
−0.087





AK
GCTAAA
2928.46
2022
0.690
−0.370





AK
GCGAAG
1559.29
765
0.491
−0.712





AK
GCTAAG
3792.68
1725
0.455
−0.788





AK
GCGAAA
1203.98
409
0.340
−1.080





AL
GCGCTG
2369.16
4619
1.950
0.668





AL
GCGCTC
1140.05
1765
1.548
0.437





AL
GCTTTG
1873.51
2601
1.388
0.328





AL
GCCCTG
8762.30
11409
1.302
0.264





AL
GCCTTG
2848.79
3695
1.297
0.260





AL
GCTTTA
1115.24
1385
1.242
0.217





AL
GCCCTC
4216.45
4499
1.067
0.065





AL
GCTCTT
1912.07
2038
1.066
0.064





AL
GCATTA
976.28
986
1.010
0.010





AL
GCTCTA
1031.16
940
0.912
−0.093





AL
GCACTT
1673.82
1444
0.863
−0.148





AL
GCATTG
1640.07
1364
0.832
−0.184





AL
GCACTA
902.68
747
0.828
−0.189





AL
GCGCTA
423.94
342
0.807
−0.215





AL
GCCCTA
1567.95
1228
0.783
−0.244





AL
GCTCTG
5762.53
4505
0.782
−0.246





AL
GCCCTT
2907.42
2230
0.767
−0.265





AL
GCTCTC
2772.95
2036
0.734
−0.309





AL
GCCTTA
1695.80
1205
0.711
−0.342





AL
GCACTG
5044.51
3522
0.698
−0.359





AL
GCGTTG
770.26
476
0.618
−0.481





AL
GCGCTT
786.11
459
0.584
−0.538





AL
GCACTC
2427.43
1415
0.583
−0.540





AL
GCGTTA
458.51
169
0.369
−0.998





AM
GCCATG
4236.47
6521
1.539
0.431





AM
GCAATG
2438.96
1900
0.779
−0.250





AM
GCTATG
2786.11
1561
0.560
−0.579





AM
GCGATG
1145.46
625
0.546
−0.606





AN
GCCAAC
3190.28
5452
1.709
0.536





AN
GCAAAT
1667.60
2282
1.368
0.314





AN
GCCAAT
2896.62
3122
1.078
0.075





AN
GCAAAC
1836.66
1512
0.823
−0.195





AN
GCTAAT
1904.97
1356
0.712
−0.340





AN
GCTAAC
2098.09
925
0.441
−0.819





AN
GCGAAC
862.59
331
0.384
−0.958





AN
GCGAAT
783.19
260
0.332
−1.103





AP
GCGCCG
406.74
1172
2.881
1.058





AP
GCGCCC
1122.56
2271
2.023
0.705





AP
GCCCCG
1504.34
2335
1.552
0.440





AP
GCTCCA
2360.19
2463
1.044
0.043





AP
GCTCCT
2445.47
2548
1.042
0.041





AP
GCCCCC
4151.78
3957
0.953
−0.048





AP
GCACCT
2140.76
2028
0.947
−0.054





AP
GCCCCA
3588.82
3371
0.939
−0.063





AP
GCACCA
2066.10
1831
0.886
−0.121





AP
GCACCC
2390.20
2111
0.883
−0.124





AP
GCCCCT
3718.49
3269
0.879
−0.129





AP
GCTCCC
2730.42
2384
0.873
−0.136





AP
GCTCCG
989.33
773
0.781
−0.247





AP
GCGCCT
1005.41
778
0.774
−0.256





AP
GCACCG
866.06
571
0.659
−0.417





AP
GCGCCA
970.35
595
0.613
−0.489





AQ
GCCCAG
7143.67
9550
1.337
0.290





AQ
GCGCAG
1931.51
2101
1.088
0.084





AQ
GCACAA
1472.79
1416
0.961
−0.039





AQ
GCTCAA
1682.42
1522
0.905
−0.100





AQ
GCTCAG
4698.04
4141
0.881
−0.126





AQ
GCACAG
4112.65
3374
0.820
−0.198





AQ
GCCCAA
2558.23
1943
0.760
−0.275





AQ
GCGCAA
691.70
244
0.353
−1.042





AR
GCGCGC
580.17
1255
2.163
0.772





AR
GCGCGG
634.54
1175
1.852
0.616





AR
GCCCGG
2346.82
3946
1.681
0.520





AR
GCCCGC
2145.76
3135
1.461
0.379





AR
GCCAGG
2323.57
3242
1.395
0.333





AR
GCAAGA
1362.59
1559
1.144
0.135





AR
GCTCGA
836.64
943
1.127
0.120





AR
GCCCGA
1272.16
1418
1.115
0.109





AR
GCCCGT
918.67
935
1.018
0.018





AR
GCTCGT
604.17
595
0.985
−0.015





AR
GCCAGA
2366.81
2219
0.938
−0.064





AR
GCTCGG
1543.39
1295
0.839
−0.175





AR
GCGCGT
248.39
205
0.825
−0.192





AR
GCAAGG
1337.69
1089
0.814
−0.206





AR
GCGAGG
628.25
486
0.774
−0.257





AR
GCACGA
732.39
533
0.728
−0.318





AR
GCTCGC
1411.16
941
0.667
−0.405





AR
GCGCGA
343.97
226
0.657
−0.420





AR
GCACGT
528.89
338
0.639
−0.448





AR
GCACGG
1351.08
859
0.636
−0.453





AR
GCACGC
1235.33
619
0.501
−0.691





AR
GCTAGA
1556.53
714
0.459
−0.779





AR
GCGAGA
639.94
263
0.411
−0.889





AR
GCTAGG
1528.10
487
0.319
−1.144





AS
GCCTCG
963.41
1977
2.052
0.719





AS
GCGTCG
260.49
465
1.785
0.579





AS
GCCAGC
4127.58
6466
1.567
0.449





AS
GCCTCC
3643.21
5443
1.494
0.401





AS
GCTTCT
2084.25
2488
1.194
0.177





AS
GCCAGT
2604.12
3085
1.185
0.169





AS
GCATCT
1824.55
2154
1.181
0.166





AS
GCTTCA
1684.99
1932
1.147
0.137





AS
GCGTCC
985.05
1079
1.095
0.091





AS
GCATCA
1475.04
1531
1.038
0.037





AS
GCCTCT
3169.23
3235
1.021
0.021





AS
GCCTCA
2562.14
2514
0.981
−0.019





AS
GCTTCC
2395.96
2295
0.958
−0.043





AS
GCAAGT
1499.21
1307
0.872
−0.137





AS
GCTTCG
633.59
516
0.814
−0.205





AS
GCATCC
2097.42
1658
0.790
−0.235





AS
GCATCG
554.64
403
0.727
−0.319





AS
GCGTCT
856.90
521
0.608
−0.498





AS
GCGAGC
1116.02
595
0.533
−0.629





AS
GCGTCA
692.75
319
0.460
−0.775





AS
GCAAGC
2376.27
1080
0.454
−0.789





AS
GCTAGT
1712.60
737
0.430
−0.843





AS
GCGAGT
704.10
265
0.376
−0.977





AS
GCTAGC
2714.51
673
0.248
−1.395





AT
GCCACG
1262.40
2478
1.963
0.674





AT
GCCACC
3842.98
6598
1.717
0.541





AT
GCCACA
3111.04
4031
1.296
0.259





AT
GCCACT
2751.18
3205
1.165
0.153





AT
GCAACA
1791.05
1761
0.983
−0.017





AT
GCGACG
341.33
329
0.964
−0.037





AT
GCAACT
1583.87
1509
0.953
−0.048





AT
GCTACT
1809.31
1395
0.771
−0.260





AT
GCTACA
2045.98
1528
0.747
−0.292





AT
GCGACC
1039.07
601
0.578
−0.547





AT
GCAACC
2212.43
1259
0.569
−0.564





AT
GCTACC
2527.34
1364
0.540
−0.617





AT
GCAACG
726.77
384
0.528
−0.638





AT
GCTACG
830.22
363
0.437
−0.827





AT
GCGACT
743.87
308
0.414
−0.882





AT
GCGACA
841.17
347
0.413
−0.885





AV
GCTGTT
1736.99
3025
1.742
0.555





AV
GCTGTG
4399.56
7279
1.654
0.503





AV
GCTGTA
1127.89
1750
1.552
0.439





AV
GCTGTC
2223.90
3351
1.507
0.410





AV
GCAGTA
987.35
1401
1.419
0.350





AV
GCGGTG
1808.80
2487
1.375
0.318





AV
GCAGTT
1520.56
2087
1.373
0.317





AV
GCAGTG
3851.36
4349
1.129
0.122





AV
GCGGTC
914.32
883
0.966
−0.035





AV
GCAGTC
1946.80
1806
0.928
−0.075





AV
GCCGTG
6689.81
4322
0.646
−0.437





AV
GCGGTT
714.13
423
0.592
−0.524





AV
GCGGTA
463.71
270
0.582
−0.541





AV
GCCGTC
3381.59
1798
0.532
−0.632





AV
GCCGTT
2641.21
563
0.213
−1.546





AV
GCCGTA
1715.03
329
0.192
−1.651





AW
GCCTGG
2528.22
3848
1.522
0.420





AW
GCGTGG
683.58
558
0.816
−0.203





AW
GCTTGG
1662.69
1066
0.641
−0.445





AW
GCATGG
1455.51
858
0.589
−0.529





AY
GCCTAC
2643.77
4073
1.541
0.432





AY
GCCTAT
2148.26
2457
1.144
0.134





AY
GCTTAT
1412.81
1478
1.046
0.045





AY
GCATAT
1236.77
1244
1.006
0.006





AY
GCTTAC
1738.68
1139
0.655
−0.423





AY
GCGTAC
714.83
429
0.600
−0.511





AY
GCATAC
1522.04
868
0.570
−0.562





AY
GCGTAT
580.85
310
0.534
−0.628





CA
TGTGCT
1164.04
2021
1.736
0.552





CA
TGTGCC
1769.99
2992
1.690
0.525





CA
TGTGCA
1019.00
1708
1.676
0.517





CA
TGTGCG
478.57
477
0.997
−0.003





CA
TGCGCG
568.18
502
0.884
−0.124





CA
TGCGCC
2101.42
1313
0.625
−0.470





CA
TGCGCT
1382.00
368
0.266
−1.323





CA
TGCGCA
1209.80
312
0.258
−1.355





CC
TGCTGC
1534.17
2610
1.701
0.531





CC
TGCTGT
1292.21
1571
1.216
0.195





CC
TGTTGT
1088.41
529
0.486
−0.721





CC
TGTTGC
1292.21
497
0.385
−0.956





CD
TGTGAC
1920.20
3470
1.807
0.592





CD
TGTGAT
1699.87
2853
1.678
0.518





CD
TGCGAC
2279.75
1134
0.497
−0.698





CD
TGCGAT
2018.17
461
0.228
−1.477





CE
TGTGAA
1901.69
3636
1.912
0.648





CE
TGTGAG
2543.16
3935
1.547
0.437





CE
TGCGAG
3019.37
1709
0.566
−0.569





CE
TGCGAA
2257.78
442
0.196
−1.631





CF
TGCTTC
1891.74
2684
1.419
0.350





CF
TGCTTT
1652.78
1685
1.019
0.019





CF
TGTTTT
1392.11
1096
0.787
−0.239





CF
TGTTTC
1593.38
1065
0.668
−0.403





CG
TGTGGG
1594.78
3240
2.032
0.709





CG
TGTGGA
1633.57
2846
1.742
0.555





CG
TGTGGT
1057.61
1627
1.538
0.431





CG
TGTGGC
2214.90
3133
1.415
0.347





CG
TGCGGG
1893.40
1137
0.601
−0.510





CG
TGCGGC
2629.63
1461
0.556
−0.588





CG
TGCGGT
1255.64
344
0.274
−1.295





CG
TGCGGA
1939.46
431
0.222
−1.504





CH
TGCCAC
1618.50
2144
1.325
0.281





CH
TGCCAT
1173.68
1253
1.068
0.065





CH
TGTCAT
988.58
831
0.841
−0.174





CH
TGTCAC
1363.24
916
0.672
−0.398





CI
TGCATC
1821.04
2813
1.545
0.435





CI
TGCATT
1440.05
1579
1.096
0.092





CI
TGCATA
662.30
576
0.870
−0.140





CI
TGTATA
557.84
474
0.850
−0.163





CI
TGTATT
1212.94
927
0.764
−0.269





CI
TGTATC
1533.83
859
0.560
−0.580





CK
TGCAAG
2777.53
3348
1.205
0.187





CK
TGCAAA
2144.62
2441
1.138
0.129





CK
TGTAAA
1806.38
1770
0.980
−0.020





CK
TGTAAG
2339.47
1509
0.645
−0.438





CL
TGCCTC
1722.14
2468
1.433
0.360





CL
TGCCTG
3578.83
4525
1.264
0.235





CL
TGTTTA
583.38
704
1.207
0.188





CL
TGCCTT
1187.49
1384
1.165
0.153





CL
TGTTTG
980.04
1079
1.101
0.096





CL
TGCTTG
1163.55
1179
1.013
0.013





CL
TGTCTT
1000.21
940
0.940
−0.062





CL
TGCCTA
640.41
585
0.913
−0.090





CL
TGTCTA
539.40
481
0.892
−0.115





CL
TGCTTA
692.62
565
0.816
−0.204





CL
TGTCTC
1450.53
1010
0.696
−0.362





CL
TGTCTG
3014.39
1633
0.542
−0.613





CM
TGCATG
1518.22
1979
1.304
0.265





CM
TGTATG
1278.78
818
0.640
−0.447





CN
TGCAAC
1825.04
2351
1.288
0.253





CN
TGCAAT
1657.05
1636
0.987
−0.013





CN
TGTAAT
1395.71
1349
0.967
−0.034





CN
TGTAAC
1537.20
1079
0.702
−0.354





CP
TGCCCG
687.28
978
1.423
0.353





CP
TGCCCC
1896.80
2279
1.201
0.184





CP
TGCCCA
1639.61
1728
1.054
0.053





CP
TGCCCT
1698.85
1690
0.995
−0.005





CP
TGTCCT
1430.91
1333
0.932
−0.071





CP
TGTCCA
1381.01
1263
0.915
−0.089





CP
TGTCCC
1597.65
1369
0.857
−0.154





CP
TGTCCG
578.88
271
0.468
−0.759





CQ
TGCCAG
3338.89
4321
1.294
0.258





CQ
TGCCAA
1195.69
1319
1.103
0.098





CQ
TGTCAA
1007.11
905
0.899
−0.107





CQ
TGTCAG
2812.30
1809
0.643
−0.441





CR
TGCCGC
1031.52
1860
1.803
0.590





CR
TGCCGG
1128.18
1543
1.368
0.313





CR
TGCAGG
1117.00
1450
1.298
0.261





CR
TGCCGT
441.63
541
1.225
0.203





CR
TGCCGA
611.56
742
1.213
0.193





CR
TGCAGA
1137.78
1252
1.100
0.096





CR
TGTCGA
515.11
458
0.889
−0.118





CR
TGTCGT
371.98
308
0.828
−0.189





CR
TGTAGA
958.34
570
0.595
−0.520





CR
TGTCGC
868.83
497
0.572
−0.559





CR
TGTCGG
950.24
463
0.487
−0.719





CR
TGTAGG
940.83
389
0.413
−0.883





CS
TGCAGC
1990.73
3150
1.582
0.459





CS
TGCTCC
1757.12
2397
1.364
0.311





CS
TGCAGT
1255.97
1701
1.354
0.303





CS
TGCTCG
464.65
571
1.229
0.206





CS
TGTTCT
1287.45
1184
0.920
−0.084





CS
TGCTCT
1528.52
1393
0.911
−0.093





CS
TGTTCA
1040.83
932
0.895
−0.110





CS
TGCTCA
1235.72
1079
0.873
−0.136





CS
TGTTCC
1479.99
1102
0.745
−0.295





CS
TGTAGT
1057.88
699
0.661
−0.414





CS
TGTTCG
391.37
192
0.491
−0.712





CS
TGTAGC
1676.76
767
0.457
−0.782





CT
TGCACG
535.88
829
1.547
0.436





CT
TGCACC
1631.31
2321
1.423
0.353





CT
TGCACA
1320.60
1508
1.142
0.133





CT
TGCACT
1167.85
1185
1.015
0.015





CT
TGTACT
983.66
802
0.815
−0.204





CT
TGTACA
1112.32
830
0.746
−0.293





CT
TGTACC
1374.02
942
0.686
−0.377





CT
TGTACG
451.36
160
0.354
−1.037





CV
TGTGTC
1064.94
1821
1.710
0.536





CV
TGTGTT
831.78
1383
1.663
0.508





CV
TGTGTA
540.10
866
1.603
0.472





CV
TGTGTG
2106.78
3241
1.538
0.431





CV
TGCGTG
2501.27
1537
0.614
−0.487





CV
TGCGTC
1264.35
734
0.581
−0.544





CV
TGCGTT
987.53
219
0.222
−1.506





CV
TGCGTA
641.24
137
0.214
−1.543





CW
TGCTGG
1275.05
1842
1.445
0.368





CW
TGTTGG
1073.95
507
0.472
−0.751





CY
TGCTAC
1379.34
1995
1.446
0.369





CY
TGCTAT
1120.82
1170
1.044
0.043





CY
TGTTAT
944.05
653
0.692
−0.369





CY
TGTTAC
1161.80
788
0.678
−0.388





DA
GATGCT
2675.13
5292
1.978
0.682





DA
GATGCA
2341.80
3898
1.665
0.510





DA
GATGCC
4067.71
5983
1.471
0.386





DA
GACGCG
1242.39
1116
0.898
−0.107





DA
GATGCG
1099.83
972
0.884
−0.124





DA
GACGCC
4594.94
2668
0.581
−0.544





DA
GACGCA
2645.34
852
0.322
−1.133





DA
GACGCT
3021.87
908
0.300
−1.202





DC
GACTGC
2386.86
3465
1.452
0.373





DC
GACTGT
2010.41
2804
1.395
0.333





DC
GATTGT
1779.74
1163
0.653
−0.425





DC
GATTGC
2112.99
858
0.406
−0.901





DD
GATGAT
4271.42
7846
1.837
0.608





DD
GATGAC
4825.06
7181
1.488
0.398





DD
GACGAC
5450.46
2965
0.544
−0.609





DD
GACGAT
4825.06
1380
0.286
−1.252





DE
GATGAA
5114.33
10045
1.964
0.675





DE
GATGAG
6839.48
9573
1.400
0.336





DE
GACGAG
7725.97
4498
0.582
−0.541





DE
GACGAA
5777.22
1341
0.232
−1.461





DF
GACTTC
4696.28
6094
1.298
0.261





DF
GACTTT
4103.05
4250
1.036
0.035





DF
GATTTT
3632.26
3485
0.959
−0.041





DF
GATTTC
4157.42
2760
0.664
−0.410





DG
GATGGT
1910.36
3443
1.802
0.589





DG
GATGGA
2950.72
5133
1.740
0.554





DG
GATGGG
2880.65
4437
1.540
0.432





DG
GATGGC
4000.77
5419
1.354
0.303





DG
GACGGC
4519.33
2987
0.661
−0.414





DG
GACGGG
3254.02
1979
0.608
−0.497





DG
GACGGT
2157.97
723
0.335
−1.094





DG
GACGGA
3333.18
886
0.266
−1.325





DH
GACCAC
2653.74
3480
1.311
0.271





DH
GACCAT
1924.41
2014
1.047
0.046





DH
GATCAT
1703.60
1623
0.953
−0.048





DH
GATCAC
2349.25
1514
0.644
−0.439





DI
GACATC
4715.94
6532
1.385
0.326





DI
GACATT
3729.31
4087
1.096
0.092





DI
GATATT
3301.40
3271
0.991
−0.009





DI
GATATA
1518.36
1495
0.985
−0.016





DI
GACATA
1715.16
1565
0.912
−0.092





DI
GATATC
4174.83
2205
0.528
−0.638





DK
GACAAG
5562.52
7324
1.317
0.275





DK
GACAAA
4295.02
4794
1.116
0.110





DK
GATAAA
3802.20
3855
1.014
0.014





DK
GATAAG
4924.27
2611
0.530
−0.634





DL
GACCTC
3785.97
5029
1.328
0.284





DL
GACTTG
2557.95
3396
1.328
0.283





DL
GATTTA
1347.95
1740
1.291
0.255





DL
GACCTG
7867.71
9796
1.245
0.219





DL
GATTTG
2264.44
2687
1.187
0.171





DL
GACCTT
2610.58
2774
1.063
0.061





DL
GATCTT
2311.04
2416
1.045
0.044





DL
GACCTA
1407.87
1416
1.006
0.006





DL
GACTTA
1522.66
1403
0.921
−0.082





DL
GATCTA
1246.33
1020
0.818
−0.200





DL
GATCTC
3351.56
2214
0.661
−0.415





DL
GATCTG
6964.95
3348
0.481
−0.733





DM
GACATG
4089.63
5411
1.323
0.280





DM
GATATG
3620.37
2299
0.635
−0.454





DN
GACAAC
3511.00
4849
1.381
0.323





DN
GACAAT
3187.82
3349
1.051
0.049





DN
GATAAT
2822.05
2549
0.903
−0.102





DN
GATAAC
3108.14
1882
0.606
−0.502





DP
GACCCC
3732.11
5119
1.372
0.316





DP
GACCCG
1352.28
1692
1.251
0.224





DP
GACCCT
3342.62
3700
1.107
0.102





DP
GATCCT
2959.08
3111
1.051
0.050





DP
GACCCA
3226.05
3205
0.993
−0.007





DP
GATCCA
2855.89
2349
0.823
−0.195





DP
GATCCC
3303.88
2338
0.708
−0.346





DP
GATCCG
1197.11
455
0.380
−0.967





DQ
GACCAG
5250.37
6524
1.243
0.217





DQ
GACCAA
1880.22
2169
1.154
0.143





DQ
GATCAA
1664.48
1808
1.086
0.083





DQ
GATCAG
4647.93
2942
0.633
−0.457





DR
GACCGC
1807.77
2634
1.457
0.376





DR
GACAGA
1994.00
2869
1.439
0.364





DR
GACAGG
1957.57
2730
1.395
0.333





DR
GACCGT
773.97
1029
1.330
0.285





DR
GACCGG
1977.16
2568
1.299
0.261





DR
GACCGA
1071.78
1292
1.205
0.187





DR
GATCGA
948.80
923
0.973
−0.028





DR
GATCGT
685.16
626
0.914
−0.090





DR
GATAGA
1765.20
1123
0.636
−0.452





DR
GATCGG
1750.30
859
0.491
−0.712





DR
GATCGC
1600.34
754
0.471
−0.753





DR
GATAGG
1732.96
658
0.380
−0.968





DS
GACTCG
918.57
1527
1.662
0.508





DS
GACAGC
3935.48
6143
1.561
0.445





DS
GACAGT
2482.92
3657
1.473
0.387





DS
GATTCT
2675.01
2968
1.110
0.104





DS
GACTCC
3473.65
3800
1.094
0.090





DS
GATTCA
2162.59
2129
0.984
−0.016





DS
GACTCA
2442.89
2382
0.975
−0.025





DS
GACTCT
3021.73
2910
0.963
−0.038





DS
GATTCC
3075.07
2186
0.711
−0.341





DS
GATAGT
2198.02
1355
0.616
−0.484





DS
GATTCG
813.17
414
0.509
−0.675





DS
GATAGC
3483.91
1212
0.348
−1.056





DT
GACACG
1110.58
1842
1.659
0.506





DT
GACACC
3380.79
4666
1.380
0.322





DT
GACACA
2736.88
3538
1.293
0.257





DT
GACACT
2420.30
2688
1.111
0.105





DT
GATACT
2142.59
1731
0.808
−0.213





DT
GATACA
2422.85
1788
0.738
−0.304





DT
GATACC
2992.87
1586
0.530
−0.635





DT
GATACG
983.15
351
0.357
−1.030





DV
GATGTT
1957.96
3699
1.889
0.636





DV
GATGTA
1271.37
2214
1.741
0.555





DV
GATGTC
2506.81
3869
1.543
0.434





DV
GATGTG
4959.23
6668
1.345
0.296





DV
GACGTG
5602.02
3616
0.645
−0.438





DV
GACGTC
2831.73
1654
0.584
−0.538





DV
GACGTT
2211.73
672
0.304
−1.191





DV
GACGTA
1436.16
385
0.268
−1.316





DW
GACTGG
2619.27
3853
1.471
0.386





DW
GATTGG
2318.73
1085
0.468
−0.759





DY
GACTAC
3307.71
3930
1.188
0.172





DY
GATTAT
2379.36
2608
1.096
0.092





DY
GACTAT
2687.76
2853
1.061
0.060





DY
GATTAC
2928.18
1912
0.653
−0.426





EA
GAGGCG
2437.29
3179
1.304
0.266





EA
GAAGCA
3880.59
4844
1.248
0.222





EA
GAAGCT
4432.94
5143
1.160
0.149





EA
GAGGCC
9014.27
9805
1.088
0.084





EA
GAGGCT
5928.25
5314
0.896
−0.109





EA
GAGGCA
5189.57
4530
0.873
−0.136





EA
GAAGCC
6740.57
5649
0.838
−0.177





EA
GAAGCG
1822.52
982
0.539
−0.618





EC
GAATGT
2182.58
3541
1.622
0.484





EC
GAGTGT
2918.80
2792
0.957
−0.044





EC
GAGTGC
3465.35
2987
0.862
−0.149





EC
GAATGC
2591.27
1838
0.709
−0.343





ED
GAAGAT
6605.82
9691
1.467
0.383





ED
GAGGAC
9979.09
9684
0.970
−0.030





ED
GAAGAC
7462.02
6820
0.914
−0.090





ED
GAGGAT
8834.07
6686
0.757
−0.279





EE
GAAGAA
10747.11
14461
1.346
0.297





EE
GAGGAG
19220.31
21731
1.131
0.123





EE
GAAGAG
14372.29
11875
0.826
−0.191





EE
GAGGAA
14372.29
10645
0.741
−0.300





EF
GAATTT
3136.91
4237
1.351
0.301





EF
GAGTTC
4801.58
4739
0.987
−0.013





EF
GAGTTT
4195.05
4095
0.976
−0.024





EF
GAATTC
3590.46
2653
0.739
−0.303





EG
GAAGGA
3358.73
5032
1.498
0.404





EG
GAAGGT
2174.51
2839
1.306
0.267





EG
GAAGGG
3278.97
3559
1.085
0.082





EG
GAGGGC
6090.10
6505
1.068
0.066





EG
GAAGGC
4553.97
4340
0.953
−0.048





EG
GAGGGG
4385.02
3795
0.865
−0.145





EG
GAGGGT
2908.01
2378
0.818
−0.201





EG
GAGGGA
4491.69
2793
0.622
−0.475





EH
GAACAT
2017.28
2539
1.259
0.230





EH
GAGCAC
3720.16
4190
1.126
0.119





EH
GAGCAT
2697.74
2448
0.907
−0.097





EH
GAACAC
2781.81
2040
0.733
−0.310





EI
GAAATA
1687.78
3007
1.782
0.578





EI
GAAATT
3669.78
4788
1.305
0.266





EI
GAGATC
6206.03
6191
0.998
−0.002





EI
GAGATT
4907.66
3978
0.811
−0.210





EI
GAGATA
2257.09
1785
0.791
−0.235





EI
GAAATC
4640.66
3620
0.780
−0.248





EK
GAGAAG
12729.57
15133
1.189
0.173





EK
GAAAAA
7349.75
7522
1.023
0.023





EK
GAGAAA
9828.94
9127
0.929
−0.074





EK
GAAAAG
9518.74
7645
0.803
−0.219





EL
GAGCTG
10945.64
15625
1.428
0.356





EL
GAATTA
1584.03
2256
1.424
0.354





EL
GAACTA
1464.61
1830
1.249
0.223





EL
GAACTT
2715.79
3371
1.241
0.216





EL
GAGCTC
5267.08
5877
1.116
0.110





EL
GAGCTA
1958.64
2049
1.046
0.045





EL
GAATTG
2661.03
2335
0.877
−0.131





EL
GAGCTT
3631.87
3084
0.849
−0.164





EL
GAGTTG
3558.64
2719
0.764
−0.269





EL
GAACTC
3938.54
2632
0.668
−0.403





EL
GAGTTA
2118.35
1357
0.641
−0.445





EL
GAACTG
8184.78
4894
0.598
−0.514





EM
GAAATG
4983.92
5010
1.005
0.005





EM
GAGATG
6665.08
6639
0.996
−0.004





EN
GAAAAT
4791.73
6977
1.456
0.376





EN
GAGAAC
7057.70
6756
0.957
−0.044





EN
GAAAAC
5277.51
4930
0.934
−0.068





EN
GAGAAT
6408.07
4872
0.760
−0.274





EP
GAGCCG
1650.94
2438
1.477
0.390





EP
GAGCCC
4556.38
6270
1.376
0.319





EP
GAGCCT
4080.86
4236
1.038
0.037





EP
GAGCCA
3938.55
4067
1.033
0.032





EP
GAACCA
2945.12
2684
0.911
−0.093





EP
GAACCT
3051.53
2547
0.835
−0.181





EP
GAACCC
3407.10
2106
0.618
−0.481





EP
GAACCG
1234.52
517
0.419
−0.870





EQ
GAACAA
2579.50
3396
1.317
0.275





EQ
GAGCAG
9632.80
11185
1.161
0.149





EQ
GAGCAA
3449.61
3185
0.923
−0.080





EQ
GAACAG
7203.08
5099
0.708
−0.345





ER
GAAAGA
2650.27
3769
1.422
0.352





ER
GAGAGG
3479.50
4315
1.240
0.215





ER
GAGCGG
3514.32
4356
1.240
0.215





ER
GAGCGC
3213.23
3682
1.146
0.136





ER
GAAAGG
2601.85
2679
1.030
0.029





ER
GAGAGA
3544.25
3633
1.025
0.025





ER
GAGCGT
1375.70
1286
0.935
−0.067





ER
GAACGT
1028.70
894
0.869
−0.140





ER
GAACGA
1424.52
1188
0.834
−0.182





ER
GAGCGA
1905.04
1562
0.820
−0.199





ER
GAACGG
2627.88
1333
0.507
−0.679





ER
GAACGC
2402.74
1071
0.446
−0.808





ES
GAAAGT
2081.93
3138
1.507
0.410





ES
GAGAGC
4413.03
5786
1.311
0.271





ES
GAGAGT
2784.21
3237
1.163
0.151





ES
GAGTCG
1030.03
1174
1.140
0.131





ES
GAATCT
2533.73
2812
1.110
0.104





ES
GAATCA
2048.37
2131
1.040
0.040





ES
GAAAGC
3299.91
2880
0.873
−0.136





ES
GAGTCC
3895.16
3392
0.871
−0.138





ES
GAGTCT
3388.40
2799
0.826
−0.191





ES
GAGTCA
2739.33
2198
0.802
−0.220





ES
GAATCC
2912.67
1943
0.667
−0.405





ES
GAATCG
770.22
407
0.528
−0.638





ET
GAGACG
1658.42
2190
1.321
0.278





ET
GAAACA
3056.09
3851
1.260
0.231





ET
GAAACT
2702.59
3224
1.193
0.176





ET
GAGACC
5048.51
5514
1.092
0.088





ET
GAGACA
4086.97
3619
0.885
−0.122





ET
GAGACT
3614.21
3028
0.838
−0.177





ET
GAAACC
3775.11
2950
0.781
−0.247





ET
GAAACG
1240.11
806
0.650
−0.431





EV
GAAGTA
1580.16
2675
1.693
0.526





EV
GAAGTT
2433.50
3724
1.530
0.425





EV
GAGGTG
8242.83
9074
1.101
0.096





EV
GAAGTC
3115.66
2860
0.918
−0.086





EV
GAGGTC
4166.62
3741
0.898
−0.108





EV
GAAGTG
6163.71
5122
0.831
−0.185





EV
GAGGTT
3254.36
2359
0.725
−0.322





EV
GAGGTA
2113.17
1515
0.717
−0.333





EW
GAGTGG
3085.08
3238
1.050
0.048





EW
GAATGG
2306.92
2154
0.934
−0.069





EY
GAATAT
2307.55
3428
1.486
0.396





EY
GAGTAC
3797.72
3796
1.000
0.000





EY
GAGTAT
3085.93
2596
0.841
−0.173





EY
GAATAC
2839.80
2211
0.779
−0.250





FA
TTTGCA
1643.98
3299
2.007
0.696





FA
TTTGCT
1877.98
3746
1.995
0.690





FA
TTTGCC
2855.59
4348
1.523
0.420





FA
TTTGCG
772.10
622
0.806
−0.216





FA
TTCGCG
883.73
598
0.677
−0.391





FA
TTCGCC
3268.46
1802
0.551
−0.595





FA
TTCGCT
2149.50
516
0.240
−1.427





FA
TTCGCA
1881.67
402
0.214
−1.543





FC
TTCTGC
2058.60
3045
1.479
0.391





FC
TTCTGT
1733.93
2055
1.185
0.170





FC
TTTTGT
1514.90
1159
0.765
−0.268





FC
TTTTGC
1798.56
847
0.471
−0.753





FD
TTTGAT
2786.65
5380
1.931
0.658





FD
TTTGAC
3147.84
4737
1.505
0.409





FD
TTCGAC
3602.96
1746
0.485
−0.724





FD
TTCGAT
3189.55
864
0.271
−1.306





FE
TTTGAA
3016.02
6247
2.071
0.728





FE
TTTGAG
4033.37
6066
1.504
0.408





FE
TTCGAG
4616.53
2165
0.469
−0.757





FE
TTCGAA
3452.08
640
0.185
−1.685





FF
TTCTTC
3429.53
5168
1.507
0.410





FF
TTCTTT
2996.32
2989
0.998
−0.002





FF
TTTTTT
2617.83
1937
0.740
−0.301





FF
TTTTTC
2996.32
1946
0.649
−0.432





FG
TTTGGA
2068.21
4271
2.065
0.725





FG
TTTGGT
1339.00
2552
1.906
0.645





FG
TTTGGG
2019.09
3449
1.708
0.535





FG
TTTGGC
2804.20
3462
1.235
0.211





FG
TTCGGG
2311.02
1292
0.559
−0.581





FG
TTCGGC
3209.64
1648
0.513
−0.667





FG
TTCGGT
1532.60
419
0.273
−1.297





FG
TTCGGA
2367.24
558
0.236
−1.445





FH
TTCCAC
2463.48
3200
1.299
0.262





FH
TTTCAT
1560.78
1697
1.087
0.084





FH
TTCCAT
1786.44
1866
1.045
0.044





FH
TTTCAC
2152.30
1200
0.558
−0.584





FI
TTCATC
3454.46
5156
1.493
0.400





FI
TTCATT
2731.75
2953
1.081
0.078





FI
TTTATT
2386.67
2296
0.962
−0.039





FI
TTTATA
1097.66
950
0.865
−0.144





FI
TTCATA
1256.36
1035
0.824
−0.194





FI
TTTATC
3018.10
1555
0.515
−0.663





FK
TTCAAG
4090.45
5137
1.256
0.228





FK
TTCAAA
3158.38
3245
1.027
0.027





FK
TTTAAA
2759.42
2762
1.001
0.001





FK
TTTAAG
3573.75
2438
0.682
−0.382





FL
TTCCTC
3228.53
4426
1.371
0.315





FL
TTCCTG
6709.28
8734
1.302
0.264





FL
TTTTTA
1134.45
1334
1.176
0.162





FL
TTTCTT
1945.00
2267
1.166
0.153





FL
TTCCTA
1200.58
1280
1.066
0.064





FL
TTTCTA
1048.92
1087
1.036
0.036





FL
TTCTTG
2181.32
2239
1.026
0.026





FL
TTCCTT
2226.21
2150
0.966
−0.035





FL
TTTTTG
1905.78
1799
0.944
−0.058





FL
TTCTTA
1298.47
1144
0.881
−0.127





FL
TTTCTC
2820.70
1904
0.675
−0.393





FL
TTTCTG
5861.77
3197
0.545
−0.606





FM
TTCATG
2804.11
3662
1.306
0.267





FM
TTTATG
2449.89
1592
0.650
−0.431





FN
TTCAAC
2855.47
3919
1.372
0.317





FN
TTTAAT
2265.13
2185
0.965
−0.036





FN
TTCAAT
2592.63
2456
0.947
−0.054





FN
TTTAAC
2494.77
1648
0.661
−0.415





FP
TTCCCG
961.40
1205
1.253
0.226





FP
TTTCCT
2076.25
2539
1.223
0.201





FP
TTCCCC
2653.35
3099
1.168
0.155





FP
TTTCCA
2003.85
2141
1.068
0.066





FP
TTCCCA
2293.57
2310
1.007
0.007





FP
TTCCCT
2376.44
2379
1.001
0.001





FP
TTTCCC
2318.18
1529
0.660
−0.416





FP
TTTCCG
839.96
321
0.382
−0.962





FQ
TTCCAG
5468.69
7069
1.293
0.257





FQ
TTTCAA
1711.02
1803
1.054
0.052





FQ
TTCCAA
1958.40
1980
1.011
0.011





FQ
TTTCAG
4777.89
3064
0.641
−0.444





FR
TTCCGC
1531.47
2588
1.690
0.525





FR
TTCCGA
907.97
1410
1.553
0.440





FR
TTCCGG
1674.97
2451
1.463
0.381





FR
TTCCGT
655.68
893
1.362
0.309





FR
TTCAGA
1689.24
1852
1.096
0.092





FR
TTCAGG
1658.38
1810
1.091
0.087





FR
TTTCGA
793.28
850
1.072
0.069





FR
TTTCGT
572.85
490
0.855
−0.156





FR
TTTAGA
1475.86
947
0.642
−0.444





FR
TTTAGG
1448.90
691
0.477
−0.740





FR
TTTCGG
1463.39
688
0.470
−0.755





FR
TTTCGC
1338.02
540
0.404
−0.907





FS
TTCTCC
2990.83
4507
1.507
0.410





FS
TTCAGC
3388.47
4577
1.351
0.301





FS
TTCAGT
2137.80
2692
1.259
0.231





FS
TTCTCG
790.89
910
1.151
0.140





FS
TTTTCT
2273.08
2536
1.116
0.109





FS
TTCTCT
2601.73
2741
1.054
0.052





FS
TTTTCA
1837.65
1903
1.036
0.035





FS
TTCTCA
2103.34
1997
0.949
−0.052





FS
TTTTCC
2613.03
1872
0.716
−0.334





FS
TTTAGT
1867.76
1201
0.643
−0.442





FS
TTTTCG
690.99
258
0.373
−0.985





FS
TTTAGC
2960.44
1062
0.359
−1.025





FT
TTCACC
2909.29
4513
1.551
0.439





FT
TTCACG
955.69
1315
1.376
0.319





FT
TTCACT
2082.75
2494
1.197
0.180





FT
TTCACA
2355.18
2372
1.007
0.007





FT
TTTACT
1819.66
1622
0.891
−0.115





FT
TTTACA
2057.68
1485
0.722
−0.326





FT
TTTACC
2541.79
1495
0.588
−0.531





FT
TTTACG
834.97
261
0.313
−1.163





FV
TTTGTA
912.19
1711
1.876
0.629





FV
TTTGTT
1404.80
2620
1.865
0.623





FV
TTTGTC
1798.60
2635
1.465
0.382





FV
TTTGTG
3558.17
5206
1.463
0.381





FV
TTCGTG
4072.62
2589
0.636
−0.453





FV
TTCGTC
2058.64
1086
0.528
−0.640





FV
TTCGTT
1607.91
386
0.240
−1.427





FV
TTCGTA
1044.07
224
0.215
−1.539





FW
TTCTGG
2126.30
2834
1.333
0.287





FW
TTTTGG
1857.70
1150
0.619
−0.480





FY
TTCTAC
2720.70
3710
1.364
0.310





FY
TTTTAT
1931.51
2003
1.037
0.036





FY
TTCTAT
2210.77
2145
0.970
−0.030





FY
TTTTAC
2377.02
1382
0.581
−0.542





GA
GGTGCT
1531.20
2505
1.636
0.492





GA
GGGGCG
949.27
1433
1.510
0.412





GA
GGGGCC
3510.85
5061
1.442
0.366





GA
GGTGCC
2328.29
3109
1.335
0.289





GA
GGAGCA
2070.38
2678
1.293
0.257





GA
GGTGCA
1340.41
1715
1.279
0.246





GA
GGCGCG
1318.38
1659
1.258
0.230





GA
GGAGCT
2365.08
2975
1.258
0.229





GA
GGGGCT
2308.91
2850
1.234
0.211





GA
GGAGCC
3596.25
3845
1.069
0.067





GA
GGGGCA
2021.22
2074
1.026
0.026





GA
GGTGCG
629.52
501
0.796
−0.228





GA
GGAGCG
972.36
712
0.732
−0.312





GA
GGCGCC
4876.02
3121
0.640
−0.446





GA
GGCGCT
3206.72
906
0.283
−1.264





GA
GGCGCA
2807.15
688
0.245
−1.406





GC
GGCTGC
1888.96
4102
2.172
0.775





GC
GGCTGT
1591.04
2360
1.483
0.394





GC
GGTTGT
759.72
658
0.866
−0.144





GC
GGATGT
1173.45
793
0.676
−0.392





GC
GGTTGC
901.97
523
0.580
−0.545





GC
GGATGC
1393.18
655
0.470
−0.755





GC
GGGTGC
1360.09
628
0.462
−0.773





GC
GGGTGT
1145.59
495
0.432
−0.839





GD
GGGGAC
3126.50
4967
1.589
0.463





GD
GGTGAT
1835.49
2621
1.428
0.356





GD
GGTGAC
2073.40
2960
1.428
0.356





GD
GGAGAT
2835.09
3829
1.351
0.301





GD
GGAGAC
3202.56
4240
1.324
0.281





GD
GGGGAT
2767.76
2575
0.930
−0.072





GD
GGCGAC
4342.22
1955
0.450
−0.798





GD
GGCGAT
3843.98
880
0.229
−1.474





GE
GGAGAA
3433.99
5903
1.719
0.542





GE
GGGGAG
4483.27
6552
1.461
0.379





GE
GGTGAA
2223.23
3248
1.461
0.379





GE
GGAGAG
4592.33
5961
1.298
0.261





GE
GGTGAG
2973.17
2988
1.005
0.005





GE
GGGGAA
3352.44
3041
0.907
−0.098





GE
GGCGAG
6226.56
3530
0.567
−0.568





GE
GGCGAA
4656.01
718
0.154
−1.869





GF
GGCTTC
3466.22
6121
1.766
0.569





GF
GGATTT
2233.54
2666
1.194
0.177





GF
GGTTTT
1446.04
1665
1.151
0.141





GF
GGCTTT
3028.37
3201
1.057
0.055





GF
GGTTTC
1655.11
1548
0.935
−0.067





GF
GGATTC
2556.47
1534
0.600
−0.511





GF
GGGTTT
2180.50
1244
0.571
−0.561





GF
GGGTTC
2495.76
1083
0.434
−0.835





GG
GGTGGT
1061.28
2286
2.154
0.767





GG
GGTGGC
2222.59
3657
1.645
0.498





GG
GGTGGA
1639.25
2618
1.597
0.468





GG
GGAGGA
2531.97
3609
1.425
0.354





GG
GGTGGG
1600.32
2267
1.417
0.348





GG
GGGGGC
3351.47
4673
1.394
0.332





GG
GGAGGT
1639.25
2152
1.313
0.272





GG
GGAGGC
3433.00
3776
1.100
0.095





GG
GGCGGC
4654.67
4787
1.028
0.028





GG
GGGGGT
1600.32
1543
0.964
−0.036





GG
GGAGGG
2471.84
2351
0.951
−0.050





GG
GGGGGA
2471.84
1517
0.614
−0.488





GG
GGCGGG
3351.47
2001
0.597
−0.516





GG
GGGGGG
2413.14
1080
0.448
−0.804





GG
GGCGGT
2222.59
936
0.421
−0.865





GG
GGCGGA
3433.00
845
0.246
−1.402





GH
GGCCAC
2540.15
3679
1.448
0.370





GH
GGTCAT
879.57
1022
1.162
0.150





GH
GGACAT
1358.57
1438
1.058
0.057





GH
GGCCAT
1842.04
1679
0.911
−0.093





GH
GGGCAC
1828.97
1629
0.891
−0.116





GH
GGTCAC
1212.92
1008
0.831
−0.185





GH
GGACAC
1873.46
1479
0.789
−0.236





GH
GGGCAT
1326.31
928
0.700
−0.357





GI
GGCATC
3372.48
5474
1.623
0.484





GI
GGAATA
904.63
1338
1.479
0.391





GI
GGAATT
1966.96
2560
1.302
0.264





GI
GGCATT
2666.92
2670
1.001
0.001





GI
GGTATT
1273.45
1052
0.826
−0.191





GI
GGGATC
2428.27
1958
0.806
−0.215





GI
GGTATA
585.67
461
0.787
−0.239





GI
GGAATC
2487.34
1910
0.768
−0.264





GI
GGGATA
883.14
666
0.754
−0.282





GI
GGGATT
1920.24
1421
0.740
−0.301





GI
GGCATA
1226.55
885
0.722
−0.326





GI
GGTATC
1610.35
931
0.578
−0.548





GK
GGAAAA
3199.11
4553
1.423
0.353





GK
GGGAAG
4044.81
5674
1.403
0.338





GK
GGGAAA
3123.14
4119
1.319
0.277





GK
GGCAAG
5617.61
5712
1.017
0.017





GK
GGAAAG
4143.21
3706
0.894
−0.112





GK
GGCAAA
4337.55
3581
0.826
−0.192





GK
GGTAAA
2071.17
1334
0.644
−0.440





GK
GGTAAG
2682.40
540
0.201
−1.603





GL
GGCCTC
3017.19
4559
1.511
0.413





GL
GGTTTA
579.43
820
1.415
0.347





GL
GGTTTG
973.39
1294
1.329
0.285





GL
GGGCTG
4514.62
5878
1.302
0.264





GL
GGTCTT
993.42
1258
1.266
0.236





GL
GGCCTG
6270.10
7822
1.248
0.221





GL
GGGCTC
2172.45
2563
1.180
0.165





GL
GGATTA
894.98
991
1.107
0.102





GL
GGACTT
1534.44
1613
1.051
0.050





GL
GGCTTG
2038.53
2109
1.035
0.034





GL
GGCCTT
2080.48
2098
1.008
0.008





GL
GGACTA
827.51
799
0.966
−0.035





GL
GGGCTT
1497.99
1445
0.965
−0.036





GL
GGTCTC
1440.70
1365
0.947
−0.054





GL
GGTCTA
535.75
487
0.909
−0.095





GL
GGGCTA
807.86
726
0.899
−0.107





GL
GGCCTA
1121.99
968
0.863
−0.148





GL
GGCTTA
1213.47
935
0.771
−0.261





GL
GGACTC
2225.29
1656
0.744
−0.295





GL
GGATTG
1503.50
1062
0.706
−0.348





GL
GGTCTG
2993.96
2034
0.679
−0.387





GL
GGGTTG
1467.79
870
0.593
−0.523





GL
GGGTTA
873.73
467
0.534
−0.626





GL
GGACTG
4624.44
2384
0.516
−0.663





GM
GGCATG
3177.11
3953
1.244
0.219





GM
GGAATG
2343.24
2482
1.059
0.058





GM
GGGATG
2287.59
2247
0.982
−0.018





GM
GGTATG
1517.06
643
0.424
−0.858





GN
GGAAAT
2150.19
3332
1.550
0.438





GN
GGGAAC
2311.93
2816
1.218
0.197





GN
GGCAAC
3210.92
3701
1.153
0.142





GN
GGAAAC
2368.18
2679
1.131
0.123





GN
GGGAAT
2099.13
1823
0.868
−0.141





GN
GGCAAT
2915.36
2061
0.707
−0.347





GN
GGTAAT
1392.08
784
0.563
−0.574





GN
GGTAAC
1533.21
785
0.512
−0.669





GP
GGGCCC
2634.22
3947
1.498
0.404





GP
GGGCCG
954.47
1417
1.485
0.395





GP
GGCCCC
3658.52
4576
1.251
0.224





GP
GGCCCG
1325.61
1623
1.224
0.202





GP
GGTCCT
1564.62
1910
1.221
0.199





GP
GGGCCT
2359.31
2542
1.077
0.075





GP
GGTCCC
1746.93
1827
1.046
0.045





GP
GGCCCT
3276.71
2994
0.914
−0.090





GP
GGGCCA
2277.03
2003
0.880
−0.128





GP
GGTCCA
1510.06
1264
0.837
−0.178





GP
GGACCC
2698.30
2240
0.830
−0.186





GP
GGACCA
2332.42
1908
0.818
−0.201





GP
GGACCT
2416.70
1957
0.810
−0.211





GP
GGCCCA
3162.44
2548
0.806
−0.216





GP
GGTCCG
632.98
351
0.555
−0.590





GP
GGACCG
977.69
421
0.431
−0.843





GQ
GGACAA
1382.58
1677
1.213
0.193





GQ
GGGCAG
3769.06
4425
1.174
0.160





GQ
GGCCAG
5234.64
6081
1.162
0.150





GQ
GGTCAA
895.11
953
1.065
0.063





GQ
GGCCAA
1874.58
1593
0.850
−0.163





GQ
GGGCAA
1349.74
1124
0.833
−0.183





GQ
GGACAG
3860.75
3134
0.812
−0.209





GQ
GGTCAG
2499.53
1879
0.752
−0.285





GR
GGCCGC
1832.29
3615
1.973
0.680





GR
GGAAGA
1490.60
2294
1.539
0.431





GR
GGCCGG
2003.98
2892
1.443
0.367





GR
GGCCGT
784.47
1022
1.303
0.265





GR
GGTCGT
374.58
450
1.201
0.183





GR
GGCCGA
1086.32
1252
1.153
0.142





GR
GGGCGC
1319.29
1471
1.115
0.109





GR
GGTCGA
518.71
546
1.053
0.051





GR
GGCAGG
1984.13
2022
1.019
0.019





GR
GGGAGG
1428.62
1435
1.004
0.004





GR
GGGCGG
1442.91
1437
0.996
−0.004





GR
GGAAGG
1463.37
1370
0.936
−0.066





GR
GGGAGA
1455.20
1344
0.924
−0.079





GR
GGACGT
578.58
514
0.888
−0.118





GR
GGACGA
801.20
671
0.837
−0.177





GR
GGGCGT
564.84
471
0.834
−0.182





GR
GGCAGA
2021.05
1684
0.833
−0.182





GR
GGGCGA
782.17
626
0.800
−0.223





GR
GGTCGC
874.92
596
0.681
−0.384





GR
GGTCGG
956.90
555
0.580
−0.545





GR
GGTAGA
965.05
529
0.548
−0.601





GR
GGACGC
1351.39
729
0.539
−0.617





GR
GGACGG
1478.01
737
0.499
−0.696





GR
GGTAGG
947.42
244
0.258
−1.357





GS
GGCAGC
3581.32
6542
1.827
0.603





GS
GGCTCC
3161.05
5376
1.701
0.531





GS
GGCTCG
835.91
1323
1.583
0.459





GS
GGCAGT
2259.47
2875
1.272
0.241





GS
GGAAGT
1666.45
2085
1.251
0.224





GS
GGTTCT
1313.02
1563
1.190
0.174





GS
GGCTCT
2749.80
3087
1.123
0.116





GS
GGGAGC
2578.63
2566
0.995
−0.005





GS
GGTTCC
1509.39
1428
0.946
−0.055





GS
GGCTCA
2223.05
2101
0.945
−0.056





GS
GGTTCA
1061.50
981
0.924
−0.079





GS
GGAAGC
2641.36
2137
0.809
−0.212





GS
GGATCA
1639.59
1281
0.781
−0.247





GS
GGGAGT
1626.88
1267
0.779
−0.250





GS
GGATCT
2028.08
1470
0.725
−0.322





GS
GGGTCC
2276.03
1646
0.723
−0.324





GS
GGGTCT
1979.92
1280
0.646
−0.436





GS
GGGTCG
601.87
379
0.630
−0.463





GS
GGTAGT
1078.89
646
0.599
−0.513





GS
GGATCC
2331.40
1342
0.576
−0.552





GS
GGGTCA
1600.65
887
0.554
−0.590





GS
GGTTCG
399.14
209
0.524
−0.647





GS
GGATCG
616.51
276
0.448
−0.804





GS
GGTAGC
1710.07
723
0.423
−0.861





GT
GGCACC
3271.07
4870
1.489
0.398





GT
GGCACG
1074.53
1368
1.273
0.241





GT
GGGACC
2355.25
2817
1.196
0.179





GT
GGAACA
1953.05
2290
1.173
0.159





GT
GGAACT
1727.13
1900
1.100
0.095





GT
GGGACG
773.69
838
1.083
0.080





GT
GGGACA
1906.66
1903
0.998
−0.002





GT
GGCACT
2341.75
2331
0.995
−0.005





GT
GGCACA
2648.06
2499
0.944
−0.058





GT
GGGACT
1686.11
1534
0.910
−0.095





GT
GGAACC
2412.54
1841
0.763
−0.270





GT
GGTACT
1118.18
840
0.751
−0.286





GT
GGTACC
1561.93
994
0.636
−0.452





GT
GGTACA
1264.44
780
0.617
−0.483





GT
GGAACG
792.51
445
0.562
−0.577





GT
GGTACG
513.09
150
0.292
−1.230





GV
GGTGTT
816.93
1802
2.206
0.791





GV
GGTGTC
1045.94
2070
1.979
0.683





GV
GGTGTA
530.46
957
1.804
0.590





GV
GGTGTG
2069.18
3207
1.550
0.438





GV
GGAGTA
819.35
1225
1.495
0.402





GV
GGAGTT
1261.83
1841
1.459
0.378





GV
GGGGTC
1577.18
2150
1.363
0.310





GV
GGAGTC
1615.55
1839
1.138
0.130





GV
GGGGTT
1231.86
1123
0.912
−0.093





GV
GGGGTG
3120.14
2770
0.888
−0.119





GV
GGAGTG
3196.04
2641
0.826
−0.191





GV
GGGGTA
799.89
631
0.789
−0.237





GV
GGCGTC
2190.46
1653
0.755
−0.282





GV
GGCGTG
4333.39
2790
0.644
−0.440





GV
GGCGTT
1710.87
499
0.292
−1.232





GV
GGCGTA
1110.93
232
0.209
−1.566





GW
GGCTGG
2102.85
3748
1.782
0.578





GW
GGTTGG
1004.11
690
0.687
−0.375





GW
GGATGG
1550.94
1012
0.653
−0.427





GW
GGGTGG
1514.10
722
0.477
−0.741





GY
GGCTAC
2577.81
4581
1.777
0.575





GY
GGTTAT
1000.20
1309
1.309
0.269





GY
GGCTAT
2094.66
2528
1.207
0.188





GY
GGATAT
1544.90
1478
0.957
−0.044





GY
GGTTAC
1230.90
1074
0.873
−0.136





GY
GGATAC
1901.24
1052
0.553
−0.592





GY
GGGTAC
1856.09
982
0.529
−0.637





GY
GGGTAT
1508.21
710
0.471
−0.753





HA
CATGCT
1101.90
1959
1.778
0.575





HA
CATGCA
964.61
1670
1.731
0.549





HA
CATGCC
1675.52
2408
1.437
0.363





HA
CACGCG
624.72
681
1.090
0.086





HA
CATGCG
453.03
447
0.987
−0.013





HA
CACGCC
2310.52
1649
0.714
−0.337





HA
CACGCA
1330.18
617
0.464
−0.768





HA
CACGCT
1519.52
549
0.361
−1.018





HC
CACTGC
1778.65
2629
1.478
0.391





HC
CACTGT
1498.13
1717
1.146
0.136





HC
CATTGT
1086.40
673
0.619
−0.479





HC
CATTGC
1289.82
634
0.492
−0.710





HD
CATGAT
1329.76
2349
1.766
0.569





HD
CATGAC
1502.11
2329
1.550
0.439





HD
CACGAC
2071.40
1343
0.648
−0.433





HD
CACGAT
1833.73
716
0.390
−0.940





HE
CATGAA
1769.46
3512
1.985
0.686





HE
CATGAG
2366.33
3307
1.398
0.335





HE
CACGAG
3263.15
2230
0.683
−0.381





HE
CACGAA
2440.07
790
0.324
−1.128





HF
CACTTC
2538.66
3116
1.227
0.205





HF
CATTTT
1608.41
1806
1.123
0.116





HF
CACTTT
2217.98
1884
0.849
−0.163





HF
CATTTC
1840.95
1400
0.760
−0.274





HG
CATGGA
1246.72
2238
1.795
0.585





HG
CATGGT
807.15
1426
1.767
0.569





HG
CATGGG
1217.11
1849
1.519
0.418





HG
CATGGC
1690.37
2320
1.372
0.317





HG
CACGGC
2331.01
1680
0.721
−0.328





HG
CACGGG
1678.38
1184
0.705
−0.349





HG
CACGGT
1113.05
468
0.420
−0.866





HG
CACGGA
1719.21
638
0.371
−0.991





HH
CACCAC
2269.33
2795
1.232
0.208





HH
CATCAT
1193.37
1250
1.047
0.046





HH
CACCAT
1645.65
1453
0.883
−0.125





HH
CATCAC
1645.65
1256
0.763
−0.270





HI
CACATC
2433.52
3538
1.454
0.374





HI
CACATT
1924.40
1924
1.000
0.000





HI
CACATA
885.05
867
0.980
−0.021





HI
CATATT
1395.51
1260
0.903
−0.102





HI
CATATA
641.81
552
0.860
−0.151





HI
CATATC
1764.71
904
0.512
−0.669





HK
CACAAG
3102.81
3928
1.266
0.236





HK
CACAAA
2395.79
2432
1.015
0.015





HK
CATAAA
1737.35
1690
0.973
−0.028





HK
CATAAG
2250.06
1436
0.638
−0.449





HL
CATTTA
707.71
1053
1.488
0.397





HL
CATTTG
1188.90
1485
1.249
0.222





HL
CACCTG
5042.69
6030
1.196
0.179





HL
CACCTC
2426.56
2850
1.175
0.161





HL
CATCTT
1213.36
1409
1.161
0.149





HL
CACTTG
1639.48
1700
1.037
0.036





HL
CATCTA
654.36
649
0.992
−0.008





HL
CACCTT
1673.21
1499
0.896
−0.110





HL
CACCTA
902.35
761
0.843
−0.170





HL
CATCTC
1759.66
1422
0.808
−0.213





HL
CACTTA
975.93
781
0.800
−0.223





HL
CATCTG
3656.80
2202
0.602
−0.507





HM
CACATG
2348.18
3023
1.287
0.253





HM
CATATG
1702.82
1028
0.604
−0.505





HN
CACAAC
2031.88
2762
1.359
0.307





HN
CACAAT
1844.85
1832
0.993
−0.007





HN
CATAAT
1337.83
1225
0.916
−0.088





HN
CATAAC
1473.45
869
0.590
−0.528





HP
CACCCG
846.94
1341
1.583
0.460





HP
CATCCT
1518.15
1770
1.166
0.153





HP
CACCCC
2337.46
2530
1.082
0.079





HP
CATCCA
1465.21
1577
1.076
0.074





HP
CACCCA
2020.51
1919
0.950
−0.052





HP
CACCCT
2093.51
1859
0.888
−0.119





HP
CATCCC
1695.05
1265
0.746
−0.293





HP
CATCCG
614.18
330
0.537
−0.621





HQ
CATCAA
1143.96
1358
1.187
0.172





HQ
CACCAG
4405.09
4761
1.081
0.078





HQ
CATCAG
3194.43
2957
0.926
−0.077





HQ
CACCAA
1577.51
1245
0.789
−0.237





HR
CACAGG
1447.19
1936
1.338
0.291





HR
CACCGC
1336.44
1772
1.326
0.282





HR
CACAGA
1474.12
1788
1.213
0.193





HR
CACCGG
1461.67
1772
1.212
0.193





HR
CACCGT
572.18
667
1.166
0.153





HR
CATCGA
574.58
627
1.091
0.087





HR
CATCGT
414.93
452
1.089
0.086





HR
CACCGA
792.34
855
1.079
0.076





HR
CATCGG
1059.96
729
0.688
−0.374





HR
CATAGA
1068.98
635
0.594
−0.521





HR
CATCGC
969.15
565
0.583
−0.540





HR
CATAGG
1049.46
423
0.403
−0.909





HS
CACTCG
551.81
880
1.595
0.467





HS
CACAGC
2364.16
3726
1.576
0.455





HS
CACAGT
1491.56
1957
1.312
0.272





HS
CATTCA
1064.20
1307
1.228
0.206





HS
CATTCT
1316.36
1517
1.152
0.142





HS
CACTCC
2086.72
1964
0.941
−0.061





HS
CACTCA
1467.52
1318
0.898
−0.107





HS
CATTCC
1513.23
1219
0.806
−0.216





HS
CACTCT
1815.24
1231
0.678
−0.388





HS
CATAGT
1081.63
710
0.656
−0.421





HS
CATTCG
400.16
256
0.640
−0.447





HS
CATAGC
1714.41
782
0.456
−0.785





HT
CACACG
778.62
1526
1.960
0.673





HT
CACACT
1696.86
2036
1.200
0.182





HT
CACACA
1918.82
2255
1.175
0.161





HT
CACACC
2370.26
2537
1.070
0.068





HT
CATACT
1230.51
1306
1.061
0.060





HT
CATACA
1391.46
979
0.704
−0.352





HT
CATACC
1718.84
806
0.469
−0.757





HT
CATACG
564.63
225
0.398
−0.920





HV
CATGTT
869.32
1563
1.798
0.587





HV
CATGTA
564.48
880
1.559
0.444





HV
CATGTC
1113.00
1607
1.444
0.367





HV
CATGTG
2201.86
2797
1.270
0.239





HV
CACGTG
3036.34
2579
0.849
−0.163





HV
CACGTC
1534.82
1158
0.754
−0.282





HV
CACGTT
1198.78
434
0.362
−1.016





HV
CACGTA
778.41
279
0.358
−1.026





HW
CACTGG
1602.74
2197
1.371
0.315





HW
CATTGG
1162.26
568
0.489
−0.716





HY
CACTAC
1943.40
2385
1.227
0.205





HY
CATTAT
1145.15
1240
1.083
0.080





HY
CACTAT
1579.16
1378
0.873
−0.136





HY
CATTAC
1409.29
1074
0.762
−0.272





IA
ATTGCT
1886.56
3678
1.950
0.668





IA
ATAGCA
759.54
1446
1.904
0.644





IA
ATTGCA
1651.49
2818
1.706
0.534





IA
ATAGCT
867.65
1289
1.486
0.396





IA
ATTGCC
2868.63
3435
1.197
0.180





IA
ATAGCC
1319.32
1191
0.903
−0.102





IA
ATCGCG
980.82
708
0.722
−0.326





IA
ATCGCC
3627.56
2570
0.708
−0.345





IA
ATTGCG
775.62
494
0.637
−0.451





IA
ATAGCG
356.72
198
0.555
−0.589





IA
ATCGCA
2088.41
831
0.398
−0.922





IA
ATCGCT
2385.67
910
0.381
−0.964





IC
ATCTGC
2115.05
3055
1.444
0.368





IC
ATCTGT
1781.48
2074
1.164
0.152





IC
ATATGT
647.91
731
1.128
0.121





IC
ATTTGT
1408.77
1197
0.850
−0.163





IC
ATATGC
769.23
470
0.611
−0.493





IC
ATTTGC
1672.56
868
0.519
−0.656





ID
ATTGAT
2604.76
4341
1.667
0.511





ID
ATAGAT
1197.96
1947
1.625
0.486





ID
ATTGAC
2942.37
3938
1.338
0.291





ID
ATAGAC
1353.23
1476
1.091
0.087





ID
ATCGAC
3720.81
2270
0.610
−0.494





ID
ATCGAT
3293.87
1141
0.346
−1.060





IE
ATAGAA
1371.51
2939
2.143
0.762





IE
ATTGAA
2982.12
5518
1.850
0.615





IE
ATTGAG
3988.04
4634
1.162
0.150





IE
ATAGAG
1834.15
1898
1.035
0.034





IE
ATCGAG
5043.12
3007
0.596
−0.517





IE
ATCGAA
3771.07
994
0.264
−1.333





IF
ATATTT
1144.73
1929
1.685
0.522





IF
ATCTTC
3602.60
4836
1.342
0.294





IF
ATTTTT
2489.02
2226
0.894
−0.112





IF
ATCTTT
3147.52
2779
0.883
−0.125





IF
ATATTC
1310.24
886
0.676
−0.391





IF
ATTTTC
2848.89
1887
0.662
−0.412





IG
ATTGGT
1013.16
2102
2.075
0.730





IG
ATTGGA
1564.91
3151
2.014
0.700





IG
ATAGGA
719.72
1054
1.464
0.381





IG
ATTGGG
1527.75
2144
1.403
0.339





IG
ATAGGT
465.96
596
1.279
0.246





IG
ATTGGC
2121.81
2706
1.275
0.243





IG
ATAGGG
702.63
549
0.781
−0.247





IG
ATAGGC
975.84
700
0.717
−0.332





IG
ATCGGG
1931.93
1244
0.644
−0.440





IG
ATCGGC
2683.15
1619
0.603
−0.505





IG
ATCGGT
1281.20
498
0.389
−0.945





IG
ATCGGA
1978.93
604
0.305
−1.187





IH
ATTCAT
1622.93
2242
1.381
0.323





IH
ATCCAC
2830.09
3367
1.190
0.174





IH
ATACAT
746.40
760
1.018
0.018





IH
ATCCAT
2052.29
1814
0.884
−0.123





IH
ATTCAC
2238.00
1778
0.794
−0.230





IH
ATACAC
1029.28
558
0.542
−0.612





II
ATCATC
3797.03
5979
1.575
0.454





II
ATAATA
502.24
700
1.394
0.332





II
ATAATT
1092.04
1309
1.199
0.181





II
ATCATT
3002.64
3321
1.106
0.101





II
ATTATT
2374.46
2157
0.908
−0.096





II
ATCATA
1380.95
1183
0.857
−0.155





II
ATTATA
1092.04
921
0.843
−0.170





II
ATAATC
1380.95
715
0.518
−0.658





II
ATTATC
3002.64
1340
0.446
−0.807





IK
ATAAAA
1419.09
2244
1.581
0.458





IK
ATCAAG
5053.39
5884
1.164
0.152





IK
ATAAAG
1837.88
1943
1.057
0.056





IK
ATTAAA
3085.58
3107
1.007
0.007





IK
ATCAAA
3901.90
3830
0.982
−0.019





IK
ATTAAG
3996.16
2286
0.572
−0.559





IL
ATTTTA
977.08
1679
1.718
0.541





IL
ATATTA
449.37
723
1.609
0.476





IL
ATTTTG
1641.41
2339
1.425
0.354





IL
ATTCTT
1675.18
2271
1.356
0.304





IL
ATCCTC
3072.14
4017
1.308
0.268





IL
ATCCTG
6384.29
7754
1.215
0.194





IL
ATTCTA
903.41
1021
1.130
0.122





IL
ATCTTG
2075.66
2250
1.084
0.081





IL
ATCCTA
1142.42
1170
1.024
0.024





IL
ATACTA
415.49
416
1.001
0.001





IL
ATCCTT
2118.37
2058
0.972
−0.029





IL
ATATTG
754.90
717
0.950
−0.052





IL
ATACTT
770.44
726
0.942
−0.059





IL
ATCTTA
1235.57
1077
0.872
−0.137





IL
ATTCTC
2429.41
1918
0.789
−0.236





IL
ATTCTG
5048.62
3005
0.595
−0.519





IL
ATACTC
1117.32
458
0.410
−0.892





IL
ATACTG
2321.92
934
0.402
−0.911





IM
ATCATG
3206.80
4314
1.345
0.297





IM
ATAATG
1166.29
1196
1.025
0.025





IM
ATTATG
2535.90
1399
0.552
−0.595





IN
ATAAAT
1088.42
1649
1.515
0.415





IN
ATCAAC
3296.07
4599
1.395
0.333





IN
ATCAAT
2992.68
2890
0.966
−0.035





IN
ATAAAC
1198.76
1113
0.928
−0.074





IN
ATTAAT
2366.58
1967
0.831
−0.185





IN
ATTAAC
2606.49
1331
0.511
−0.672





IP
ATTCCT
2051.78
2787
1.358
0.306





IP
ATTCCA
1980.23
2644
1.335
0.289





IP
ATACCA
910.73
1047
1.150
0.139





IP
ATCCCC
2896.94
3229
1.115
0.109





IP
ATACCT
943.64
995
1.054
0.053





IP
ATCCCG
1049.66
1073
1.022
0.022





IP
ATCCCA
2504.13
2366
0.945
−0.057





IP
ATCCCT
2594.61
2451
0.945
−0.057





IP
ATTCCC
2290.86
1775
0.775
−0.255





IP
ATACCC
1053.60
610
0.579
−0.547





IP
ATTCCG
830.06
386
0.465
−0.766





IP
ATACCG
381.76
125
0.327
−1.116





IQ
ATACAA
765.47
950
1.241
0.216





IQ
ATTCAA
1664.38
2045
1.229
0.206





IQ
ATCCAG
5877.26
6881
1.171
0.158





IQ
ATTCAG
4647.67
3987
0.858
−0.153





IQ
ATCCAA
2104.71
1765
0.839
−0.176





IQ
ATACAG
2137.52
1569
0.734
−0.309





IR
ATCCGC
1552.18
2623
1.690
0.525





IR
ATTCGA
727.72
1142
1.569
0.451





IR
ATCCGA
920.25
1434
1.558
0.444





IR
ATCCGT
664.55
943
1.419
0.350





IR
ATAAGA
622.67
877
1.408
0.342





IR
ATCCGG
1697.63
2265
1.334
0.288





IR
ATTCGT
525.51
677
1.288
0.253





IR
ATCAGA
1712.09
1680
0.981
−0.019





IR
ATCAGG
1680.81
1513
0.900
−0.105





IR
ATAAGG
611.30
547
0.895
−0.111





IR
ATACGT
241.69
213
0.881
−0.126





IR
ATACGA
334.69
292
0.872
−0.136





IR
ATTCGG
1342.46
907
0.676
−0.392





IR
ATTAGA
1353.90
900
0.665
−0.408





IR
ATTCGC
1227.45
780
0.635
−0.453





IR
ATACGG
617.42
260
0.421
−0.865





IR
ATTAGG
1329.16
503
0.378
−0.972





IR
ATACGC
564.52
170
0.301
−1.200





IS
ATCTCC
2689.59
3743
1.392
0.330





IS
ATATCA
687.92
954
1.387
0.327





IS
ATCAGC
3047.17
3998
1.312
0.272





IS
ATTTCT
1850.19
2423
1.310
0.270





IS
ATTTCA
1495.77
1957
1.308
0.269





IS
ATCAGT
1922.48
2287
1.190
0.174





IS
ATATCT
850.92
1012
1.189
0.173





IS
ATCTCG
711.23
773
1.087
0.083





IS
ATAAGT
699.19
695
0.994
−0.006





IS
ATCTCT
2339.68
2317
0.990
−0.010





IS
ATCTCA
1891.49
1767
0.934
−0.068





IS
ATTTCC
2126.89
1795
0.844
−0.170





IS
ATATCC
978.18
703
0.719
−0.330





IS
ATTAGT
1520.28
906
0.596
−0.518





IS
ATAAGC
1108.24
636
0.574
−0.555





IS
ATATCG
258.67
132
0.510
−0.673





IS
ATTTCG
562.43
255
0.453
−0.791





IS
ATTAGC
2409.67
797
0.331
−1.106





IT
ATCACC
3094.94
4722
1.526
0.422





IT
ATCACG
1016.68
1306
1.285
0.250





IT
ATAACT
805.82
1009
1.252
0.225





IT
ATCACT
2215.66
2751
1.242
0.216





IT
ATCACA
2505.48
2989
1.193
0.176





IT
ATAACA
911.22
1079
1.184
0.169





IT
ATTACT
1752.12
1369
0.781
−0.247





IT
ATTACA
1981.30
1531
0.773
−0.258





IT
ATAACC
1125.61
741
0.658
−0.418





IT
ATAACG
369.76
204
0.552
−0.595





IT
ATTACC
2447.44
1083
0.443
−0.815





IT
ATTACG
803.98
246
0.306
−1.184





IV
ATTGTT
1261.28
2414
1.914
0.649





IV
ATTGTA
819.00
1478
1.805
0.590





IV
ATAGTA
376.67
645
1.712
0.538





IV
ATAGTT
580.08
877
1.512
0.413





IV
ATTGTC
1614.84
2315
1.434
0.360





IV
ATTGTG
3194.65
3762
1.178
0.163





IV
ATCGTC
2042.07
1679
0.822
−0.196





IV
ATAGTG
1469.26
1196
0.814
−0.206





IV
ATAGTC
742.69
575
0.774
−0.256





IV
ATCGTG
4039.83
2922
0.723
−0.324





IV
ATCGTA
1035.67
361
0.349
−1.054





IV
ATCGTT
1594.97
547
0.343
−1.070





IW
ATCTGG
1887.23
2427
1.286
0.252





IW
ATATGG
686.37
622
0.906
−0.098





IW
ATTTGG
1492.40
1017
0.681
−0.384





IY
ATCTAC
2708.47
3486
1.287
0.252





IY
ATATAT
800.43
953
1.191
0.174





IY
ATTTAT
1740.39
1984
1.140
0.131





IY
ATCTAT
2200.83
2196
0.998
−0.002





IY
ATTTAC
2141.83
1403
0.655
−0.423





IY
ATATAC
985.05
555
0.563
−0.574





KA
AAAGCA
3029.93
4322
1.426
0.355





KA
AAAGCT
3461.21
4262
1.231
0.208





KA
AAGGCC
6816.15
6676
0.979
−0.021





KA
AAGGCG
1842.96
1790
0.971
−0.029





KA
AAGGCA
3924.10
3654
0.931
−0.071





KA
AAAGCC
5262.99
4742
0.901
−0.104





KA
AAGGCT
4482.65
4032
0.899
−0.106





KA
AAAGCG
1423.01
765
0.538
−0.621





KC
AAATGT
1815.55
2671
1.471
0.386





KC
AAGTGT
2351.33
2267
0.964
−0.037





KC
AAGTGC
2791.62
2498
0.895
−0.111





KC
AAATGC
2155.50
1678
0.778
−0.250





KD
AAAGAT
4684.00
6115
1.306
0.267





KD
AAGGAC
6852.58
6836
0.998
−0.002





KD
AAGGAT
6066.30
5379
0.887
−0.120





KD
AAAGAC
5291.12
4564
0.863
−0.148





KE
AAAGAA
6989.41
9895
1.416
0.348





KE
AAGGAG
12105.47
12287
1.015
0.015





KE
AAGGAA
9052.06
8366
0.924
−0.079





KE
AAAGAG
9347.06
6946
0.743
−0.297





KF
AAATTT
2631.62
3140
1.193
0.177





KF
AAGTTT
3408.25
3638
1.067
0.065





KF
AAGTTC
3901.02
3950
1.013
0.012





KF
AAATTC
3012.11
2225
0.739
−0.303





KG
AAAGGA
2672.15
4509
1.687
0.523





KG
AAAGGT
1730.00
2402
1.388
0.328





KG
AAAGGC
3623.06
3435
0.948
−0.053





KG
AAAGGG
2608.69
2465
0.945
−0.057





KG
AAGGGC
4692.27
4309
0.918
−0.085





KG
AAGGGT
2240.55
1978
0.883
−0.125





KG
AAGGGG
3378.54
2740
0.811
−0.209





KG
AAGGGA
3460.73
2568
0.742
−0.298





KH
AAACAT
1929.29
2356
1.221
0.200





KH
AAGCAC
3445.60
3583
1.040
0.039





KH
AAGCAT
2498.64
2430
0.973
−0.028





KH
AAACAC
2660.47
2165
0.814
−0.206





KI
AAAATA
1547.96
2667
1.723
0.544





KI
AAAATT
3365.76
3894
1.157
0.146





KI
AAGATC
5512.26
5523
1.002
0.002





KI
AAGATA
2004.77
1943
0.969
−0.031





KI
AAGATT
4359.03
3732
0.856
−0.155





KI
AAAATC
4256.21
3287
0.772
−0.258





KK
AAGAAG
11070.03
13815
1.248
0.222





KK
AAGAAA
8547.55
10129
1.185
0.170





KK
AAAAAG
8547.55
6145
0.719
−0.330





KK
AAAAAA
6599.86
4676
0.708
−0.345





KL
AAATTA
1273.72
2084
1.636
0.492





KL
AAACTA
1177.70
1750
1.486
0.396





KL
AAACTT
2183.78
3014
1.380
0.322





KL
AAGCTG
8523.68
9600
1.126
0.119





KL
AAGCTA
1525.25
1660
1.088
0.085





KL
AAGCTC
4101.62
4076
0.994
−0.006





KL
AAATTG
2139.75
2113
0.987
−0.013





KL
AAGCTT
2828.24
2772
0.980
−0.020





KL
AAGTTA
1649.61
1459
0.884
−0.123





KL
AAACTC
3167.00
2653
0.838
−0.177





KL
AAGTTG
2771.21
2280
0.823
−0.195





KL
AAACTG
6581.43
4462
0.678
−0.389





KM
AAGATG
5479.27
5650
1.031
0.031





KM
AAAATG
4230.73
4060
0.960
−0.041





KN
AAAAAT
3683.47
4378
1.189
0.173





KN
AAGAAC
5254.13
5515
1.050
0.048





KN
AAGAAT
4770.51
4618
0.968
−0.032





KN
AAAAAC
4056.89
3254
0.802
−0.221





KP
AAACCA
2803.51
3370
1.202
0.184





KP
AAGCCC
4200.41
4673
1.113
0.107





KP
AAGCCA
3630.85
4035
1.111
0.106





KP
AAACCT
2904.80
3118
1.073
0.071





KP
AAGCCG
1521.96
1544
1.014
0.014





KP
AAGCCT
3762.04
3396
0.903
−0.102





KP
AAACCC
3243.28
2624
0.809
−0.212





KP
AAACCG
1175.16
482
0.410
−0.891





KQ
AAACAA
2178.87
3274
1.503
0.407





KQ
AAGCAA
2821.88
3177
1.126
0.119





KQ
AAGCAG
7879.90
8081
1.026
0.025





KQ
AAACAG
6084.35
4433
0.729
−0.317





KR
AAAAGA
2247.57
3147
1.400
0.337





KR
AAGAGG
2857.67
3975
1.391
0.330





KR
AAGAGA
2910.85
3511
1.206
0.187





KR
AAAAGG
2206.51
2325
1.054
0.052





KR
AAACGT
872.39
862
0.988
−0.012





KR
AAGCGG
2886.27
2828
0.980
−0.020





KR
AAGCGC
2638.99
2532
0.959
−0.041





KR
AAACGA
1208.07
1087
0.900
−0.106





KR
AAGCGT
1129.84
978
0.866
−0.144





KR
AAGCGA
1564.59
1325
0.847
−0.166





KR
AAACGG
2228.59
1178
0.529
−0.638





KR
AAACGC
2037.65
1041
0.511
−0.672





KS
AAATCA
1871.14
2533
1.354
0.303





KS
AAAAGT
1901.80
2389
1.256
0.228





KS
AAATCT
2314.50
2793
1.207
0.188





KS
AAGTCA
2423.33
2566
1.059
0.057





KS
AAGAGC
3903.97
4045
1.036
0.035





KS
AAGAGT
2463.04
2459
0.998
−0.002





KS
AAGTCG
911.22
904
0.992
−0.008





KS
AAGTCC
3445.84
3100
0.900
−0.106





KS
AAGTCT
2997.54
2675
0.892
−0.114





KS
AAATCC
2660.65
2304
0.866
−0.144





KS
AAAAGC
3014.39
2381
0.790
−0.236





KS
AAATCG
703.58
462
0.657
−0.421





KT
AAAACA
2831.74
3611
1.275
0.243





KT
AAGACG
1488.17
1790
1.203
0.185





KT
AAAACT
2504.18
2969
1.186
0.170





KT
AAGACC
4530.26
4475
0.988
−0.012





KT
AAGACA
3667.42
3574
0.975
−0.026





KT
AAGACT
3243.20
2876
0.887
−0.120





KT
AAAACC
3497.97
2854
0.816
−0.203





KT
AAAACG
1149.07
763
0.664
−0.409





KV
AAAGTA
1317.00
2214
1.681
0.519





KV
AAAGTT
2028.22
3042
1.500
0.405





KV
AAAGTC
2596.78
2642
1.017
0.017





KV
AAGGTG
6653.25
6512
0.979
−0.021





KV
AAGGTC
3363.11
3016
0.897
−0.109





KV
AAGGTT
2626.77
2294
0.873
−0.135





KV
AAAGTG
5137.21
4417
0.860
−0.151





KV
AAGGTA
1705.66
1291
0.757
−0.279





KW
AAGTGG
2598.56
2701
1.039
0.039





KW
AAATGG
2006.44
1904
0.949
−0.052





KY
AAATAT
2319.32
2982
1.286
0.251





KY
AAGTAC
3696.62
3603
0.975
−0.026





KY
AAATAC
2854.29
2763
0.968
−0.033





KY
AAGTAT
3003.78
2526
0.841
−0.173





LA
CTGGCG
2275.39
3643
1.601
0.471





LA
TTGGCA
1575.16
2350
1.492
0.400





LA
CTGGCC
8415.49
12456
1.480
0.392





LA
TTGGCT
1799.36
2643
1.469
0.384





LA
TTAGCA
937.64
1314
1.401
0.337





LA
CTTGCT
1836.39
2345
1.277
0.244





LA
CTAGCA
866.95
1107
1.277
0.244





LA
CTTGCA
1607.57
1861
1.158
0.146





LA
TTAGCT
1071.10
1239
1.157
0.146





LA
CTGGCT
5534.46
6333
1.144
0.135





LA
CTAGCT
990.35
1099
1.110
0.104





LA
CTGGCA
4844.85
5013
1.035
0.034





LA
TTGGCC
2736.04
2824
1.032
0.032





LA
TTGGCG
739.77
623
0.842
−0.172





LA
CTTGCC
2792.34
2201
0.788
−0.238





LA
CTAGCC
1505.89
1159
0.770
−0.262





LA
CTAGCG
407.16
253
0.621
−0.476





LA
TTAGCC
1628.68
941
0.578
−0.549





LA
CTTGCG
755.00
346
0.458
−0.780





LA
TTAGCG
440.36
198
0.450
−0.799





LA
CTCGCC
4049.56
1527
0.377
−0.975





LA
CTCGCG
1094.93
390
0.356
−1.032





LA
CTCGCT
2663.20
605
0.227
−1.482





LA
CTCGCA
2331.36
429
0.184
−1.693





LC
CTCTGC
1769.27
3523
1.991
0.689





LC
CTCTGT
1490.23
2145
1.439
0.364





LC
CTTTGT
1027.58
1155
1.124
0.117





LC
TTATGT
599.35
627
1.046
0.045





LC
CTGTGC
3676.77
3517
0.957
−0.044





LC
TTGTGT
1006.86
856
0.850
−0.162





LC
CTTTGC
1219.99
974
0.798
−0.225





LC
CTGTGT
3096.89
2370
0.765
−0.268





LC
CTATGT
554.17
417
0.752
−0.284





LC
TTGTGC
1195.39
722
0.604
−0.504





LC
TTATGC
711.58
368
0.517
−0.659





LC
CTATGC
657.93
332
0.505
−0.684





LD
TTGGAT
2174.51
3688
1.696
0.528





LD
TTAGAT
1294.41
1977
1.527
0.424





LD
CTGGAC
7555.23
10531
1.394
0.332





LD
CTAGAT
1196.83
1584
1.323
0.280





LD
TTGGAC
2456.35
2775
1.130
0.122





LD
CTTGAT
2219.25
2463
1.110
0.104





LD
CTGGAT
6688.33
6912
1.033
0.033





LD
CTAGAC
1351.95
1390
1.028
0.028





LD
CTTGAC
2506.90
1832
0.731
−0.314





LD
TTAGAC
1462.19
969
0.663
−0.411





LD
CTCGAC
3635.60
981
0.270
−1.310





LD
CTCGAT
3218.44
658
0.204
−1.587





LE
TTAGAA
1739.66
3085
1.773
0.573





LE
CTAGAA
1608.51
2701
1.679
0.518





LE
TTGGAA
2922.49
4652
1.592
0.465





LE
CTGGAG
12021.09
18044
1.501
0.406





LE
TTGGAG
3908.29
4774
1.222
0.200





LE
CTAGAG
2151.09
2515
1.169
0.156





LE
CTTGAA
2982.63
3161
1.060
0.058





LE
CTGGAA
8988.96
7642
0.850
−0.162





LE
TTAGAG
2326.48
1873
0.805
−0.217





LE
CTTGAG
3988.72
2484
0.623
−0.474





LE
CTCGAG
5784.58
1305
0.226
−1.489





LE
CTCGAA
4325.51
512
0.118
−2.134





LF
CTCTTC
2629.18
6495
2.470
0.904





LF
TTATTT
923.85
1405
1.521
0.419





LF
CTCTTT
2297.07
3446
1.500
0.406





LF
CTTTTT
1583.93
1937
1.223
0.201





LF
CTTTTC
1812.93
1936
1.068
0.066





LF
CTATTT
854.20
876
1.026
0.025





LF
TTGTTT
1551.99
1544
0.995
−0.005





LF
CTGTTT
4773.59
2957
0.619
−0.479





LF
CTGTTC
5463.77
3119
0.571
−0.561





LF
TTATTC
1057.42
583
0.551
−0.595





LF
TTGTTC
1776.38
940
0.529
−0.636





LF
CTATTC
977.70
464
0.475
−0.745





LG
CTTGGA
1534.14
2667
1.738
0.553





LG
CTTGGT
993.23
1579
1.590
0.464





LG
CTGGGC
6268.87
9794
1.562
0.446





LG
CTAGGA
827.35
1087
1.314
0.273





LG
CTTGGG
1497.70
1881
1.256
0.228





LG
TTAGGA
894.81
1114
1.245
0.219





LG
CTGGGG
4513.74
5602
1.241
0.216





LG
TTGGGT
973.20
1194
1.227
0.204





LG
TTGGGA
1503.20
1820
1.211
0.191





LG
CTAGGT
535.64
611
1.141
0.132





LG
TTAGGT
579.32
611
1.055
0.053





LG
TTGGGG
1467.50
1452
0.989
−0.011





LG
CTGGGT
2993.37
2947
0.985
−0.016





LG
CTTGGC
2080.08
2009
0.966
−0.035





LG
CTAGGG
807.70
766
0.948
−0.053





LG
TTGGGC
2038.13
1786
0.876
−0.132





LG
CTGGGA
4623.54
4034
0.872
−0.136





LG
CTAGGC
1121.77
940
0.838
−0.177





LG
TTAGGG
873.56
529
0.606
−0.502





LG
CTCGGG
2172.02
1076
0.495
−0.702





LG
CTCGGC
3016.60
1313
0.435
−0.832





LG
TTAGGC
1213.24
507
0.418
−0.873





LG
CTCGGT
1440.42
365
0.253
−1.373





LG
CTCGGA
2224.86
510
0.229
−1.473





LH
CTTCAT
1127.31
1980
1.756
0.563





LH
TTACAT
657.52
935
1.422
0.352





LH
CTACAT
607.95
741
1.219
0.198





LH
CTGCAC
4685.05
5459
1.165
0.153





LH
CTCCAC
2254.46
2204
0.978
−0.023





LH
CTTCAC
1554.55
1490
0.958
−0.042





LH
CTCCAT
1634.86
1521
0.930
−0.072





LH
CTACAC
838.36
777
0.927
−0.076





LH
TTGCAT
1104.58
1017
0.921
−0.083





LH
TTGCAC
1523.20
1140
0.748
−0.290





LH
CTGCAT
3397.45
2394
0.705
−0.350





LH
TTACAC
906.71
634
0.699
−0.358





LI
CTCATC
2602.42
6250
2.402
0.876





LI
TTAATA
380.66
798
2.096
0.740





LI
TTAATT
827.68
1290
1.559
0.444





LI
CTCATT
2057.96
3117
1.515
0.415





LI
CTAATA
351.96
516
1.466
0.383





LI
CTAATT
765.28
952
1.244
0.218





LI
CTTATT
1419.05
1761
1.241
0.216





LI
TTGATA
639.48
791
1.237
0.213





LI
TTGATT
1390.44
1468
1.056
0.054





LI
CTTATA
652.64
683
1.047
0.045





LI
CTCATA
946.48
919
0.971
−0.029





LI
CTTATC
1794.48
1189
0.663
−0.412





LI
TTGATC
1758.29
1135
0.646
−0.438





LI
CTGATC
5408.15
3356
0.621
−0.477





LI
CTGATT
4276.70
2639
0.617
−0.483





LI
CTGATA
1966.91
1193
0.607
−0.500





LI
TTAATC
1046.66
633
0.605
−0.503





LI
CTAATC
967.75
563
0.582
−0.542





LK
TTAAAA
1429.91
2557
1.788
0.581





LK
CTAAAA
1322.10
1842
1.393
0.332





LK
TTGAAA
2402.12
3193
1.329
0.285





LK
CTCAAG
4604.55
6048
1.313
0.273





LK
CTAAAG
1712.27
2078
1.214
0.194





LK
TTAAAG
1851.89
2128
1.149
0.139





LK
CTGAAG
9568.82
10212
1.067
0.065





LK
TTGAAG
3111.01
3222
1.036
0.035





LK
CTCAAA
3555.33
2768
0.779
−0.250





LK
CTTAAA
2451.55
1850
0.755
−0.282





LK
CTGAAA
7388.42
5227
0.707
−0.346





LK
CTTAAG
3175.03
1448
0.456
−0.785





LL
TTATTA
500.55
802
1.602
0.471





LL
CTTCTA
793.49
1132
1.427
0.355





LL
CTTCTT
1471.36
2099
1.427
0.355





LL
CTTTTA
858.19
1203
1.402
0.338





LL
CTGCTG
13364.10
18236
1.365
0.311





LL
CTTTTG
1441.69
1945
1.349
0.299





LL
TTACTA
462.82
608
1.314
0.273





LL
CTCCTC
3094.54
3800
1.228
0.205





LL
CTCCTG
6430.85
7786
1.211
0.191





LL
TTACTT
858.19
1039
1.211
0.191





LL
TTGCTA
777.49
929
1.195
0.178





LL
CTGCTC
6430.85
7550
1.174
0.160





LL
CTACTA
427.93
474
1.108
0.102





LL
CTTCTC
2133.82
2292
1.074
0.072





LL
CTACTT
793.49
839
1.057
0.056





LL
CTCTTG
2090.79
2131
1.019
0.019





LL
TTGCTT
1441.69
1464
1.015
0.015





LL
TTATTG
840.89
818
0.973
−0.028





LL
CTCCTT
2133.82
2034
0.953
−0.048





LL
TTGTTA
840.89
771
0.917
−0.087





LL
TTGTTG
1412.62
1289
0.912
−0.092





LL
CTCCTA
1150.75
1034
0.899
−0.107





LL
TTGCTG
4344.93
3820
0.879
−0.129





LL
CTTCTG
4434.34
3837
0.865
−0.145





LL
CTGCTA
2391.41
1913
0.800
−0.223





LL
CTCTTA
1244.58
959
0.771
−0.261





LL
CTATTA
462.82
354
0.765
−0.268





LL
CTGCTT
4434.34
3148
0.710
−0.343





LL
TTGCTC
2090.79
1440
0.689
−0.373





LL
CTACTC
1150.75
792
0.688
−0.374





LL
CTATTG
777.49
532
0.684
−0.379





LL
CTACTG
2391.41
1583
0.662
−0.413





LL
CTGTTG
4344.93
2615
0.602
−0.508





LL
TTACTC
1244.58
657
0.528
−0.639





LL
TTACTG
2586.40
1358
0.525
−0.644





LL
CTGTTA
2586.40
953
0.368
−0.998





LM
CTCATG
2631.41
4030
1.531
0.426





LM
TTAATG
1058.32
1228
1.160
0.149





LM
CTAATG
978.53
1101
1.125
0.118





LM
TTGATG
1777.88
1763
0.992
−0.008





LM
CTGATG
5468.39
4470
0.817
−0.202





LM
CTTATG
1814.47
1137
0.627
−0.467





LN
TTAAAT
962.36
1926
2.001
0.694





LN
CTCAAC
2635.40
4681
1.776
0.574





LN
CTAAAT
889.81
1446
1.625
0.486





LN
TTGAAT
1616.68
2048
1.267
0.236





LN
CTCAAT
2392.82
2652
1.108
0.103





LN
CTAAAC
980.01
922
0.941
−0.061





LN
TTAAAC
1059.92
965
0.910
−0.094





LN
CTTAAT
1649.95
1441
0.873
−0.135





LN
TTGAAC
1780.58
1541
0.865
−0.145





LN
CTGAAC
5476.68
4308
0.787
−0.240





LN
CTGAAT
4972.58
3413
0.686
−0.376





LN
CTTAAC
1817.22
891
0.490
−0.713





LP
CTTCCT
1728.14
2795
1.617
0.481





LP
CTTCCA
1667.88
2369
1.420
0.351





LP
CTGCCC
5815.10
7856
1.351
0.301





LP
TTACCT
1007.96
1244
1.234
0.210





LP
CTGCCG
2107.02
2489
1.181
0.167





LP
TTACCA
972.81
1140
1.172
0.159





LP
CTCCCG
1013.90
1184
1.168
0.155





LP
TTGCCA
1634.25
1897
1.161
0.149





LP
CTACCT
931.97
1045
1.121
0.114





LP
TTGCCT
1693.30
1800
1.063
0.061





LP
CTTCCC
1929.51
1889
0.979
−0.021





LP
CTACCA
899.47
850
0.945
−0.057





LP
CTCCCA
2418.82
2126
0.879
−0.129





LP
CTGCCT
5208.23
4563
0.876
−0.132





LP
CTCCCT
2506.21
2192
0.875
−0.134





LP
CTACCC
1040.57
888
0.853
−0.159





LP
CTCCCC
2798.25
2369
0.847
−0.167





LP
TTGCCC
1890.60
1560
0.825
−0.192





LP
TTGCCG
685.03
478
0.698
−0.360





LP
CTGCCA
5026.60
3348
0.666
−0.406





LP
CTTCCG
699.13
451
0.645
−0.438





LP
TTACCC
1125.42
666
0.592
−0.525





LP
CTACCG
377.04
211
0.560
−0.580





LP
TTACCG
407.78
175
0.429
−0.846





LQ
TTACAA
864.28
1290
1.493
0.401





LQ
CTACAA
799.12
1188
1.487
0.397





LQ
CTTCAA
1481.79
2098
1.416
0.348





LQ
CTACAG
2231.48
2674
1.198
0.181





LQ
CTGCAG
12470.36
14508
1.163
0.151





LQ
CTTCAG
4137.79
4363
1.054
0.053





LQ
TTGCAA
1451.91
1467
1.010
0.010





LQ
CTCCAG
6000.78
5430
0.905
−0.100





LQ
TTACAG
2413.43
2107
0.873
−0.136





LQ
TTGCAG
4054.36
3177
0.784
−0.244





LQ
CTCCAA
2148.94
1524
0.709
−0.344





LQ
CTGCAA
4465.77
2694
0.603
−0.505





LR
CTTCGA
661.43
1365
2.064
0.725





LR
CTTCGT
477.64
784
1.641
0.496





LR
CTGCGG
3677.31
5467
1.487
0.397





LR
TTAAGA
717.74
1026
1.429
0.357





LR
CTGCGC
3362.26
4574
1.360
0.308





LR
CTCCGA
959.23
1289
1.344
0.295





LR
CTCCGG
1769.53
2229
1.260
0.231





LR
CTAAGA
663.63
821
1.237
0.213





LR
CTCAGG
1752.00
2047
1.168
0.156





LR
CTTCGG
1220.17
1415
1.160
0.148





LR
CTCCGT
692.69
771
1.113
0.107





LR
TTACGA
385.79
427
1.107
0.101





LR
CTAAGG
651.51
721
1.107
0.101





LR
CTCCGC
1617.93
1790
1.106
0.101





LR
TTGAGA
1205.75
1290
1.070
0.068





LR
CTACGT
257.59
275
1.068
0.065





LR
CTACGA
356.70
378
1.060
0.058





LR
CTGAGG
3640.88
3637
0.999
−0.001





LR
TTAAGG
704.63
678
0.962
−0.039





LR
TTACGT
278.59
264
0.948
−0.054





LR
CTGCGT
1439.50
1363
0.947
−0.055





LR
TTGAGG
1183.72
1080
0.912
−0.092





LR
CTACGG
658.03
577
0.877
−0.131





LR
CTCAGA
1784.60
1469
0.823
−0.195





LR
CTTCGC
1115.63
819
0.734
−0.309





LR
CTACGC
601.65
438
0.728
−0.317





LR
CTGCGA
1993.40
1399
0.702
−0.354





LR
TTGCGT
468.01
321
0.686
−0.377





LR
CTGAGA
3708.63
2486
0.670
−0.400





LR
TTGCGG
1195.56
772
0.646
−0.437





LR
TTGCGA
648.09
418
0.645
−0.439





LR
CTTAGA
1230.56
694
0.564
−0.573





LR
TTACGG
711.68
383
0.538
−0.620





LR
TTGCGC
1093.14
542
0.496
−0.702





LR
CTTAGG
1208.08
503
0.416
−0.876





LR
TTACGC
650.71
232
0.357
−1.031





LS
CTCAGC
2740.30
5167
1.886
0.634





LS
CTTTCT
1450.83
2502
1.725
0.545





LS
CTCTCC
2418.72
4070
1.683
0.520





LS
CTCTCG
639.61
1016
1.588
0.463





LS
CTCAGT
1728.87
2589
1.498
0.404





LS
TTATCA
684.12
963
1.408
0.342





LS
TTATCT
846.22
1175
1.389
0.328





LS
CTTTCA
1172.91
1626
1.386
0.327





LS
TTAAGT
695.33
886
1.274
0.242





LS
CTCTCT
2104.05
2553
1.213
0.193





LS
CTAAGT
642.91
770
1.198
0.180





LS
CTCTCA
1701.00
2003
1.178
0.163





LS
CTTTCC
1667.81
1819
1.091
0.087





LS
TTGTCA
1149.26
1210
1.053
0.052





LS
CTGTCG
1329.18
1392
1.047
0.046





LS
TTGTCT
1421.58
1461
1.028
0.027





LS
CTGAGC
5694.68
5805
1.019
0.019





LS
CTGTCC
5026.41
4628
0.921
−0.083





LS
TTGAGT
1168.09
1035
0.886
−0.121





LS
TTGTCC
1634.18
1334
0.816
−0.203





LS
CTATCA
632.54
512
0.809
−0.211





LS
CTAAGC
1019.02
791
0.776
−0.253





LS
TTATCC
972.78
727
0.747
−0.291





LS
CTGAGT
3592.81
2665
0.742
−0.299





LS
CTTAGT
1192.13
856
0.718
−0.331





LS
CTATCT
782.42
557
0.712
−0.340





LS
CTGTCT
4372.48
2950
0.675
−0.394





LS
CTTTCG
441.04
291
0.660
−0.416





LS
TTGTCG
432.14
278
0.643
−0.441





LS
CTGTCA
3534.89
2228
0.630
−0.462





LS
TTGAGC
1851.45
1128
0.609
−0.496





LS
CTATCC
899.44
541
0.601
−0.508





LS
TTATCG
257.24
152
0.591
−0.526





LS
TTAAGC
1102.11
551
0.500
−0.693





LS
CTATCG
237.85
102
0.429
−0.847





LS
CTTAGC
1889.55
793
0.420
−0.868





LT
CTCACC
2534.19
4959
1.957
0.671





LT
CTCACG
832.47
1510
1.814
0.595





LT
TTAACA
825.09
1163
1.410
0.343





LT
CTCACT
1814.22
2521
1.390
0.329





LT
TTAACT
729.65
969
1.328
0.284





LT
CTAACT
674.64
817
1.211
0.191





LT
CTAACA
762.89
898
1.177
0.163





LT
CTCACA
2051.52
2374
1.157
0.146





LT
CTGACG
1729.98
1795
1.038
0.037





LT
TTGACT
1225.76
1259
1.027
0.027





LT
TTGACA
1386.09
1401
1.011
0.011





LT
CTTACT
1250.98
1259
1.006
0.006





LT
CTGACC
5266.36
5160
0.980
−0.020





LT
CTTACA
1414.61
1109
0.784
−0.243





LT
CTGACT
3770.17
2808
0.745
−0.295





LT
TTGACC
1712.20
1235
0.721
−0.327





LT
CTAACC
942.38
678
0.719
−0.329





LT
TTGACG
562.45
399
0.709
−0.343





LT
CTGACA
4263.32
3003
0.704
−0.350





LT
CTAACG
309.57
215
0.695
−0.365





LT
TTAACC
1019.22
687
0.674
−0.394





LT
CTTACC
1747.43
1104
0.632
−0.459





LT
TTAACG
334.81
164
0.490
−0.714





LT
CTTACG
574.02
247
0.430
−0.843





LV
CTTGTT
1029.60
1741
1.691
0.525





LV
TTAGTA
389.95
602
1.544
0.434





LV
TTGGTA
655.07
980
1.496
0.403





LV
CTTGTA
668.56
993
1.485
0.396





LV
CTGGTG
7859.41
11424
1.454
0.374





LV
CTAGTA
360.55
519
1.439
0.364





LV
TTGGTT
1008.84
1427
1.414
0.347





LV
CTTGTC
1318.22
1541
1.169
0.156





LV
TTAGTT
600.53
690
1.149
0.139





LV
CTGGTC
3972.81
4541
1.143
0.134





LV
TTGGTG
2555.25
2882
1.128
0.120





LV
CTAGTT
555.26
580
1.045
0.044





LV
TTGGTC
1291.64
1345
1.041
0.040





LV
CTTGTG
2607.83
2540
0.974
−0.026





LV
CTAGTG
1406.38
1272
0.904
−0.100





LV
CTGGTA
2014.87
1720
0.854
−0.158





LV
CTGGTT
3102.98
2576
0.830
−0.186





LV
CTAGTC
710.90
551
0.775
−0.255





LV
TTAGTG
1521.06
947
0.623
−0.474





LV
TTAGTC
768.87
416
0.541
−0.614





LV
CTCGTC
1911.73
1013
0.530
−0.635





LV
CTCGTG
3781.97
1691
0.447
−0.805





LV
CTCGTT
1493.16
373
0.250
−1.387





LV
CTCGTA
969.56
191
0.197
−1.625





LW
CTCTGG
1742.64
2796
1.604
0.473





LW
CTGTGG
3621.43
3365
0.929
−0.073





LW
CTTTGG
1201.63
1018
0.847
−0.166





LW
CTATGG
648.03
501
0.773
−0.257





LW
TTATGG
700.87
535
0.763
−0.270





LW
TTGTGG
1177.40
877
0.745
−0.295





LY
CTCTAC
2082.09
4204
2.019
0.703





LY
TTATAT
680.44
1022
1.502
0.407





LY
CTCTAT
1691.85
2487
1.470
0.385





LY
CTTTAT
1166.60
1591
1.364
0.310





LY
CTATAT
629.14
596
0.947
−0.054





LY
TTGTAT
1143.08
1063
0.930
−0.073





LY
CTGTAC
4326.84
3390
0.783
−0.244





LY
CTTTAC
1435.69
1069
0.745
−0.295





LY
TTGTAC
1406.74
1006
0.715
−0.335





LY
TTATAC
837.39
579
0.691
−0.369





LY
CTGTAT
3515.88
2202
0.626
−0.468





LY
CTATAC
774.26
481
0.621
−0.476





MA
ATGGCG
1645.46
2370
1.440
0.365





MA
ATGGCA
3503.58
3580
1.022
0.022





MA
ATGGCT
4002.27
4003
1.000
0.000





MA
ATGGCC
6085.70
5284
0.868
−0.141





MC
ATGTGT
1386.67
1448
1.044
0.043





MC
ATGTGC
1646.33
1585
0.963
−0.038





MD
ATGGAT
4467.48
4634
1.037
0.037





MD
ATGGAC
5046.52
4880
0.967
−0.034





ME
ATGGAG
8054.28
8223
1.021
0.021





ME
ATGGAA
6022.72
5854
0.972
−0.028





MF
ATGTTT
2565.53
2833
1.104
0.099





MF
ATGTTC
2936.47
2669
0.909
−0.096





MG
ATGGGC
3467.73
3533
1.019
0.019





MG
ATGGGT
1655.83
1675
1.012
0.012





MG
ATGGGA
2557.59
2526
0.988
−0.012





MG
ATGGGG
2496.85
2444
0.979
−0.021





MH
ATGCAT
1465.33
1478
1.009
0.009





MH
ATGCAC
2020.67
2008
0.994
−0.006





MI
ATGATT
2305.40
2382
1.033
0.033





MI
ATGATA
1060.28
1094
1.032
0.031





MI
ATGATC
2915.32
2805
0.962
−0.039





MK
ATGAAG
6107.32
6423
1.052
0.050





MK
ATGAAA
4715.68
4400
0.933
−0.069





ML
ATGCTG
5938.40
6536
1.101
0.096





ML
ATGCTA
1062.63
1122
1.056
0.054





ML
ATGTTG
1930.69
1922
0.995
−0.005





ML
ATGTTA
1149.28
1134
0.987
−0.013





ML
ATGCTT
1970.42
1887
0.958
−0.043





ML
ATGCTC
2857.58
2308
0.808
−0.214





MM
ATGATG
3925.00
3925
1.000
0.000





MN
ATGAAT
3249.30
3301
1.016
0.016





MN
ATGAAC
3578.70
3527
0.986
−0.015





MP
ATGCCC
2676.16
2752
1.028
0.028





MP
ATGCCA
2313.29
2313
1.000
0.000





MP
ATGCCT
2396.87
2372
0.990
−0.010





MP
ATGCCG
969.67
919
0.948
−0.054





MQ
ATGCAG
5141.70
5165
1.005
0.005





MQ
ATGCAA
1841.30
1818
0.987
−0.013





MR
ATGAGG
1626.37
2127
1.308
0.268





MR
ATGAGA
1656.63
1974
1.192
0.175





MR
ATGCGG
1642.64
1513
0.921
−0.082





MR
ATGCGT
643.02
531
0.826
−0.191





MR
ATGCGA
890.44
684
0.768
−0.264





MR
ATGCGC
1501.91
1132
0.754
−0.283





MS
ATGTCG
666.33
809
1.214
0.194





MS
ATGTCT
2191.95
2338
1.067
0.065





MS
ATGTCA
1772.07
1781
1.005
0.005





MS
ATGTCC
2519.77
2493
0.989
−0.011





MS
ATGAGT
1801.10
1770
0.983
−0.017





MS
ATGAGC
2854.78
2615
0.916
−0.088





MT
ATGACT
2098.83
2195
1.046
0.045





MT
ATGACC
2931.75
2927
0.998
−0.002





MT
ATGACA
2373.36
2337
0.985
−0.015





MT
ATGACG
963.07
908
0.943
−0.059





MV
ATGGTG
4813.46
5122
1.064
0.062





MV
ATGGTT
1900.41
1915
1.008
0.008





MV
ATGGTA
1234.00
1191
0.965
−0.035





MV
ATGGTC
2433.13
2153
0.885
−0.122





MW
ATGTGG
1876.00
1876
1.000
0.000





MY
ATGTAC
2354.66
2363
1.004
0.004





MY
ATGTAT
1913.34
1905
0.996
−0.004





NA
AATGCA
1705.68
3344
1.961
0.673





NA
AATGCT
1948.47
3458
1.775
0.574





NA
AATGCC
2962.77
4259
1.438
0.363





NA
AATGCG
801.08
624
0.779
−0.250





NA
AACGCG
882.29
661
0.749
−0.289





NA
AACGCC
3263.12
1899
0.582
−0.541





NA
AACGCA
1878.60
700
0.373
−0.987





NA
AACGCT
2146.00
643
0.300
−1.205





NC
AACTGC
1868.57
2826
1.512
0.414





NC
AACTGT
1573.86
2016
1.281
0.248





NC
AATTGT
1429.00
935
0.654
−0.424





NC
AATTGC
1696.57
791
0.466
−0.763





ND
AATGAT
2555.01
4420
1.730
0.548





ND
AATGAC
2886.18
4521
1.566
0.449





ND
AACGAC
3178.77
1654
0.520
−0.653





ND
AACGAT
2814.03
839
0.298
−1.210





NE
AATGAA
3381.19
7367
2.179
0.779





NE
AATGAG
4521.72
5796
1.282
0.248





NE
AACGAG
4980.12
2476
0.497
−0.699





NE
AACGAA
3723.97
968
0.260
−1.347





NF
AACTTC
3150.86
4259
1.352
0.301





NF
AACTTT
2752.85
2846
1.034
0.033





NF
AATTTT
2499.46
2350
0.940
−0.062





NF
AATTTC
2860.84
1809
0.632
−0.458





NG
AATGGA
2235.93
4484
2.005
0.696





NG
AATGGT
1447.59
2430
1.679
0.518





NG
AATGGG
2182.83
3202
1.467
0.383





NG
AATGGC
3031.62
4001
1.320
0.277





NG
AACGGG
2404.12
1508
0.627
−0.466





NG
AACGGC
3338.95
1752
0.525
−0.645





NG
AACGGA
2462.61
804
0.326
−1.119





NG
AACGGT
1594.34
517
0.324
−1.126





NH
AACCAC
2167.68
2776
1.281
0.247





NH
AACCAT
1571.93
1639
1.043
0.042





NH
AATCAT
1427.24
1456
1.020
0.020





NH
AATCAC
1968.15
1264
0.642
−0.443





NI
AACATC
3876.27
5487
1.416
0.348





NI
AACATT
3065.31
3184
1.039
0.038





NI
AATATA
1280.01
1309
1.023
0.022





NI
AACATA
1409.77
1384
0.982
−0.018





NI
AATATT
2783.16
2725
0.979
−0.021





NI
AATATC
3519.48
1845
0.524
−0.646





NK
AACAAG
4824.98
5918
1.227
0.204





NK
AACAAA
3725.54
4221
1.133
0.125





NK
AATAAA
3382.62
3607
1.066
0.064





NK
AATAAG
4380.86
2568
0.586
−0.534





NL
AATTTA
1025.31
1571
1.532
0.427





NL
AACCTC
2807.78
3954
1.408
0.342





NL
AACTTG
1897.05
2429
1.280
0.247





NL
AACCTG
5834.92
6690
1.147
0.137





NL
AATTTG
1722.43
1947
1.130
0.123





NL
AATCTT
1757.88
1943
1.105
0.100





NL
AACCTA
1044.12
1135
1.087
0.083





NL
AACCTT
1936.08
2021
1.044
0.043





NL
AACTTA
1129.25
1129
1.000
0.000





NL
AATCTA
948.01
893
0.942
−0.060





NL
AATCTC
2549.34
1713
0.672
−0.398





NL
AATCTG
5297.84
2525
0.477
−0.741





NM
AACATG
3351.76
4374
1.305
0.266





NM
AATATG
3043.24
2021
0.664
−0.409





NN
AACAAC
3150.02
4430
1.406
0.341





NN
AACAAT
2860.08
2830
0.989
−0.011





NN
AATAAT
2596.82
2424
0.933
−0.069





NN
AATAAC
2860.08
1783
0.623
−0.473





NP
AACCCC
2770.02
3474
1.254
0.226





NP
AATCCA
2174.02
2380
1.095
0.091





NP
AACCCA
2394.42
2612
1.091
0.087





NP
AATCCT
2252.58
2414
1.072
0.069





NP
AACCCG
1003.68
1048
1.044
0.043





NP
AACCCT
2480.94
2578
1.039
0.038





NP
AATCCC
2515.05
1641
0.652
−0.427





NP
AATCCG
911.29
355
0.390
−0.943





NQ
AATCAA
1516.57
1905
1.256
0.228





NQ
AACCAA
1670.31
1955
1.170
0.157





NQ
AACCAG
4664.22
5409
1.160
0.148





NQ
AATCAG
4234.90
2817
0.665
−0.408





NR
AACAGA
1511.98
2383
1.576
0.455





NR
AACCGC
1370.77
1966
1.434
0.361





NR
AACAGG
1484.36
1903
1.282
0.248





NR
AACCGA
812.69
998
1.228
0.205





NR
AACCGT
586.88
706
1.203
0.185





NR
AACCGG
1499.21
1779
1.187
0.171





NR
AATCGA
737.89
687
0.931
−0.071





NR
AATCGT
532.86
486
0.912
−0.092





NR
AATAGA
1372.81
1117
0.814
−0.206





NR
AATCGC
1244.60
602
0.484
−0.726





NR
AATAGG
1347.73
643
0.477
−0.740





NR
AATCGG
1361.22
593
0.436
−0.831





NS
AACAGC
2917.73
4490
1.539
0.431





NS
AACAGT
1840.81
2414
1.311
0.271





NS
AACTCG
681.02
821
1.206
0.187





NS
AATTCA
1644.43
1970
1.198
0.181





NS
AATTCT
2034.08
2383
1.172
0.158





NS
AACTCC
2575.33
2818
1.094
0.090





NS
AACTCA
1811.14
1783
0.984
−0.016





NS
AACTCT
2240.29
1981
0.884
−0.123





NS
AATAGT
1671.38
1193
0.714
−0.337





NS
AATTCC
2338.29
1655
0.708
−0.346





NS
AATAGC
2649.17
1273
0.481
−0.733





NS
AATTCG
618.33
241
0.390
−0.942





NT
AACACG
860.22
1238
1.439
0.364





NT
AACACA
2119.90
2783
1.313
0.272





NT
AACACC
2618.65
3278
1.252
0.225





NT
AACACT
1874.68
2099
1.120
0.113





NT
AATACT
1702.13
1540
0.905
−0.100





NT
AATACA
1924.77
1692
0.879
−0.129





NT
AATACC
2377.62
1312
0.552
−0.595





NT
AATACG
781.04
317
0.406
−0.902





NV
AATGTA
927.15
1710
1.844
0.612





NV
AATGTT
1427.85
2573
1.802
0.589





NV
AATGTC
1828.10
2877
1.574
0.453





NV
AATGTG
3616.54
4314
1.193
0.176





NV
AACGTG
3983.18
2772
0.696
−0.363





NV
AACGTC
2013.43
1341
0.666
−0.406





NV
AACGTT
1572.60
509
0.324
−1.128





NV
AACGTA
1021.14
294
0.288
−1.245





NW
AACTGG
1808.22
2595
1.435
0.361





NW
AATTGG
1641.78
855
0.521
−0.652





NY
AACTAC
2506.72
3191
1.273
0.241





NY
AACTAT
2036.89
2145
1.053
0.052





NY
AATTAT
1849.41
1795
0.971
−0.030





NY
AATTAC
2275.98
1538
0.676
−0.392





PA
CCGGCG
470.57
1166
2.478
0.907





PA
CCGGCC
1740.39
2666
1.532
0.426





PA
CCAGCA
2390.31
3368
1.409
0.343





PA
CCAGCT
2730.54
3622
1.326
0.283





PA
CCTGCT
2829.20
3750
1.325
0.282





PA
CCTGCA
2476.67
3178
1.283
0.249





PA
CCAGCC
4151.96
4942
1.190
0.174





PA
CCCGCG
1298.71
1528
1.177
0.163





PA
CCTGCC
4301.98
5000
1.162
0.150





PA
CCAGCG
1122.61
1078
0.960
−0.041





PA
CCTGCG
1163.17
1105
0.950
−0.051





PA
CCGGCT
1144.57
1013
0.885
−0.122





PA
CCGGCA
1001.95
777
0.775
−0.254





PA
CCCGCC
4803.25
2690
0.560
−0.580





PA
CCCGCA
2765.26
846
0.306
−1.184





PA
CCCGCT
3158.86
821
0.260
−1.347





PC
CCCTGC
1550.51
2870
1.851
0.616





PC
CCCTGT
1305.97
1577
1.208
0.189





PC
CCGTGC
561.80
630
1.121
0.115





PC
CCTTGT
1169.67
1001
0.856
−0.156





PC
CCATGT
1128.89
831
0.736
−0.306





PC
CCGTGT
473.20
340
0.719
−0.331





PC
CCTTGC
1388.69
937
0.675
−0.393





PC
CCATGC
1340.27
733
0.547
−0.603





PD
CCAGAT
2721.60
4165
1.530
0.425





PD
CCTGAT
2819.94
3781
1.341
0.293





PD
CCGGAC
1288.69
1659
1.287
0.253





PD
CCAGAC
3074.36
3766
1.225
0.203





PD
CCTGAC
3185.44
3646
1.145
0.135





PD
CCGGAT
1140.82
895
0.785
−0.243





PD
CCCGAC
3556.62
2215
0.623
−0.474





PD
CCCGAT
3148.53
809
0.257
−1.359





PE
CCAGAA
3999.86
5699
1.425
0.354





PE
CCTGAG
5542.36
7122
1.285
0.251





PE
CCGGAG
2242.20
2870
1.280
0.247





PE
CCAGAG
5349.08
6777
1.267
0.237





PE
CCTGAA
4144.39
5108
1.233
0.209





PE
CCCGAG
6188.17
4149
0.670
−0.400





PE
CCGGAA
1676.64
1032
0.616
−0.485





PE
CCCGAA
4627.30
1013
0.219
−1.519





PF
CCCTTC
2555.92
4301
1.683
0.520





PF
CCATTT
1930.27
2057
1.066
0.064





PF
CCTTTT
2000.01
1967
0.983
−0.017





PF
CCCTTT
2233.06
2159
0.967
−0.034





PF
CCTTTC
2289.18
2078
0.908
−0.097





PF
CCGTTC
926.10
662
0.715
−0.336





PF
CCATTC
2209.35
1290
0.584
−0.538





PF
CCGTTT
809.12
439
0.543
−0.611





PG
CCTGGG
2918.52
4310
1.477
0.390





PG
CCTGGA
2989.52
4317
1.444
0.367





PG
CCGGGC
1639.82
2353
1.435
0.361





PG
CCGGGG
1180.71
1657
1.403
0.339





PG
CCTGGT
1935.48
2673
1.381
0.323





PG
CCAGGA
2885.27
3897
1.351
0.301





PG
CCAGGG
2816.75
3472
1.233
0.209





PG
CCAGGT
1867.98
2259
1.209
0.190





PG
CCTGGC
4053.37
4622
1.140
0.131





PG
CCAGGC
3912.02
4106
1.050
0.048





PG
CCGGGT
783.01
661
0.844
−0.169





PG
CCGGGA
1209.43
963
0.796
−0.228





PG
CCCGGG
3258.60
2136
0.655
−0.422





PG
CCCGGC
4525.68
2555
0.565
−0.572





PG
CCCGGA
3337.86
968
0.290
−1.238





PG
CCCGGT
2161.00
526
0.243
−1.413





PH
CCGCAC
725.13
972
1.340
0.293





PH
CCCCAC
2001.25
2505
1.252
0.225





PH
CCTCAT
1299.79
1592
1.225
0.203





PH
CCACAT
1254.46
1222
0.974
−0.026





PH
CCCCAT
1451.24
1303
0.898
−0.108





PH
CCTCAC
1792.40
1531
0.854
−0.158





PH
CCACAC
1729.89
1366
0.790
−0.236





PH
CCGCAT
525.84
289
0.550
−0.599





PI
CCCATC
2119.04
4651
2.195
0.786





PI
CCCATT
1675.71
2102
1.254
0.227





PI
CCAATA
666.18
819
1.229
0.207





PI
CCCATA
770.68
776
1.007
0.007





PI
CCAATT
1448.49
1386
0.957
−0.044





PI
CCTATA
690.25
603
0.874
−0.135





PI
CCTATT
1500.83
1266
0.844
−0.170





PI
CCAATC
1831.71
939
0.513
−0.668





PI
CCTATC
1897.89
957
0.504
−0.685





PI
CCGATT
607.17
299
0.492
−0.708





PI
CCGATC
767.80
342
0.445
−0.809





PI
CCGATA
279.24
115
0.412
−0.887





PK
CCCAAG
3738.47
6383
1.707
0.535





PK
CCCAAA
2886.60
3787
1.312
0.271





PK
CCAAAA
2495.20
2489
0.998
−0.002





PK
CCAAAG
3231.55
3127
0.968
−0.033





PK
CCTAAA
2585.35
1840
0.712
−0.340





PK
CCGAAG
1354.58
940
0.694
−0.365





PK
CCTAAG
3348.32
1660
0.496
−0.702





PK
CCGAAA
1045.92
460
0.440
−0.821





PL
CCGCTG
1824.84
3343
1.832
0.605





PL
CCGCTC
878.12
1254
1.428
0.356





PL
CCTTTG
1466.52
2054
1.401
0.337





PL
CCTTTA
872.97
1195
1.369
0.314





PL
CCCTTG
1637.40
2122
1.296
0.259





PL
CCTCTT
1496.70
1827
1.221
0.199





PL
CCCCTG
5036.31
5760
1.144
0.134





PL
CCCCTC
2423.49
2646
1.092
0.088





PL
CCTCTA
807.16
871
1.079
0.076





PL
CCATTA
842.53
826
0.980
−0.020





PL
CCACTT
1444.51
1371
0.949
−0.052





PL
CCACTA
779.01
729
0.936
−0.066





PL
CCTCTC
2170.57
1934
0.891
−0.115





PL
CCTCTG
4510.71
3745
0.830
−0.186





PL
CCATTG
1415.38
1172
0.828
−0.189





PL
CCCCTT
1671.10
1324
0.792
−0.233





PL
CCGCTA
326.54
255
0.781
−0.247





PL
CCCCTA
901.21
689
0.765
−0.268





PL
CCACTG
4353.41
3218
0.739
−0.302





PL
CCCTTA
974.69
709
0.727
−0.318





PL
CCACTC
2094.88
1475
0.704
−0.351





PL
CCGTTG
593.29
402
0.678
−0.389





PL
CCGCTT
605.50
402
0.664
−0.410





PL
CCGTTA
353.17
157
0.445
−0.811





PM
CCCATG
2307.54
3923
1.700
0.531





PM
CCAATG
1994.65
1552
0.778
−0.251





PM
CCGATG
836.10
520
0.622
−0.475





PM
CCTATG
2066.72
1210
0.585
−0.535





PN
CCCAAC
2313.61
4255
1.839
0.609





PN
CCAAAT
1815.81
2453
1.351
0.301





PN
CCCAAT
2100.65
2296
1.093
0.089





PN
CCAAAC
1999.90
1735
0.868
−0.142





PN
CCTAAT
1881.42
1342
0.713
−0.338





PN
CCTAAC
2072.16
997
0.481
−0.732





PN
CCGAAT
761.14
340
0.447
−0.806





PN
CCGAAC
838.30
365
0.435
−0.831





PP
CCGCCG
608.57
2335
3.837
1.345





PP
CCGCCC
1679.58
2697
1.606
0.474





PP
CCCCCG
1679.58
2420
1.441
0.365





PP
CCTCCA
3588.72
4314
1.202
0.184





PP
CCTCCT
3718.39
4305
1.158
0.146





PP
CCACCA
3463.58
3850
1.112
0.106





PP
CCACCT
3588.72
3798
1.058
0.057





PP
CCCCCA
4006.89
4095
1.022
0.022





PP
CCACCC
4006.89
3595
0.897
−0.108





PP
CCGCCA
1451.84
1280
0.882
−0.126





PP
CCACCG
1451.84
1252
0.862
−0.148





PP
CCGCCT
1504.30
1286
0.855
−0.157





PP
CCTCCC
4151.67
3338
0.804
−0.218





PP
CCTCCG
1504.30
1152
0.766
−0.267





PP
CCCCCT
4151.67
3160
0.761
−0.273





PP
CCCCCC
4635.43
2315
0.499
−0.694





PQ
CCCCAG
5063.98
6421
1.268
0.237





PQ
CCGCAG
1834.86
2187
1.192
0.176





PQ
CCTCAA
1624.21
1752
1.079
0.076





PQ
CCTCAG
4535.49
4221
0.931
−0.072





PQ
CCACAA
1567.57
1405
0.896
−0.109





PQ
CCACAG
4377.33
3670
0.838
−0.176





PQ
CCCCAA
1813.47
1497
0.825
−0.192





PQ
CCGCAA
657.08
321
0.489
−0.716





PR
CCGCGC
563.43
1094
1.942
0.664





PR
CCGCGG
616.23
1113
1.806
0.591





PR
CCCAGG
1683.86
2927
1.738
0.553





PR
CCCCGG
1700.71
2608
1.533
0.428





PR
CCCCGC
1555.00
1979
1.273
0.241





PR
CCCCGA
921.92
1166
1.265
0.235





PR
CCTCGA
825.71
1015
1.229
0.206





PR
CCAAGA
1482.62
1608
1.085
0.081





PR
CCTCGT
596.27
644
1.080
0.077





PR
CCCAGA
1715.19
1801
1.050
0.049





PR
CCGAGG
610.12
636
1.042
0.042





PR
CCTCGG
1523.22
1511
0.992
−0.008





PR
CCCCGT
665.75
655
0.984
−0.016





PR
CCAAGG
1455.54
1347
0.925
−0.077





PR
CCACGA
796.91
632
0.793
−0.232





PR
CCGCGT
241.23
191
0.792
−0.233





PR
CCACGT
575.48
418
0.726
−0.320





PR
CCACGG
1470.10
1040
0.707
−0.346





PR
CCGCGA
334.04
226
0.677
−0.391





PR
CCTCGC
1392.72
838
0.602
−0.508





PR
CCACGC
1344.15
701
0.522
−0.651





PR
CCGAGA
621.48
308
0.496
−0.702





PR
CCTAGA
1536.19
692
0.450
−0.797





PR
CCTAGG
1508.13
586
0.389
−0.945





PS
CCCAGC
3196.25
6398
2.002
0.694





PS
CCCTCG
746.03
1385
1.856
0.619





PS
CCGTCG
270.31
483
1.787
0.580





PS
CCCAGT
2016.53
2743
1.360
0.308





PS
CCTTCA
1776.97
2263
1.274
0.242





PS
CCTTCT
2198.02
2711
1.233
0.210





PS
CCCTCC
2821.16
3353
1.189
0.173





PS
CCATCA
1715.00
1819
1.061
0.059





PS
CCATCT
2121.37
2183
1.029
0.029





PS
CCTTCC
2526.74
2594
1.027
0.026





PS
CCGTCC
1022.21
1048
1.025
0.025





PS
CCCTCA
1984.02
1945
0.980
−0.020





PS
CCAAGT
1743.10
1582
0.908
−0.097





PS
CCCTCT
2454.14
2113
0.861
−0.150





PS
CCTTCG
668.17
552
0.826
−0.191





PS
CCATCC
2438.63
1995
0.818
−0.201





PS
CCGAGC
1158.11
885
0.764
−0.269





PS
CCATCG
644.87
475
0.737
−0.306





PS
CCAAGC
2762.85
1659
0.600
−0.510





PS
CCGTCT
889.22
523
0.588
−0.531





PS
CCGAGT
730.66
371
0.508
−0.678





PS
CCGTCA
718.88
364
0.506
−0.681





PS
CCTAGT
1806.08
860
0.476
−0.742





PS
CCTAGC
2862.68
968
0.338
−1.084





PT
CCCACG
829.55
1764
2.126
0.754





PT
CCCACC
2525.29
4586
1.816
0.597





PT
CCCACA
2044.32
2719
1.330
0.285





PT
CCCACT
1807.85
2282
1.262
0.233





PT
CCAACA
1767.12
1895
1.072
0.070





PT
CCAACT
1562.71
1593
1.019
0.019





PT
CCGACG
300.57
305
1.015
0.015





PT
CCTACT
1619.18
1252
0.773
−0.257





PT
CCAACC
2182.87
1514
0.694
−0.366





PT
CCTACA
1830.97
1241
0.678
−0.389





PT
CCGACC
915.00
592
0.647
−0.435





PT
CCAACG
717.06
463
0.646
−0.437





PT
CCTACC
2261.75
1251
0.553
−0.592





PT
CCGACT
655.05
342
0.522
−0.650





PT
CCGACA
740.73
352
0.475
−0.744





PT
CCTACG
742.97
352
0.474
−0.747





PV
CCTGTT
1493.79
2375
1.590
0.464





PV
CCTGTA
969.97
1482
1.528
0.424





PV
CCAGTA
936.15
1352
1.444
0.368





PV
CCTGTG
3783.57
5362
1.417
0.349





PV
CCAGTT
1441.70
2038
1.414
0.346





PV
CCTGTC
1912.53
2666
1.394
0.332





PV
CCGGTG
1530.67
1911
1.248
0.222





PV
CCAGTG
3651.63
3787
1.037
0.036





PV
CCAGTC
1845.84
1863
1.009
0.009





PV
CCGGTC
773.73
778
1.006
0.006





PV
CCCGTG
4224.44
2576
0.610
−0.495





PV
CCGGTT
604.32
351
0.581
−0.543





PV
CCGGTA
392.41
215
0.548
−0.602





PV
CCCGTC
2135.39
1084
0.508
−0.678





PV
CCCGTT
1667.85
391
0.234
−1.451





PV
CCCGTA
1083.00
216
0.199
−1.612





PW
CCCTGG
1769.80
2753
1.556
0.442





PW
CCGTGG
641.26
661
1.031
0.030





PW
CCATGG
1529.83
1060
0.693
−0.367





PW
CCTTGG
1585.10
1052
0.664
−0.410





PY
CCCTAC
2166.25
3378
1.559
0.444





PY
CCCTAT
1760.24
2097
1.191
0.175





PY
CCTTAT
1576.54
1702
1.080
0.077





PY
CCATAT
1521.56
1513
0.994
−0.006





PY
CCTTAC
1940.18
1485
0.765
−0.267





PY
CCGTAC
784.91
592
0.754
−0.282





PY
CCGTAT
637.80
429
0.673
−0.397





PY
CCATAC
1872.52
1064
0.568
−0.565





QA
CAAGCA
1597.87
2339
1.464
0.381





QA
CAAGCT
1825.31
2409
1.320
0.277





QA
CAGGCG
2095.55
2271
1.084
0.080





QA
CAGGCC
7750.37
7695
0.993
−0.007





QA
CAAGCC
2775.49
2655
0.957
−0.044





QA
CAGGCT
5097.04
4584
0.899
−0.106





QA
CAGGCA
4461.94
3943
0.884
−0.124





QA
CAAGCG
750.44
458
0.610
−0.494





QC
CAGTGT
2490.13
2791
1.121
0.114





QC
CAGTGC
2956.40
3260
1.103
0.098





QC
CAATGT
891.74
822
0.922
−0.081





QC
CAATGC
1058.72
524
0.495
−0.703





QD
CAAGAT
2128.42
3326
1.563
0.446





QD
CAAGAC
2404.29
2506
1.042
0.041





QD
CAGGAC
6713.82
6642
0.989
−0.011





QD
CAGGAT
5943.46
4716
0.793
−0.231





QE
CAAGAA
3247.03
5286
1.628
0.487





QE
CAGGAG
12125.58
12556
1.035
0.035





QE
CAAGAG
4342.30
4206
0.969
−0.032





QE
CAGGAA
9067.09
6734
0.743
−0.297





QF
CAGTTT
3509.26
4032
1.149
0.139





QF
CAGTTC
4016.64
4205
1.047
0.046





QF
CAATTT
1256.70
1156
0.920
−0.084





QF
CAATTC
1438.40
828
0.576
−0.552





QG
CAAGGA
1440.03
2837
1.970
0.678





QG
CAAGGT
932.30
1506
1.615
0.480





QG
CAAGGG
1405.83
1700
1.209
0.190





QG
CAAGGC
1952.47
2192
1.123
0.116





QG
CAGGGC
5452.14
5605
1.028
0.028





QG
CAGGGT
2603.39
2292
0.880
−0.127





QG
CAGGGA
4021.17
2871
0.714
−0.337





QG
CAGGGG
3925.67
2730
0.695
−0.363





QH
CAACAT
1067.82
1364
1.277
0.245





QH
CAGCAC
4111.88
4483
1.090
0.086





QH
CAGCAT
2981.80
2794
0.937
−0.065





QH
CAACAC
1472.51
993
0.674
−0.394





QI
CAAATA
656.37
1125
1.714
0.539





QI
CAAATT
1427.17
1667
1.168
0.155





QI
CAGATC
5039.60
5197
1.031
0.031





QI
CAGATA
1832.87
1802
0.983
−0.017





QI
CAGATT
3985.26
3693
0.927
−0.076





QI
CAAATC
1804.74
1262
0.699
−0.358





QK
CAGAAG
8990.94
9726
1.082
0.079





QK
CAAAAA
2486.09
2610
1.050
0.049





QK
CAGAAA
6942.22
6532
0.941
−0.061





QK
CAAAAG
3219.76
2771
0.861
−0.150





QL
CAGCTG
10304.18
12629
1.226
0.203





QL
CAACTA
660.31
798
1.209
0.189





QL
CAACTT
1224.39
1479
1.208
0.189





QL
CAGCTC
4958.40
5986
1.207
0.188





QL
CAGCTA
1843.86
2002
1.086
0.082





QL
CAGCTT
3419.03
3476
1.017
0.017





QL
CAATTA
714.15
642
0.899
−0.107





QL
CAGTTG
3350.09
2597
0.775
−0.255





QL
CAGTTA
1994.20
1518
0.761
−0.273





QL
CAACTC
1775.66
1279
0.720
−0.328





QL
CAACTG
3690.04
2093
0.567
−0.567





QL
CAATTG
1199.70
635
0.529
−0.636





QM
CAGATG
5587.91
5592
1.001
0.001





QM
CAAATG
2001.09
1997
0.998
−0.002





QN
CAAAAT
1720.47
2394
1.391
0.330





QN
CAGAAC
5291.34
5195
0.982
−0.018





QN
CAGAAT
4804.30
4430
0.922
−0.081





QN
CAAAAC
1894.89
1692
0.893
−0.113





QP
CAGCCG
1816.66
2237
1.231
0.208





QP
CAGCCC
5013.75
6143
1.225
0.203





QP
CAGCCT
4490.51
4526
1.008
0.008





QP
CAGCCA
4333.91
4235
0.977
−0.023





QP
CAACCA
1552.02
1441
0.928
−0.074





QP
CAACCT
1608.10
1304
0.811
−0.210





QP
CAACCC
1795.48
1132
0.630
−0.461





QP
CAACCG
650.57
243
0.374
−0.985





QQ
CAACAA
1545.49
1866
1.207
0.188





QQ
CAGCAG
12051.19
13131
1.090
0.086





QQ
CAGCAA
4315.66
4034
0.935
−0.067





QQ
CAACAG
4315.66
3197
0.741
−0.300





QR
CAAAGA
1214.45
1863
1.534
0.428





QR
CAGAGG
3329.32
4331
1.301
0.263





QR
CAAAGG
1192.27
1360
1.141
0.132





QR
CAGAGA
3391.27
3777
1.114
0.108





QR
CAGCGC
3074.54
3169
1.031
0.030





QR
CAGCGG
3362.63
3352
0.997
−0.003





QR
CAGCGT
1316.32
1215
0.923
−0.080





QR
CAGCGA
1822.82
1469
0.806
−0.216





QR
CAACGT
471.39
327
0.694
−0.366





QR
CAACGA
652.77
413
0.633
−0.458





QR
CAACGG
1204.20
453
0.376
−0.978





QR
CAACGC
1101.03
404
0.367
−1.003





QS
CAAAGT
904.91
1408
1.556
0.442





QS
CAGAGC
4005.17
5248
1.310
0.270





QS
CAGAGT
2526.89
2963
1.173
0.159





QS
CAAAGC
1434.30
1465
1.021
0.021





QS
CAGTCG
934.84
923
0.987
−0.013





QS
CAGTCA
2486.15
2379
0.957
−0.044





QS
CAGTCT
3075.24
2806
0.912
−0.092





QS
CAATCA
890.32
781
0.877
−0.131





QS
CAGTCC
3535.16
3051
0.863
−0.147





QS
CAATCT
1101.28
765
0.695
−0.364





QS
CAATCC
1265.98
587
0.464
−0.769





QS
CAATCG
334.78
119
0.355
−1.034





QT
CAAACT
1116.05
1463
1.311
0.271





QT
CAAACA
1262.03
1602
1.269
0.239





QT
CAGACG
1430.02
1665
1.164
0.152





QT
CAGACC
4353.25
4301
0.988
−0.012





QT
CAGACA
3524.12
3445
0.978
−0.023





QT
CAGACT
3116.48
2792
0.896
−0.110





QT
CAAACC
1558.95
1232
0.790
−0.235





QT
CAAACG
512.11
373
0.728
−0.317





QV
CAAGTA
657.01
1210
1.842
0.611





QV
CAAGTT
1011.82
1737
1.717
0.540





QV
CAAGTC
1295.45
1468
1.133
0.125





QV
CAAGTG
2562.79
2712
1.058
0.057





QV
CAGGTG
7156.41
7062
0.987
−0.013





QV
CAGGTC
3617.45
3213
0.888
−0.119





QV
CAGGTT
2825.43
2269
0.803
−0.219





QV
CAGGTA
1834.65
1290
0.703
−0.352





QW
CAGTGG
3057.92
3447
1.127
0.120





QW
CAATGG
1095.08
706
0.645
−0.439





QY
CAATAT
1029.01
1120
1.088
0.085





QY
CAGTAC
3536.21
3820
1.080
0.077





QY
CAGTAT
2873.43
2979
1.037
0.036





QY
CAATAC
1266.36
786
0.621
−0.477





RA
CGGGCG
659.18
1185
1.798
0.587





RA
CGGGCC
2437.97
3513
1.441
0.365





RA
AGAGCA
1415.51
1970
1.392
0.331





RA
CGCGCG
602.71
827
1.372
0.316





RA
CGTGCC
954.35
1266
1.327
0.283





RA
CGAGCA
760.84
970
1.275
0.243





RA
CGAGCT
869.13
1108
1.275
0.243





RA
CGAGCC
1321.57
1595
1.207
0.188





RA
AGAGCT
1616.99
1949
1.205
0.187





RA
CGTGCT
627.63
744
1.185
0.170





RA
CGGGCA
1403.55
1612
1.149
0.138





RA
CGTGCA
549.43
570
1.037
0.037





RA
CGTGCG
258.04
250
0.969
−0.032





RA
CGAGCG
357.33
341
0.954
−0.047





RA
AGGGCC
2413.81
2173
0.900
−0.105





RA
AGAGCC
2458.73
2202
0.896
−0.110





RA
CGGGCT
1603.33
1435
0.895
−0.111





RA
AGGGCA
1389.65
1242
0.894
−0.112





RA
AGGGCT
1587.45
1311
0.826
−0.191





RA
AGGGCG
652.65
524
0.803
−0.220





RA
CGCGCC
2229.09
1712
0.768
−0.264





RA
AGAGCG
664.79
384
0.578
−0.549





RA
CGCGCA
1283.30
331
0.258
−1.355





RA
CGCGCT
1465.97
369
0.252
−1.379





RC
CGCTGC
986.26
2873
2.913
1.069





RC
CGCTGT
830.71
1313
1.581
0.458





RC
CGTTGT
355.66
320
0.900
−0.106





RC
CGTTGC
422.25
372
0.881
−0.127





RC
AGATGT
916.29
806
0.880
−0.128





RC
CGATGT
492.51
421
0.855
−0.157





RC
AGGTGT
899.55
671
0.746
−0.293





RC
AGGTGC
1067.99
758
0.710
−0.343





RC
CGATGC
584.73
381
0.652
−0.428





RC
CGGTGC
1078.67
660
0.612
−0.491





RC
AGATGC
1087.86
642
0.590
−0.527





RC
CGGTGT
908.55
414
0.456
−0.786





RD
AGAGAT
2027.66
2952
1.456
0.376





RD
CGGGAC
2271.13
3231
1.423
0.353





RD
CGAGAT
1089.87
1500
1.376
0.319





RD
CGAGAC
1231.14
1693
1.375
0.319





RD
CGTGAC
889.05
1044
1.174
0.161





RD
AGAGAC
2290.48
2433
1.062
0.060





RD
CGTGAT
787.04
833
1.058
0.057





RD
AGGGAC
2248.63
2322
1.033
0.032





RD
AGGGAT
1990.62
1732
0.870
−0.139





RD
CGGGAT
2010.54
1606
0.799
−0.225





RD
CGCGAC
2076.56
1092
0.526
−0.643





RD
CGCGAT
1838.29
313
0.170
−1.770





RE
AGAGAA
2644.21
4195
1.586
0.462





RE
CGGGAG
3506.29
5344
1.524
0.421





RE
CGAGAG
1900.69
2475
1.302
0.264





RE
CGAGAA
1421.27
1844
1.297
0.260





RE
CGTGAG
1372.55
1453
1.059
0.057





RE
AGGGAG
3471.55
3469
0.999
−0.001





RE
AGAGAG
3536.15
3392
0.959
−0.042





RE
CGTGAA
1026.35
947
0.923
−0.080





RE
AGGGAA
2595.91
2343
0.903
−0.103





RE
CGGGAA
2621.88
2131
0.813
−0.207





RE
CGCGAG
3205.89
1839
0.574
−0.556





RE
CGCGAA
2397.25
268
0.112
−2.191





RF
CGCTTC
1446.49
3411
2.358
0.858





RF
CGTTTC
619.29
823
1.329
0.284





RF
CGTTTT
541.07
705
1.303
0.265





RF
AGATTT
1393.96
1531
1.098
0.094





RF
CGCTTT
1263.77
1366
1.081
0.078





RF
CGATTT
749.26
772
1.030
0.030





RF
AGGTTT
1368.50
1295
0.946
−0.055





RF
AGGTTC
1566.36
1192
0.761
−0.273





RF
CGATTC
857.59
632
0.737
−0.305





RF
CGGTTC
1582.03
951
0.601
−0.509





RF
AGATTC
1595.50
944
0.592
−0.525





RF
CGGTTT
1382.19
744
0.538
−0.619





RG
CGTGGT
370.38
685
1.849
0.615





RG
CGTGGG
558.50
980
1.755
0.562





RG
CGTGGC
775.66
1315
1.695
0.528





RG
CGAGGA
792.21
1266
1.598
0.469





RG
CGAGGG
773.39
1219
1.576
0.455





RG
AGAGGA
1473.87
2281
1.548
0.437





RG
CGAGGT
512.89
789
1.538
0.431





RG
CGGGGC
1981.48
2952
1.490
0.399





RG
CGTGGA
572.08
844
1.475
0.389





RG
CGAGGC
1074.12
1569
1.461
0.379





RG
AGAGGT
954.21
1128
1.182
0.167





RG
CGGGGT
946.15
918
0.970
−0.030





RG
CGCGGC
1811.72
1574
0.869
−0.141





RG
AGGGGC
1961.86
1660
0.846
−0.167





RG
AGAGGC
1998.36
1680
0.841
−0.174





RG
AGAGGG
1438.87
1203
0.836
−0.179





RG
AGGGGT
936.78
777
0.829
−0.187





RG
CGGGGG
1426.72
1146
0.803
−0.219





RG
CGGGGA
1461.42
1140
0.780
−0.248





RG
CGCGGG
1304.48
904
0.693
−0.367





RG
AGGGGA
1446.94
923
0.638
−0.450





RG
AGGGGG
1412.58
683
0.484
−0.727





RG
CGCGGT
865.09
248
0.287
−1.249





RG
CGCGGA
1336.22
302
0.226
−1.487





RH
CGCCAC
1288.00
1861
1.445
0.368





RH
CGGCAC
1408.69
1707
1.212
0.192





RH
AGACAT
1030.24
1201
1.166
0.153





RH
CGTCAT
399.89
447
1.118
0.111





RH
AGGCAT
1011.41
988
0.977
−0.023





RH
CGACAT
553.75
530
0.957
−0.044





RH
AGGCAC
1394.73
1292
0.926
−0.077





RH
AGACAC
1420.69
1212
0.853
−0.159





RH
CGTCAC
551.44
468
0.849
−0.164





RH
CGACAC
763.62
614
0.804
−0.218





RH
CGCCAT
934.02
728
0.779
−0.249





RH
CGGCAT
1021.53
730
0.715
−0.336





RI
CGCATC
1625.56
2948
1.814
0.595





RI
AGAATA
652.11
1175
1.802
0.589





RI
AGAATT
1417.90
2185
1.541
0.432





RI
AGGATA
640.20
804
1.256
0.228





RI
CGAATA
350.51
439
1.252
0.225





RI
CGAATT
762.13
850
1.115
0.109





RI
AGGATT
1392.00
1366
0.981
−0.019





RI
AGGATC
1760.27
1662
0.944
−0.057





RI
CGAATC
963.75
802
0.832
−0.184





RI
CGGATC
1777.88
1479
0.832
−0.184





RI
AGAATC
1793.03
1389
0.775
−0.255





RI
CGTATT
550.36
408
0.741
−0.299





RI
CGCATT
1285.48
913
0.710
−0.342





RI
CGGATA
646.60
451
0.697
−0.360





RI
CGTATC
695.96
440
0.632
−0.459





RI
CGTATA
253.12
152
0.601
−0.510





RI
CGGATT
1405.93
825
0.587
−0.533





RI
CGCATA
591.21
276
0.467
−0.762





RK
AGGAAG
3199.71
4856
1.518
0.417





RK
AGGAAA
2470.61
3737
1.513
0.414





RK
AGAAAA
2516.58
3482
1.384
0.325





RK
CGCAAG
2954.85
2981
1.009
0.009





RK
CGGAAG
3231.73
3225
0.998
−0.002





RK
AGAAAG
3259.25
2909
0.893
−0.114





RK
CGAAAA
1352.67
1189
0.879
−0.129





RK
CGGAAA
2495.33
1834
0.735
−0.308





RK
CGAAAG
1751.85
1265
0.722
−0.326





RK
CGTAAA
976.81
566
0.579
−0.546





RK
CGCAAA
2281.54
1209
0.530
−0.635





RK
CGTAAG
1265.08
503
0.398
−0.922





RL
CGCCTC
1491.12
2511
1.684
0.521





RL
CGCCTG
3098.73
4809
1.552
0.439





RL
CGGCTG
3389.08
5029
1.484
0.395





RL
CGGCTC
1630.84
2301
1.411
0.344





RL
CGTTTA
256.76
337
1.313
0.272





RL
AGATTA
661.49
862
1.303
0.265





RL
CGTCTT
440.20
562
1.277
0.244





RL
CGTCTA
237.40
296
1.247
0.221





RL
CGTTTG
431.33
526
1.219
0.198





RL
CGTCTC
638.40
723
1.133
0.124





RL
AGGCTA
600.44
669
1.114
0.108





RL
AGACTT
1134.11
1227
1.082
0.079





RL
AGGCTG
3355.51
3531
1.052
0.051





RL
AGACTA
611.62
617
1.009
0.009





RL
AGGCTT
1113.39
1104
0.992
−0.008





RL
CGACTA
328.75
324
0.986
−0.015





RL
CGGCTA
606.45
593
0.978
−0.022





RL
CGTCTG
1326.68
1281
0.966
−0.035





RL
AGGCTC
1614.68
1540
0.954
−0.047





RL
CGATTA
355.55
337
0.948
−0.054





RL
CGACTT
609.59
576
0.945
−0.057





RL
CGCCTA
554.49
501
0.904
−0.101





RL
AGGTTA
649.40
586
0.902
−0.103





RL
CGCCTT
1028.19
862
0.838
−0.176





RL
CGCTTG
1007.46
804
0.798
−0.226





RL
CGGCTT
1124.53
866
0.770
−0.261





RL
AGATTG
1111.24
839
0.755
−0.281





RL
CGACTC
884.04
663
0.750
−0.288





RL
AGGTTG
1090.94
774
0.709
−0.343





RL
AGACTC
1644.73
1142
0.694
−0.365





RL
CGATTG
597.29
408
0.683
−0.381





RL
CGACTG
1837.15
1128
0.614
−0.488





RL
CGCTTA
599.71
345
0.575
−0.553





RL
CGGTTG
1101.86
566
0.514
−0.666





RL
AGACTG
3417.95
1701
0.498
−0.698





RL
CGGTTA
655.90
297
0.453
−0.792





RM
CGCATG
1558.32
1961
1.258
0.230





RM
AGGATG
1687.45
1974
1.170
0.157





RM
CGAATG
923.88
932
1.009
0.009





RM
AGAATG
1718.85
1690
0.983
−0.017





RM
CGGATG
1704.33
1374
0.806
−0.215





RM
CGTATG
667.17
329
0.493
−0.707





RN
AGAAAT
1568.88
2627
1.674
0.515





RN
AGGAAC
1696.37
2200
1.297
0.260





RN
AGGAAT
1540.22
1796
1.166
0.154





RN
AGAAAC
1727.93
1949
1.128
0.120





RN
CGAAAT
843.28
930
1.103
0.098





RN
CGCAAC
1566.55
1575
1.005
0.005





RN
CGGAAC
1713.34
1621
0.946
−0.055





RN
CGAAAC
928.77
784
0.844
−0.169





RN
CGGAAT
1555.63
1002
0.644
−0.440





RN
CGTAAT
608.96
340
0.558
−0.583





RN
CGCAAT
1422.36
711
0.500
−0.693





RN
CGTAAC
670.70
308
0.459
−0.778





RP
CGGCCG
587.88
1226
2.085
0.735





RP
CGGCCC
1622.47
2939
1.811
0.594





RP
CGCCCG
537.51
717
1.334
0.288





RP
AGGCCC
1606.39
1982
1.234
0.210





RP
AGGCCG
582.05
666
1.144
0.135





RP
AGGCCT
1438.75
1642
1.141
0.132





RP
AGGCCA
1388.57
1511
1.088
0.084





RP
CGTCCT
568.84
589
1.035
0.035





RP
AGACCA
1414.41
1387
0.981
−0.020





RP
CGGCCT
1453.14
1390
0.957
−0.044





RP
AGACCT
1465.52
1398
0.954
−0.047





RP
CGTCCC
635.12
582
0.916
−0.087





RP
CGGCCA
1402.47
1285
0.916
−0.087





RP
CGCCCC
1483.46
1320
0.890
−0.117





RP
CGTCCA
549.00
487
0.887
−0.120





RP
AGACCC
1636.29
1283
0.784
−0.243





RP
CGACCA
760.25
591
0.777
−0.252





RP
CGACCC
879.51
671
0.763
−0.271





RP
CGACCT
787.72
580
0.736
−0.306





RP
CGCCCA
1282.31
887
0.692
−0.369





RP
CGTCCG
230.13
159
0.691
−0.370





RP
CGCCCT
1328.65
830
0.625
−0.470





RP
CGACCG
318.68
184
0.577
−0.549





RP
AGACCG
592.88
246
0.415
−0.880





RQ
AGACAA
1054.78
1456
1.380
0.322





RQ
CGGCAG
2920.52
3950
1.352
0.302





RQ
CGCCAG
2670.31
3160
1.183
0.168





RQ
AGGCAA
1035.51
1177
1.137
0.128





RQ
AGGCAG
2891.59
3013
1.042
0.041





RQ
CGACAA
566.95
522
0.921
−0.083





RQ
CGTCAG
1143.25
953
0.834
−0.182





RQ
CGTCAA
409.41
327
0.799
−0.225





RQ
CGACAG
1583.16
1249
0.789
−0.237





RQ
CGGCAA
1045.87
763
0.730
−0.315





RQ
AGACAG
2945.39
2062
0.700
−0.357





RQ
CGCCAA
956.27
591
0.618
−0.481





RR
CGCCGC
1172.08
2232
1.904
0.644





RR
CGGCGG
1402.02
2316
1.652
0.502





RR
AGAAGA
1426.00
2307
1.618
0.481





RR
CGGCGC
1281.90
2064
1.610
0.476





RR
AGGAGG
1374.38
1973
1.436
0.362





RR
CGCCGG
1281.90
1679
1.310
0.270





RR
CGAAGA
766.48
987
1.288
0.253





RR
AGGAGA
1399.95
1758
1.256
0.228





RR
CGCAGG
1269.20
1565
1.233
0.209





RR
CGGAGG
1388.13
1670
1.203
0.185





RR
CGTCGT
214.84
228
1.061
0.059





RR
CGAAGG
752.48
770
1.023
0.023





RR
CGCCGT
501.81
502
1.000
0.000





RR
AGAAGG
1399.95
1325
0.946
−0.055





RR
CGGCGT
548.83
498
0.907
−0.097





RR
CGTCGA
297.51
265
0.891
−0.116





RR
CGGCGA
760.01
675
0.888
−0.119





RR
CGTCGC
501.81
438
0.873
−0.136





RR
AGGCGG
1388.13
1177
0.848
−0.165





RR
CGTCGG
548.83
450
0.820
−0.199





RR
CGACGT
297.51
241
0.810
−0.211





RR
CGCCGA
694.89
547
0.787
−0.239





RR
AGGCGA
752.48
570
0.757
−0.278





RR
CGGAGA
1413.96
1068
0.755
−0.281





RR
AGACGA
766.48
557
0.727
−0.319





RR
AGGCGT
543.39
383
0.705
−0.350





RR
AGGCGC
1269.20
889
0.700
−0.356





RR
AGACGT
553.50
376
0.679
−0.387





RR
CGACGA
411.98
272
0.660
−0.415





RR
CGCAGA
1292.82
771
0.596
−0.517





RR
CGACGG
760.01
411
0.541
−0.615





RR
CGACGC
694.89
368
0.530
−0.636





RR
CGTAGA
553.50
271
0.490
−0.714





RR
CGTAGG
543.39
235
0.432
−0.838





RR
AGACGC
1292.82
524
0.405
−0.903





RR
AGACGG
1413.96
569
0.402
−0.910





RS
CGCTCG
332.61
817
2.456
0.899





RS
CGCAGC
1425.00
2853
2.002
0.694





RS
CGCTCC
1257.78
2184
1.736
0.552





RS
AGAAGT
991.66
1532
1.545
0.435





RS
CGTTCT
468.44
687
1.467
0.383





RS
CGAAGT
533.02
728
1.366
0.312





RS
CGTTCC
538.50
707
1.313
0.272





RS
AGGAGC
1543.09
1992
1.291
0.255





RS
CGTTCA
378.71
471
1.244
0.218





RS
CGGAGC
1558.53
1856
1.191
0.175





RS
AGGAGT
973.54
1071
1.100
0.095





RS
AGAAGC
1571.80
1628
1.036
0.035





RS
AGATCA
975.67
1000
1.025
0.025





RS
CGAAGC
844.85
859
1.017
0.017





RS
CGCTCA
884.55
860
0.972
−0.028





RS
CGCAGT
899.04
853
0.949
−0.053





RS
AGATCT
1206.86
1106
0.916
−0.087





RS
CGCTCT
1094.14
942
0.861
−0.150





RS
CGTTCG
142.40
121
0.850
−0.163





RS
AGGTCA
957.85
808
0.844
−0.170





RS
CGATCA
524.43
416
0.793
−0.232





RS
AGGTCT
1184.81
939
0.793
−0.233





RS
AGGTCG
360.17
284
0.789
−0.238





RS
CGATCT
648.69
497
0.766
−0.266





RS
AGGTCC
1362.00
1036
0.761
−0.274





RS
CGGAGT
983.28
745
0.758
−0.278





RS
CGTAGT
384.91
278
0.722
−0.325





RS
CGGTCG
363.77
235
0.646
−0.437





RS
CGATCC
745.70
455
0.610
−0.494





RS
AGATCC
1387.35
830
0.598
−0.514





RS
CGGTCC
1375.63
821
0.597
−0.516





RS
CGATCG
197.19
107
0.543
−0.611





RS
CGGTCA
967.43
507
0.524
−0.646





RS
CGTAGC
610.09
317
0.520
−0.655





RS
AGATCG
366.87
177
0.482
−0.729





RS
CGGTCT
1196.66
518
0.433
−0.837





RT
CGCACG
450.78
858
1.903
0.644





RT
AGAACT
1083.61
1467
1.354
0.303





RT
CGCACC
1372.27
1821
1.327
0.283





RT
AGGACG
488.14
646
1.323
0.280





RT
AGGACT
1063.81
1389
1.306
0.267





RT
AGAACA
1225.34
1575
1.285
0.251





RT
AGGACA
1202.96
1523
1.266
0.236





RT
AGGACC
1485.98
1773
1.193
0.177





RT
CGGACG
493.02
537
1.089
0.085





RT
CGAACA
658.62
661
1.004
0.004





RT
CGAACT
582.44
556
0.955
−0.046





RT
CGGACC
1500.85
1408
0.938
−0.064





RT
CGCACA
1110.90
984
0.886
−0.121





RT
CGGACA
1215.00
949
0.781
−0.247





RT
AGAACC
1513.63
1166
0.770
−0.261





RT
CGTACT
420.60
313
0.744
−0.295





RT
CGAACC
813.58
599
0.736
−0.306





RT
CGGACT
1074.45
712
0.663
−0.411





RT
CGCACT
982.40
638
0.649
−0.432





RT
CGTACC
587.52
361
0.614
−0.487





RT
AGAACG
497.22
302
0.607
−0.499





RT
CGTACA
475.62
288
0.606
−0.502





RT
CGAACG
267.26
154
0.576
−0.551





RT
CGTACG
193.00
79
0.409
−0.893





RV
CGTGTG
889.90
1699
1.909
0.647





RV
CGTGTC
449.83
826
1.836
0.608





RV
CGAGTA
315.92
562
1.779
0.576





RV
CGTGTA
228.14
391
1.714
0.539





RV
CGTGTT
351.34
565
1.608
0.475





RV
AGAGTT
905.17
1350
1.491
0.400





RV
AGAGTA
587.76
876
1.490
0.399





RV
CGAGTC
622.91
914
1.467
0.383





RV
CGAGTT
486.53
681
1.400
0.336





RV
CGAGTG
1232.31
1576
1.279
0.246





RV
CGGGTC
1149.12
1310
1.140
0.131





RV
AGGGTC
1137.73
1221
1.073
0.071





RV
CGGGTG
2273.30
2328
1.024
0.024





RV
AGAGTC
1158.91
1154
0.996
−0.004





RV
CGCGTG
2078.54
1725
0.830
−0.186





RV
AGGGTA
577.02
471
0.816
−0.203





RV
AGAGTG
2292.67
1750
0.763
−0.270





RV
CGGGTA
582.79
438
0.752
−0.286





RV
AGGGTG
2250.78
1658
0.737
−0.306





RV
CGCGTC
1050.67
763
0.726
−0.320





RV
AGGGTT
888.63
645
0.726
−0.320





RV
CGGGTT
897.52
548
0.611
−0.493





RV
CGCGTA
532.86
132
0.248
−1.395





RV
CGCGTT
820.63
178
0.217
−1.528





RW
CGCTGG
1038.00
2199
2.118
0.751





RW
CGTTGG
444.40
380
0.855
−0.157





RW
AGGTGG
1124.01
876
0.779
−0.249





RW
CGATGG
615.40
466
0.757
−0.278





RW
AGATGG
1144.93
804
0.702
−0.353





RW
CGGTGG
1135.26
777
0.684
−0.379





RY
CGCTAC
1173.12
2612
2.227
0.800





RY
CGCTAT
953.25
1198
1.257
0.229





RY
CGTTAC
502.25
565
1.125
0.118





RY
CGTTAT
408.12
459
1.125
0.117





RY
AGATAT
1051.45
1018
0.968
−0.032





RY
AGATAC
1293.97
1239
0.958
−0.043





RY
CGATAT
565.15
509
0.901
−0.105





RY
CGATAC
695.51
584
0.840
−0.175





RY
AGGTAC
1270.33
1007
0.793
−0.232





RY
AGGTAT
1032.24
769
0.745
−0.294





RY
CGGTAC
1283.04
856
0.667
−0.405





RY
CGGTAT
1042.57
455
0.436
−0.829





SA
TCGGCG
241.39
778
3.223
1.170





SA
TCGGCC
892.76
1976
2.213
0.795





SA
TCAGCA
1366.87
2526
1.848
0.614





SA
TCTGCA
1690.75
3035
1.795
0.585





SA
TCTGCT
1931.41
3350
1.734
0.551





SA
TCAGCT
1561.43
2630
1.684
0.521





SA
AGTGCT
1587.01
2487
1.567
0.449





SA
AGTGCA
1389.27
2040
1.468
0.384





SA
AGTGCC
2413.15
3437
1.424
0.354





SA
TCAGCC
2374.25
3294
1.387
0.327





SA
TCGGCT
587.12
808
1.376
0.319





SA
TCTGCC
2936.83
3480
1.185
0.170





SA
TCGGCA
513.97
598
1.163
0.151





SA
TCTGCG
794.06
745
0.938
−0.064





SA
TCAGCG
641.95
584
0.910
−0.095





SA
AGTGCG
652.47
532
0.815
−0.204





SA
AGCGCG
1034.18
802
0.775
−0.254





SA
AGCGCC
3824.90
2428
0.635
−0.454





SA
TCCGCG
912.82
577
0.632
−0.459





SA
TCCGCC
3376.05
1230
0.364
−1.010





SA
AGCGCT
2515.45
709
0.282
−1.266





SA
AGCGCA
2202.02
601
0.273
−1.299





SA
TCCGCA
1943.61
476
0.245
−1.407





SA
TCCGCT
2220.26
481
0.217
−1.530





SC
TCCTGC
1640.34
2828
1.724
0.545





SC
AGCTGC
1858.43
3034
1.633
0.490





SC
TCCTGT
1381.63
1779
1.288
0.253





SC
AGCTGT
1565.33
1922
1.228
0.205





SC
TCGTGC
433.77
361
0.832
−0.184





SC
TCTTGT
1201.89
941
0.783
−0.245





SC
AGTTGT
987.57
698
0.707
−0.347





SC
TCGTGT
365.36
225
0.616
−0.485





SC
TCATGT
971.65
584
0.601
−0.509





SC
TCTTGC
1426.94
758
0.531
−0.633





SC
TCATGC
1153.59
525
0.455
−0.787





SC
AGTTGC
1172.49
504
0.430
−0.844





SD
TCAGAT
1978.63
3706
1.873
0.628





SD
AGTGAT
2011.05
3683
1.831
0.605





SD
AGTGAC
2271.71
4040
1.778
0.576





SD
TCGGAC
840.43
1438
1.711
0.537





SD
TCTGAT
2447.46
3578
1.462
0.380





SD
TCAGAC
2235.09
2906
1.300
0.262





SD
TCGGAT
744.00
840
1.129
0.121





SD
TCTGAC
2764.69
2949
1.067
0.065





SD
AGCGAC
3600.71
2017
0.560
−0.580





SD
TCCGAC
3178.17
1336
0.420
−0.867





SD
AGCGAT
3187.56
920
0.289
−1.243





SD
TCCGAT
2813.50
660
0.235
−1.450





SE
TCAGAA
2420.84
4815
1.989
0.688





SE
AGTGAA
2460.50
4686
1.904
0.644





SE
TCGGAG
1217.33
2184
1.794
0.584





SE
TCTGAA
2994.45
4621
1.543
0.434





SE
TCAGAG
3237.43
4683
1.447
0.369





SE
AGTGAG
3290.47
4410
1.340
0.293





SE
TCTGAG
4004.54
4891
1.221
0.200





SE
TCGGAA
910.28
879
0.966
−0.035





SE
AGCGAG
5215.47
2961
0.568
−0.566





SE
TCCGAG
4603.44
2005
0.436
−0.831





SE
AGCGAA
3899.95
847
0.217
−1.527





SE
TCCGAA
3442.29
715
0.208
−1.572





SF
TCCTTC
2645.79
4407
1.666
0.510





SF
AGCTTC
2997.56
3942
1.315
0.274





SF
TCATTT
1625.65
1773
1.091
0.087





SF
TCCTTT
2311.58
2487
1.076
0.073





SF
AGTTTT
1652.29
1695
1.026
0.026





SF
AGCTTT
2618.91
2370
0.905
−0.100





SF
TCTTTT
2010.85
1809
0.900
−0.106





SF
TCTTTC
2301.58
1728
0.751
−0.287





SF
AGTTTC
1891.18
1353
0.715
−0.335





SF
TCGTTT
611.27
342
0.559
−0.581





SF
TCATTC
1860.69
991
0.533
−0.630





SF
TCGTTC
699.65
330
0.472
−0.751





SG
AGTGGT
1051.00
2094
1.992
0.689





SG
TCGGGG
586.31
1117
1.905
0.645





SG
TCGGGC
814.29
1487
1.826
0.602





SG
AGTGGA
1623.36
2932
1.806
0.591





SG
TCAGGA
1597.19
2760
1.728
0.547





SG
TCTGGA
1975.64
3391
1.716
0.540





SG
AGTGGG
1584.81
2584
1.630
0.489





SG
TCTGGG
1928.73
2974
1.542
0.433





SG
AGTGGC
2201.05
3314
1.506
0.409





SG
TCTGGT
1279.07
1902
1.487
0.397





SG
TCAGGG
1559.26
2161
1.386
0.326





SG
TCAGGT
1034.06
1351
1.307
0.267





SG
TCGGGA
600.57
684
1.139
0.130





SG
TCGGGT
388.82
410
1.054
0.053





SG
TCTGGC
2678.70
2734
1.021
0.020





SG
TCAGGC
2165.57
2114
0.976
−0.024





SG
AGCGGC
3488.72
2475
0.709
−0.343





SG
AGCGGG
2511.96
1464
0.583
−0.540





SG
TCCGGG
2217.18
1117
0.504
−0.686





SG
TCCGGC
3079.31
1163
0.378
−0.974





SG
AGCGGT
1665.85
536
0.322
−1.134





SG
AGCGGA
2573.06
663
0.258
−1.356





SG
TCCGGA
2271.11
560
0.247
−1.400





SG
TCCGGT
1470.37
359
0.244
−1.410





SH
AGCCAC
2202.27
3210
1.458
0.377





SH
TCTCAT
1226.22
1426
1.163
0.151





SH
TCCCAC
1943.83
2233
1.149
0.139





SH
AGTCAT
1007.57
1082
1.074
0.071





SH
AGCCAT
1597.01
1606
1.006
0.006





SH
TCGCAC
514.03
512
0.996
−0.004





SH
TCCCAT
1409.60
1349
0.957
−0.044





SH
TCACAT
991.32
929
0.937
−0.065





SH
AGTCAC
1389.42
1077
0.775
−0.255





SH
TCACAC
1367.03
956
0.699
−0.358





SH
TCTCAC
1690.94
1158
0.685
−0.379





SH
TCGCAT
372.75
174
0.467
−0.762





SI
TCCATC
2374.96
4526
1.906
0.645





SI
AGCATC
2690.72
4471
1.662
0.508





SI
TCCATT
1878.09
2383
1.269
0.238





SI
AGCATT
2127.79
2384
1.120
0.114





SI
TCCATA
863.76
963
1.115
0.109





SI
AGTATA
617.40
640
1.037
0.036





SI
TCAATA
607.45
618
1.017
0.017





SI
AGTATT
1342.43
1299
0.968
−0.033





SI
AGCATA
978.60
943
0.964
−0.037





SI
TCTATA
751.38
658
0.876
−0.133





SI
TCTATT
1633.75
1215
0.744
−0.296





SI
TCAATT
1320.79
957
0.725
−0.322





SI
AGTATC
1697.59
924
0.544
−0.608





SI
TCGATA
228.41
109
0.477
−0.740





SI
TCTATC
2065.98
958
0.464
−0.769





SI
TCGATT
496.64
185
0.373
−0.988





SI
TCAATC
1670.22
557
0.333
−1.098





SI
TCGATC
628.03
184
0.293
−1.228





SK
TCCAAG
3563.99
5021
1.409
0.343





SK
TCCAAA
2751.88
3634
1.321
0.278





SK
AGCAAG
4037.83
5128
1.270
0.239





SK
AGCAAA
3117.75
3736
1.198
0.181





SK
TCAAAA
1935.30
2282
1.179
0.165





SK
AGTAAA
1967.01
2149
1.093
0.088





SK
TCAAAG
2506.42
2082
0.831
−0.186





SK
TCTAAA
2393.86
1838
0.768
−0.264





SK
TCGAAG
942.46
522
0.554
−0.591





SK
AGTAAG
2547.49
1300
0.510
−0.673





SK
TCTAAG
3100.32
1569
0.506
−0.681





SK
TCGAAA
727.71
331
0.455
−0.788





SL
AGTTTA
709.05
1103
1.556
0.442





SL
TCGCTG
1355.42
2104
1.552
0.440





SL
TCCTTG
1666.44
2462
1.477
0.390





SL
TCTTTA
862.92
1267
1.468
0.384





SL
AGCCTC
2794.39
4013
1.436
0.362





SL
TCTTTG
1449.64
2009
1.386
0.326





SL
TCATTA
697.62
862
1.236
0.212





SL
AGCCTG
5807.08
7014
1.208
0.189





SL
AGTTTG
1191.15
1427
1.198
0.181





SL
TCGCTC
652.23
777
1.191
0.175





SL
TCTCTA
797.87
950
1.191
0.175





SL
TCTCTT
1479.47
1750
1.183
0.168





SL
TCCCTG
5125.62
6034
1.177
0.163





SL
TCCCTC
2466.46
2805
1.137
0.129





SL
TCCTTA
991.98
1076
1.085
0.081





SL
AGTCTT
1215.66
1242
1.022
0.021





SL
AGCCTT
1926.85
1959
1.017
0.017





SL
TCACTA
645.03
630
0.977
−0.024





SL
AGCTTG
1888.00
1786
0.946
−0.056





SL
TCACTT
1196.06
1111
0.929
−0.074





SL
TCCCTT
1700.73
1545
0.908
−0.096





SL
TCCCTA
917.19
810
0.883
−0.124





SL
AGTCTA
655.60
569
0.868
−0.142





SL
TCATTG
1171.95
1015
0.866
−0.144





SL
AGCCTA
1039.14
875
0.842
−0.172





SL
TCTCTC
2145.58
1760
0.820
−0.198





SL
TCTCTG
4458.78
3418
0.767
−0.266





SL
AGCTTA
1123.86
758
0.674
−0.394





SL
AGTCTC
1763.00
1158
0.657
−0.420





SL
TCGTTG
440.67
280
0.635
−0.454





SL
TCACTC
1734.58
1100
0.634
−0.455





SL
TCACTG
3604.66
2254
0.625
−0.470





SL
TCGCTT
449.74
279
0.620
−0.477





SL
TCGCTA
242.54
143
0.590
−0.528





SL
TCGTTA
262.32
140
0.534
−0.628





SL
AGTCTG
3663.72
1808
0.493
−0.706





SM
TCCATG
2282.65
3908
1.712
0.538





SM
AGCATG
2586.13
3300
1.276
0.244





SM
TCAATG
1605.31
1129
0.703
−0.352





SM
TCGATG
603.62
365
0.605
−0.503





SM
AGTATG
1631.61
966
0.592
−0.524





SM
TCTATG
1985.68
1027
0.517
−0.659





SN
AGCAAC
2539.42
3717
1.464
0.381





SN
TCCAAC
2241.42
3216
1.435
0.361





SN
TCAAAT
1431.22
1883
1.316
0.274





SN
AGCAAT
2305.68
2513
1.090
0.086





SN
TCCAAT
2035.11
2000
0.983
−0.017





SN
AGTAAT
1454.67
1425
0.980
−0.021





SN
AGTAAC
1602.14
1339
0.836
−0.179





SN
TCAAAC
1576.31
1194
0.757
−0.278





SN
TCTAAT
1770.34
1297
0.733
−0.311





SN
TCTAAC
1949.81
955
0.490
−0.714





SN
TCGAAT
538.16
258
0.479
−0.735





SN
TCGAAC
592.72
240
0.405
−0.904





SP
TCGCCG
282.21
549
1.945
0.665





SP
TCGCCC
778.87
1221
1.568
0.450





SP
TCCCCG
1067.21
1621
1.519
0.418





SP
TCTCCA
2214.76
3119
1.408
0.342





SP
AGCCCC
3336.96
4654
1.395
0.333





SP
TCTCCT
2294.78
2888
1.259
0.230





SP
AGCCCG
1209.10
1432
1.184
0.169





SP
TCCCCA
2545.99
2968
1.166
0.153





SP
TCACCA
1790.50
1869
1.044
0.043





SP
AGCCCT
2988.71
3086
1.033
0.032





SP
AGTCCT
1885.59
1904
1.010
0.010





SP
TCACCT
1855.20
1752
0.944
−0.057





SP
AGCCCA
2884.48
2607
0.904
−0.101





SP
TCCCCT
2637.98
2238
0.848
−0.164





SP
AGTCCA
1819.84
1473
0.809
−0.211





SP
TCGCCT
697.59
562
0.806
−0.216





SP
TCGCCA
673.26
541
0.804
−0.219





SP
TCTCCC
2562.18
2036
0.795
−0.230





SP
TCACCC
2071.37
1568
0.757
−0.278





SP
AGTCCC
2105.31
1534
0.729
−0.317





SP
TCTCCG
928.37
664
0.715
−0.335





SP
TCCCCC
2945.37
2058
0.699
−0.358





SP
TCACCG
750.53
426
0.568
−0.566





SP
AGTCCG
762.83
319
0.418
−0.872





SQ
TCCCAG
4427.95
5592
1.263
0.233





SQ
AGCCAG
5016.65
6041
1.204
0.186





SQ
TCTCAA
1379.40
1644
1.192
0.175





SQ
AGTCAA
1133.44
1293
1.141
0.132





SQ
TCACAA
1115.16
1196
1.072
0.070





SQ
AGCCAA
1796.52
1819
1.013
0.012





SQ
TCCCAA
1585.70
1474
0.930
−0.073





SQ
TCTCAG
3851.88
3430
0.890
−0.116





SQ
TCGCAG
1170.92
1015
0.867
−0.143





SQ
TCACAG
3114.02
2271
0.729
−0.316





SQ
AGTCAG
3165.04
2215
0.700
−0.357





SQ
TCGCAA
419.32
186
0.444
−0.813





SR
AGCCGC
1540.23
2828
1.836
0.608





SR
TCCAGG
1472.14
2309
1.568
0.450





SR
AGCCGG
1684.56
2353
1.397
0.334





SR
TCCCGG
1486.87
1976
1.329
0.284





SR
AGCAGG
1667.87
2186
1.311
0.271





SR
AGCCGT
659.43
857
1.300
0.262





SR
TCGCGC
359.50
446
1.241
0.216





SR
TCCAGA
1499.54
1850
1.234
0.210





SR
TCAAGA
1054.57
1294
1.227
0.205





SR
TCGCGG
393.19
481
1.223
0.202





SR
TCCCGC
1359.49
1605
1.181
0.166





SR
TCTCGA
701.14
826
1.178
0.164





SR
AGTCGT
416.04
484
1.163
0.151





SR
TCCCGA
806.00
937
1.163
0.151





SR
AGCAGA
1698.90
1925
1.133
0.125





SR
AGCCGA
913.16
1020
1.117
0.111





SR
TCTCGT
506.32
493
0.974
−0.027





SR
AGTCGA
576.12
553
0.960
−0.041





SR
TCCCGT
582.04
553
0.950
−0.051





SR
TCAAGG
1035.31
922
0.891
−0.116





SR
TCGAGG
389.29
324
0.832
−0.184





SR
TCTCGG
1293.43
1062
0.821
−0.197





SR
TCACGT
409.33
323
0.789
−0.237





SR
AGTAGA
1071.85
746
0.696
−0.362





SR
TCGCGT
153.92
102
0.663
−0.411





SR
AGTCGG
1062.80
675
0.635
−0.454





SR
AGTCGC
971.74
591
0.608
−0.497





SR
TCACGA
566.83
344
0.607
−0.499





SR
TCGAGA
396.54
240
0.605
−0.502





SR
TCTAGA
1304.45
750
0.575
−0.553





SR
TCGCGA
213.14
115
0.540
−0.617





SR
TCTCGC
1182.62
636
0.538
−0.620





SR
TCACGG
1045.66
534
0.511
−0.672





SR
TCTAGG
1280.62
574
0.448
−0.802





SR
TCACGC
956.08
406
0.425
−0.856





SR
AGTAGG
1052.27
443
0.421
−0.865





SS
AGCAGC
3919.72
7160
1.827
0.602





SS
TCGTCG
213.54
376
1.761
0.566





SS
TCCTCG
807.53
1302
1.612
0.478





SS
TCCAGC
3459.74
4832
1.397
0.334





SS
TCTTCA
1868.19
2596
1.390
0.329





SS
AGCAGT
2472.97
3417
1.382
0.323





SS
TCCTCC
3053.74
4162
1.363
0.310





SS
TCTTCT
2310.85
2896
1.253
0.226





SS
TCCAGT
2182.77
2691
1.233
0.209





SS
TCATCA
1510.32
1795
1.188
0.173





SS
AGCTCC
3459.74
4024
1.163
0.151





SS
TCATCT
1868.19
2118
1.134
0.126





SS
TCCTCA
2147.58
2413
1.124
0.117





SS
AGCTCG
914.89
1001
1.094
0.090





SS
TCCTCT
2656.45
2744
1.033
0.032





SS
TCGTCC
807.53
818
1.013
0.013





SS
TCTTCC
2656.45
2600
0.979
−0.021





SS
AGTTCT
1898.79
1856
0.977
−0.023





SS
AGTTCA
1535.06
1498
0.976
−0.024





SS
TCAAGT
1535.06
1404
0.915
−0.089





SS
AGCTCA
2433.11
2075
0.853
−0.159





SS
AGCTCT
3009.63
2465
0.819
−0.200





SS
TCTTCG
702.47
556
0.791
−0.234





SS
TCATCC
2147.58
1632
0.760
−0.275





SS
AGTAGT
1560.21
1030
0.660
−0.415





SS
AGTTCC
2182.77
1405
0.644
−0.441





SS
TCGTCT
702.47
434
0.618
−0.482





SS
TCATCG
567.91
343
0.604
−0.504





SS
TCGTCA
567.91
313
0.551
−0.596





SS
TCTAGT
1898.79
957
0.504
−0.685





SS
TCGAGC
914.89
440
0.481
−0.732





SS
AGTAGC
2472.97
1158
0.468
−0.759





SS
TCAAGC
2433.11
1117
0.459
−0.779





SS
TCGAGT
577.21
259
0.449
−0.801





SS
AGTTCG
577.21
251
0.435
−0.833





SS
TCTAGC
3009.63
899
0.299
−1.208





ST
TCCACG
785.52
1434
1.826
0.602





ST
AGCACC
2709.18
4149
1.531
0.426





ST
TCCACC
2391.25
3527
1.475
0.389





ST
AGCACG
889.95
1180
1.326
0.282





ST
AGCACA
2193.18
2692
1.227
0.205





ST
TCCACA
1935.81
2329
1.203
0.185





ST
TCCACT
1711.89
1937
1.131
0.124





ST
AGCACT
1939.49
2193
1.131
0.123





ST
TCAACA
1361.39
1485
1.091
0.087





ST
TCAACT
1203.91
1270
1.055
0.053





ST
TCTACT
1489.18
1390
0.933
−0.069





ST
TCTACA
1683.97
1461
0.868
−0.142





ST
AGTACT
1223.64
1036
0.847
−0.166





ST
AGTACA
1383.69
1061
0.767
−0.266





ST
TCGACG
207.72
145
0.698
−0.359





ST
TCTACC
2080.15
1218
0.586
−0.535





ST
TCGACC
632.34
365
0.577
−0.550





ST
AGTACC
1709.24
976
0.571
−0.560





ST
TCGACT
452.69
240
0.530
−0.635





ST
TCAACC
1681.68
873
0.519
−0.656





ST
TCAACG
552.43
275
0.498
−0.698





ST
TCGACA
511.90
236
0.461
−0.774





ST
TCTACG
683.32
302
0.442
−0.817





ST
AGTACG
561.48
201
0.358
−1.027





SV
TCGGTG
935.47
1822
1.948
0.667





SV
TCTGTA
788.92
1398
1.772
0.572





SV
TCTGTT
1214.96
2136
1.758
0.564





SV
TCAGTA
637.79
1121
1.758
0.564





SV
AGTGTT
998.32
1719
1.722
0.543





SV
TCAGTT
982.23
1591
1.620
0.482





SV
TCTGTC
1555.54
2367
1.522
0.420





SV
AGTGTC
1278.17
1943
1.520
0.419





SV
TCTGTG
3077.33
4672
1.518
0.418





SV
AGTGTA
648.24
976
1.506
0.409





SV
TCGGTC
472.87
683
1.444
0.368





SV
TCAGTG
2487.84
2925
1.176
0.162





SV
AGTGTG
2528.60
2901
1.147
0.137





SV
TCAGTC
1257.56
1351
1.074
0.072





SV
TCGGTA
239.82
231
0.963
−0.037





SV
TCGGTT
369.33
266
0.720
−0.328





SV
AGCGTC
2025.93
1298
0.641
−0.445





SV
TCCGTG
3537.57
2065
0.584
−0.538





SV
AGCGTG
4007.89
2221
0.554
−0.590





SV
TCCGTC
1788.18
829
0.464
−0.769





SV
AGCGTT
1582.36
446
0.282
−1.266





SV
TCCGTA
906.91
239
0.264
−1.334





SV
TCCGTT
1396.67
329
0.236
−1.446





SV
AGCGTA
1027.48
217
0.211
−1.555





SW
TCCTGG
1756.97
2825
1.608
0.475





SW
AGCTGG
1990.56
2404
1.208
0.189





SW
TCGTGG
464.61
444
0.956
−0.045





SW
TCTTGG
1528.39
1137
0.744
−0.296





SW
TCATGG
1235.61
778
0.630
−0.463





SW
AGTTGG
1255.86
644
0.513
−0.668





SY
TCCTAC
1871.53
3038
1.623
0.484





SY
AGCTAC
2120.35
2864
1.351
0.301





SY
TCCTAT
1520.75
1869
1.229
0.206





SY
AGCTAT
1722.94
1609
0.934
−0.068





SY
AGTTAT
1087.01
1010
0.929
−0.073





SY
AGTTAC
1337.74
1153
0.862
−0.149





SY
TCATAT
1069.49
897
0.839
−0.176





SY
TCTTAT
1322.91
1100
0.832
−0.185





SY
TCTTAC
1628.04
1204
0.740
−0.302





SY
TCGTAC
494.91
304
0.614
−0.487





SY
TCGTAT
402.15
204
0.507
−0.679





SY
TCATAC
1316.18
642
0.488
−0.718





TA
ACGGCG
348.71
734
2.105
0.744





TA
ACAGCA
1829.79
3283
1.794
0.585





TA
ACGGCC
1289.71
2090
1.621
0.483





TA
ACTGCA
1618.13
2557
1.580
0.458





TA
ACAGCT
2090.24
3295
1.576
0.455





TA
ACTGCT
1848.45
2764
1.495
0.402





TA
ACAGCC
3178.34
3912
1.231
0.208





TA
ACGGCA
742.49
804
1.083
0.080





TA
ACTGCC
2810.69
3015
1.073
0.070





TA
ACGGCT
848.18
804
0.948
−0.053





TA
ACAGCG
859.36
803
0.934
−0.068





TA
ACTGCG
759.96
623
0.820
−0.199





TA
ACCGCG
1061.55
584
0.550
−0.598





TA
ACCGCC
3926.11
1648
0.420
−0.868





TA
ACCGCA
2260.29
561
0.248
−1.394





TA
ACCGCT
2582.01
577
0.223
−1.498





TC
ACCTGC
1892.82
3247
1.715
0.540





TC
ACCTGT
1594.30
1994
1.251
0.224





TC
ACGTGC
621.78
691
1.111
0.106





TC
ACGTGT
523.72
484
0.924
−0.079





TC
ACTTGT
1141.35
1033
0.905
−0.100





TC
ACATGT
1290.64
938
0.727
−0.319





TC
ACTTGC
1355.07
815
0.601
−0.508





TC
ACATGC
1532.31
750
0.489
−0.714





TD
ACAGAT
2415.25
4195
1.737
0.552





TD
ACAGAC
2728.31
3765
1.380
0.322





TD
ACTGAT
2135.87
2913
1.364
0.310





TD
ACGGAC
1107.10
1446
1.306
0.267





TD
ACTGAC
2412.71
2615
1.084
0.081





TD
ACGGAT
980.07
922
0.941
−0.061





TD
ACCGAC
3370.20
1547
0.459
−0.779





TD
ACCGAT
2983.49
730
0.245
−1.408





TE
ACAGAA
3127.33
5307
1.697
0.529





TE
ACGGAG
1697.07
2517
1.483
0.394





TE
ACTGAA
2765.58
4093
1.480
0.392





TE
ACAGAG
4182.23
5419
1.296
0.259





TE
ACTGAG
3698.46
4124
1.115
0.109





TE
ACGGAA
1269.01
1080
0.851
−0.161





TE
ACCGAG
5166.20
2450
0.474
−0.746





TE
ACCGAA
3863.10
779
0.202
−1.601





TF
ACCTTC
3026.54
4955
1.637
0.493





TF
ACATTT
2140.61
2275
1.063
0.061





TF
ACTTTT
1893.00
1904
1.006
0.006





TF
ACCTTT
2644.23
2518
0.952
−0.049





TF
ACTTTC
2166.69
1822
0.841
−0.173





TF
ACGTTT
868.62
650
0.748
−0.290





TF
ACGTTC
994.21
666
0.670
−0.401





TF
ACATTC
2450.10
1394
0.569
−0.564





TG
ACTGGA
1710.74
3660
2.139
0.761





TG
ACTGGT
1107.57
1887
1.704
0.533





TG
ACAGGA
1934.51
2970
1.535
0.429





TG
ACGGGC
1064.34
1583
1.487
0.397





TG
ACTGGG
1670.12
2322
1.390
0.330





TG
ACGGGG
766.35
1049
1.369
0.314





TG
ACAGGT
1252.44
1694
1.353
0.302





TG
ACAGGG
1888.57
2148
1.137
0.129





TG
ACTGGC
2319.53
2620
1.130
0.122





TG
ACAGGC
2622.93
2664
1.016
0.016





TG
ACGGGT
508.22
484
0.952
−0.049





TG
ACGGGA
784.99
710
0.904
−0.100





TG
ACCGGG
2332.90
1093
0.469
−0.758





TG
ACCGGC
3240.03
1373
0.424
−0.859





TG
ACCGGT
1547.11
355
0.229
−1.472





TG
ACCGGA
2389.65
528
0.221
−1.510





TH
ACTCAT
1054.95
1291
1.224
0.202





TH
ACCCAC
2032.09
2408
1.185
0.170





TH
ACGCAC
667.53
764
1.145
0.135





TH
ACACAT
1192.94
1186
0.994
−0.006





TH
ACTCAC
1454.76
1384
0.951
−0.050





TH
ACCCAT
1473.60
1287
0.873
−0.135





TH
ACACAC
1645.05
1383
0.841
−0.174





TH
ACGCAT
484.07
302
0.624
−0.472





TI
ACCATC
2842.70
5915
2.081
0.733





TI
ACCATT
2247.97
2878
1.280
0.247





TI
ACAATA
836.96
980
1.171
0.158





TI
ACCATA
1033.87
1137
1.100
0.095





TI
ACAATT
1819.82
1579
0.868
−0.142





TI
ACTATA
740.14
642
0.867
−0.142





TI
ACTATT
1609.31
1337
0.831
−0.185





TI
ACGATA
339.62
190
0.559
−0.581





TI
ACGATT
738.45
389
0.527
−0.641





TI
ACGATC
933.81
463
0.496
−0.702





TI
ACTATC
2035.08
942
0.463
−0.770





TI
ACAATC
2301.27
1027
0.446
−0.807





TK
ACCAAG
3878.56
6678
1.722
0.543





TK
ACCAAA
2994.77
3789
1.265
0.235





TK
ACAAAA
2424.38
2546
1.050
0.049





TK
ACAAAG
3139.84
2507
0.798
−0.225





TK
ACTAAA
2143.95
1684
0.785
−0.241





TK
ACGAAG
1274.09
708
0.556
−0.588





TK
ACGAAA
983.77
511
0.519
−0.655





TK
ACTAAG
2776.65
1193
0.430
−0.845





TL
ACGCTG
1815.48
3357
1.849
0.615





TL
ACTTTA
765.72
1207
1.576
0.455





TL
ACTTTG
1286.34
1876
1.458
0.377





TL
ACATTA
865.87
1115
1.288
0.253





TL
ACCTTG
1796.82
2257
1.256
0.228





TL
ACTCTA
707.99
876
1.237
0.213





TL
ACGCTC
873.61
1057
1.210
0.191





TL
ACCCTC
2659.44
3133
1.178
0.164





TL
ACCCTG
5526.65
6354
1.150
0.140





TL
ACTCTT
1312.81
1469
1.119
0.112





TL
ACACTA
800.60
799
0.998
−0.002





TL
ACGCTA
324.87
307
0.945
−0.057





TL
ACCTTA
1069.59
957
0.895
−0.111





TL
ACACTT
1484.53
1316
0.886
−0.121





TL
ACGTTG
590.25
505
0.856
−0.156





TL
ACATTG
1454.60
1210
0.832
−0.184





TL
ACCCTT
1833.80
1515
0.826
−0.191





TL
ACCCTA
988.95
802
0.811
−0.210





TL
ACTCTG
3956.51
3120
0.789
−0.238





TL
ACGTTA
351.36
262
0.746
−0.293





TL
ACTCTC
1903.88
1391
0.731
−0.314





TL
ACGCTT
602.39
427
0.709
−0.344





TL
ACACTG
4474.03
3013
0.673
−0.395





TL
ACACTC
2152.92
1274
0.592
−0.525





TM
ACCATG
2733.42
4467
1.634
0.491





TM
ACAATG
2212.81
1641
0.742
−0.299





TM
ACGATG
897.92
655
0.729
−0.315





TM
ACTATG
1956.85
1038
0.530
−0.634





TN
ACCAAC
2378.62
4300
1.808
0.592





TN
ACAAAT
1748.34
2194
1.255
0.227





TN
ACCAAT
2159.68
2454
1.136
0.128





TN
ACAAAC
1925.59
1486
0.772
−0.259





TN
ACTAAT
1546.11
1077
0.697
−0.362





TN
ACGAAT
709.45
336
0.474
−0.747





TN
ACTAAC
1702.85
789
0.463
−0.769





TN
ACGAAC
781.37
316
0.404
−0.905





TP
ACGCCG
349.03
632
1.811
0.594





TP
ACGCCC
963.29
1491
1.548
0.437





TP
ACTCCA
1814.66
2359
1.300
0.262





TP
ACCCCG
1062.52
1331
1.253
0.225





TP
ACTCCT
1880.23
2186
1.163
0.151





TP
ACACCA
2052.02
2361
1.151
0.140





TP
ACCCCA
2534.80
2784
1.098
0.094





TP
ACACCT
2126.17
2104
0.990
−0.010





TP
ACCCCT
2626.39
2415
0.920
−0.084





TP
ACGCCA
832.67
748
0.898
−0.107





TP
ACCCCC
2932.43
2380
0.812
−0.209





TP
ACACCC
2373.91
1922
0.810
−0.211





TP
ACGCCT
862.76
697
0.808
−0.213





TP
ACTCCC
2099.31
1649
0.785
−0.241





TP
ACTCCG
760.66
538
0.707
−0.346





TP
ACACCG
860.15
534
0.621
−0.477





TQ
ACTCAA
1103.35
1368
1.240
0.215





TQ
ACCCAG
4303.71
5173
1.202
0.184





TQ
ACGCAG
1413.75
1518
1.074
0.071





TQ
ACACAA
1247.67
1328
1.064
0.062





TQ
ACTCAG
3081.01
2839
0.921
−0.082





TQ
ACCCAA
1541.21
1410
0.915
−0.089





TQ
ACACAG
3484.02
2765
0.794
−0.231





TQ
ACGCAA
506.28
280
0.553
−0.592





TR
ACCAGG
1331.08
2049
1.539
0.431





TR
ACGCGC
403.79
605
1.498
0.404





TR
ACGCGG
441.63
661
1.497
0.403





TR
ACTCGA
521.72
717
1.374
0.318





TR
ACAAGA
1097.61
1429
1.302
0.264





TR
ACCCGC
1229.22
1547
1.259
0.230





TR
ACCCGG
1344.40
1668
1.241
0.216





TR
ACTCGT
376.76
448
1.189
0.173





TR
ACCAGA
1355.85
1599
1.179
0.165





TR
ACCCGA
728.77
758
1.040
0.039





TR
ACCCGT
526.27
535
1.017
0.016





TR
ACAAGG
1077.56
1072
0.995
−0.005





TR
ACGAGG
437.25
433
0.990
−0.010





TR
ACTCGG
962.45
823
0.855
−0.157





TR
ACGCGT
172.88
141
0.816
−0.204





TR
ACACGT
426.04
329
0.772
−0.258





TR
ACGAGA
445.39
331
0.743
−0.297





TR
ACACGA
589.97
432
0.732
−0.312





TR
ACACGG
1088.34
756
0.695
−0.364





TR
ACTCGC
879.99
607
0.690
−0.371





TR
ACTAGA
970.65
624
0.643
−0.442





TR
ACGCGA
239.40
150
0.627
−0.468





TR
ACACGC
995.10
498
0.500
−0.692





TR
ACTAGG
952.91
383
0.402
−0.911





TS
ACCAGC
2807.29
4575
1.630
0.488





TS
ACCTCG
655.24
1060
1.618
0.481





TS
ACGTCG
215.24
348
1.617
0.480





TS
ACTTCA
1247.51
1844
1.478
0.391





TS
ACTTCT
1543.11
1974
1.279
0.246





TS
ACATCA
1410.69
1754
1.243
0.218





TS
ACCAGT
1771.14
2194
1.239
0.214





TS
ACCTCC
2477.85
3050
1.231
0.208





TS
ACCTCA
1742.59
1938
1.112
0.106





TS
ACATCT
1744.95
1911
1.095
0.091





TS
ACGTCC
813.96
840
1.032
0.031





TS
ACCTCT
2155.49
2072
0.961
−0.040





TS
ACAAGT
1433.80
1335
0.931
−0.071





TS
ACTTCC
1773.89
1524
0.859
−0.152





TS
ACGTCA
572.43
450
0.786
−0.241





TS
ACATCC
2005.92
1570
0.783
−0.245





TS
ACTTCG
469.09
353
0.753
−0.284





TS
ACGTCT
708.07
527
0.744
−0.295





TS
ACATCG
530.44
361
0.681
−0.385





TS
ACTAGT
1267.95
725
0.572
−0.559





TS
ACAAGC
2272.61
1275
0.561
−0.578





TS
ACGAGT
581.81
297
0.510
−0.672





TS
ACGAGC
922.18
469
0.509
−0.676





TS
ACTAGC
2009.73
687
0.342
−1.073





TT
ACCACG
875.88
1567
1.789
0.582





TT
ACCACC
2666.32
4767
1.788
0.581





TT
ACCACA
2158.49
2882
1.335
0.289





TT
ACCACT
1908.81
2309
1.210
0.190





TT
ACAACA
1747.38
1793
1.026
0.026





TT
ACAACT
1545.26
1567
1.014
0.014





TT
ACGACG
287.72
252
0.876
−0.133





TT
ACTACT
1366.51
1065
0.779
−0.249





TT
ACTACA
1545.26
1196
0.774
−0.256





TT
ACGACC
875.88
575
0.656
−0.421





TT
ACGACA
709.06
437
0.616
−0.484





TT
ACAACC
2158.49
1310
0.607
−0.499





TT
ACGACT
627.04
357
0.569
−0.563





TT
ACTACC
1908.81
992
0.520
−0.655





TT
ACAACG
709.06
365
0.515
−0.664





TT
ACTACG
627.04
283
0.451
−0.796





TV
ACTGTA
845.20
1425
1.686
0.522





TV
ACTGTT
1301.64
2058
1.581
0.458





TV
ACGGTG
1512.80
2306
1.524
0.422





TV
ACAGTA
955.76
1371
1.434
0.361





TV
ACTGTC
1666.51
2289
1.374
0.317





TV
ACAGTT
1471.90
2019
1.372
0.316





TV
ACTGTG
3296.87
4505
1.366
0.312





TV
ACGGTC
764.70
911
1.191
0.175





TV
ACAGTG
3728.11
4108
1.102
0.097





TV
ACAGTC
1884.50
1933
1.026
0.025





TV
ACGGTA
387.83
286
0.737
−0.305





TV
ACGGTT
597.27
415
0.695
−0.364





TV
ACCGTG
4605.23
2640
0.573
−0.556





TV
ACCGTC
2327.87
1285
0.552
−0.594





TV
ACCGTT
1818.19
496
0.273
−1.299





TV
ACCGTA
1180.62
298
0.252
−1.377





TW
ACGTGG
606.25
837
1.381
0.323





TW
ACCTGG
1845.52
2403
1.302
0.264





TW
ACATGG
1494.02
1089
0.729
−0.316





TW
ACTTGG
1321.21
938
0.710
−0.343





TY
ACCTAC
2130.11
3648
1.713
0.538





TY
ACCTAT
1730.88
1778
1.027
0.027





TY
ACTTAC
1524.94
1383
0.907
−0.098





TY
ACGTAC
699.73
621
0.887
−0.119





TY
ACATAT
1401.21
1136
0.811
−0.210





TY
ACTTAT
1239.13
907
0.732
−0.312





TY
ACGTAT
568.59
408
0.718
−0.332





TY
ACATAC
1724.41
1138
0.660
−0.416





VA
GTGGCC
6082.92
9316
1.532
0.426





VA
GTAGCA
897.78
1347
1.500
0.406





VA
GTTGCT
1579.41
2217
1.404
0.339





VA
GTAGCT
1025.57
1407
1.372
0.316





VA
GTGGCT
4000.44
5252
1.313
0.272





VA
GTGGCG
1644.71
2099
1.276
0.244





VA
GTTGCA
1382.62
1728
1.250
0.223





VA
GTGGCA
3501.98
3859
1.102
0.097





VA
GTAGCC
1559.44
1363
0.874
−0.135





VA
GTTGCC
2401.60
1808
0.753
−0.284





VA
GTAGCG
421.64
216
0.512
−0.669





VA
GTTGCG
649.35
234
0.360
−1.021





VA
GTCGCG
831.37
284
0.342
−1.074





VA
GTCGCC
3074.82
992
0.323
−1.131





VA
GTCGCT
2022.16
406
0.201
−1.606





VA
GTCGCA
1770.19
318
0.180
−1.717





VC
GTCTGC
1410.66
2160
1.531
0.426





VC
GTCTGT
1188.18
1572
1.323
0.280





VC
GTTTGT
928.03
942
1.015
0.015





VC
GTATGT
602.60
594
0.986
−0.014





VC
GTGTGC
2790.71
2583
0.926
−0.077





VC
GTGTGT
2350.57
1996
0.849
−0.164





VC
GTTTGC
1101.80
830
0.753
−0.283





VC
GTATGC
715.44
411
0.574
−0.554





VD
GTAGAT
1225.65
1924
1.570
0.451





VD
GTGGAC
5400.58
7734
1.432
0.359





VD
GTTGAT
1887.55
2389
1.266
0.236





VD
GTGGAT
4780.91
5727
1.198
0.181





VD
GTAGAC
1384.52
1346
0.972
−0.028





VD
GTTGAC
2132.21
1791
0.840
−0.174





VD
GTCGAC
2729.91
602
0.221
−1.512





VD
GTCGAT
2416.67
445
0.184
−1.692





VE
GTAGAA
1456.83
2855
1.960
0.673





VE
GTGGAG
7599.48
11579
1.524
0.421





VE
GTTGAA
2243.56
2905
1.295
0.258





VE
GTGGAA
5682.64
6229
1.096
0.092





VE
GTAGAG
1948.24
2002
1.028
0.027





VE
GTTGAG
3000.36
1987
0.662
−0.412





VE
GTCGAG
3841.42
721
0.188
−1.673





VE
GTCGAA
2872.48
367
0.128
−2.058





VF
GTCTTC
2309.08
4216
1.826
0.602





VF
GTATTT
1023.16
1512
1.478
0.391





VF
GTCTTT
2017.40
2238
1.109
0.104





VF
GTTTTT
1575.70
1706
1.083
0.079





VF
GTTTTC
1803.52
1604
0.889
−0.117





VF
GTGTTT
3991.02
3257
0.816
−0.203





VF
GTGTTC
4568.05
3205
0.702
−0.354





VF
GTATTC
1171.09
721
0.616
−0.485





VG
GTTGGT
779.74
1617
2.074
0.729





VG
GTTGGA
1204.37
2315
1.922
0.653





VG
GTGGGC
4136.07
5977
1.445
0.368





VG
GTAGGA
782.04
1089
1.393
0.331





VG
GTTGGG
1175.77
1510
1.284
0.250





VG
GTTGGC
1632.96
1794
1.099
0.094





VG
GTAGGT
506.31
554
1.094
0.090





VG
GTGGGG
2978.07
3255
1.093
0.089





VG
GTGGGT
1974.96
2009
1.017
0.017





VG
GTAGGG
763.47
683
0.895
−0.111





VG
GTGGGA
3050.51
2599
0.852
−0.160





VG
GTAGGC
1060.34
676
0.638
−0.450





VG
GTCGGG
1505.36
734
0.488
−0.718





VG
GTCGGC
2090.72
734
0.351
−1.047





VG
GTCGGT
998.31
292
0.292
−1.229





VG
GTCGGA
1541.98
343
0.222
−1.503





VH
GTTCAT
911.79
1418
1.555
0.442





VH
GTACAT
592.06
773
1.306
0.267





VH
GTCCAC
1609.82
2085
1.295
0.259





VH
GTCCAT
1167.39
1313
1.125
0.118





VH
GTTCAC
1257.35
1319
1.049
0.048





VH
GTGCAC
3184.70
2856
0.897
−0.109





VH
GTACAC
816.44
613
0.751
−0.287





VH
GTGCAT
2309.44
1472
0.637
−0.450





VI
GTCATC
2367.78
5207
2.199
0.788





VI
GTCATT
1872.41
2827
1.510
0.412





VI
GTAATA
436.74
614
1.406
0.341





VI
GTAATT
949.63
1074
1.131
0.123





VI
GTTATT
1462.46
1595
1.091
0.087





VI
GTCATA
861.15
904
1.050
0.049





VI
GTTATA
672.60
702
1.044
0.043





VI
GTGATT
3704.20
2742
0.740
−0.301





VI
GTGATC
4684.19
3353
0.716
−0.334





VI
GTGATA
1703.61
1117
0.656
−0.422





VI
GTTATC
1849.37
1053
0.569
−0.563





VI
GTAATC
1200.86
577
0.480
−0.733





VK
GTAAAA
1288.46
1945
1.510
0.412





VK
GTCAAG
3290.24
3982
1.210
0.191





VK
GTGAAG
6509.08
7513
1.154
0.143





VK
GTAAAG
1668.70
1704
1.021
0.021





VK
GTCAAA
2540.51
2376
0.935
−0.067





VK
GTTAAA
1984.27
1777
0.896
−0.110





VK
GTGAAA
5025.89
4409
0.877
−0.131





VK
GTTAAG
2569.85
1171
0.456
−0.786





VL
GTTTTA
668.83
1311
1.960
0.673





VL
GTTCTT
1146.70
1859
1.621
0.483





VL
GTTTTG
1123.58
1737
1.546
0.436





VL
GTATTA
434.30
646
1.487
0.397





VL
GTCCTC
2129.16
3019
1.418
0.349





VL
GTTCTA
618.41
832
1.345
0.297





VL
GTCCTG
4424.65
5574
1.260
0.231





VL
GTCCTT
1468.14
1722
1.173
0.159





VL
GTGCTG
8753.31
10107
1.155
0.144





VL
GTCTTG
1438.54
1628
1.132
0.124





VL
GTACTA
401.55
447
1.113
0.107





VL
GTCCTA
791.76
874
1.104
0.099





VL
GTCTTA
856.32
863
1.008
0.008





VL
GTATTG
729.58
711
0.975
−0.026





VL
GTACTT
744.59
693
0.931
−0.072





VL
GTTCTC
1662.99
1501
0.903
−0.102





VL
GTGCTC
4212.12
3765
0.894
−0.112





VL
GTGCTA
1566.34
1286
0.821
−0.197





VL
GTTCTG
3455.90
2350
0.680
−0.386





VL
GTGTTG
2845.87
1910
0.671
−0.399





VL
GTGCTT
2904.43
1933
0.666
−0.407





VL
GTGTTA
1694.06
965
0.570
−0.563





VL
GTACTC
1079.84
541
0.501
−0.691





VL
GTACTG
2244.04
1121
0.500
−0.694





VM
GTCATG
2149.52
3308
1.539
0.431





VM
GTGATG
4252.41
3872
0.911
−0.094





VM
GTAATG
1090.17
935
0.858
−0.154





VM
GTTATG
1678.90
1056
0.629
−0.464





VN
GTCAAC
2052.00
3311
1.614
0.478





VN
GTAAAT
944.92
1518
1.606
0.474





VN
GTCAAT
1863.13
2155
1.157
0.146





VN
GTTAAT
1455.20
1325
0.911
−0.094





VN
GTGAAC
4059.49
3551
0.875
−0.134





VN
GTGAAT
3685.83
3110
0.844
−0.170





VN
GTAAAC
1040.71
854
0.821
−0.198





VN
GTTAAC
1602.73
880
0.549
−0.600





VP
GTTCCT
1434.04
2257
1.574
0.454





VP
GTTCCA
1384.03
1911
1.381
0.323





VP
GTGCCC
4055.45
4998
1.232
0.209





VP
GTACCT
931.17
1048
1.125
0.118





VP
GTCCCC
2049.96
2260
1.102
0.098





VP
GTCCCT
1836.02
2014
1.097
0.093





VP
GTACCA
898.70
963
1.072
0.069





VP
GTCCCG
742.77
786
1.058
0.057





VP
GTTCCC
1601.13
1506
0.941
−0.061





VP
GTCCCA
1772.00
1596
0.901
−0.105





VP
GTGCCT
3632.21
3062
0.843
−0.171





VP
GTGCCG
1469.43
1228
0.836
−0.179





VP
GTACCC
1039.67
809
0.778
−0.251





VP
GTGCCA
3505.55
2431
0.693
−0.366





VP
GTTCCG
580.15
279
0.481
−0.732





VP
GTACCG
376.71
161
0.427
−0.850





VQ
GTACAA
633.37
1049
1.656
0.505





VQ
GTTCAA
975.42
1485
1.522
0.420





VQ
GTCCAG
3487.32
3907
1.120
0.114





VQ
GTACAG
1768.65
1752
0.991
−0.009





VQ
GTTCAG
2723.79
2689
0.987
−0.013





VQ
GTGCAG
6898.98
6734
0.976
−0.024





VQ
GTCCAA
1248.85
1067
0.854
−0.157





VQ
GTGCAA
2470.60
1524
0.617
−0.483





VR
GTTCGA
463.33
867
1.871
0.627





VR
GTTCGT
334.59
580
1.733
0.550





VR
GTCCGA
593.21
805
1.357
0.305





VR
GTCCGC
1000.57
1332
1.331
0.286





VR
GTGCGC
1979.43
2543
1.285
0.251





VR
GTCCGT
428.38
549
1.282
0.248





VR
GTCCGG
1094.32
1346
1.230
0.207





VR
GTACGA
300.86
361
1.200
0.182





VR
GTAAGA
559.73
660
1.179
0.165





VR
GTGCGG
2164.91
2552
1.179
0.164





VR
GTCAGA
1103.65
1291
1.170
0.157





VR
GTACGT
217.26
253
1.165
0.152





VR
GTCAGG
1083.48
1238
1.143
0.133





VR
GTGAGG
2143.46
1986
0.927
−0.076





VR
GTGCGT
847.46
761
0.898
−0.108





VR
GTAAGG
549.51
444
0.808
−0.213





VR
GTTCGG
854.73
650
0.760
−0.274





VR
GTGCGA
1173.55
826
0.704
−0.351





VR
GTTCGC
781.50
545
0.697
−0.360





VR
GTGAGA
2183.35
1511
0.692
−0.368





VR
GTACGG
555.00
377
0.679
−0.387





VR
GTTAGA
862.01
556
0.645
−0.438





VR
GTACGC
507.46
286
0.564
−0.573





VR
GTTAGG
846.26
309
0.365
−1.007





VS
GTTTCT
1206.81
2161
1.791
0.583





VS
GTCTCC
1776.18
2936
1.653
0.503





VS
GTCAGC
2012.32
3223
1.602
0.471





VS
GTTTCA
975.63
1465
1.502
0.407





VS
GTCAGT
1269.59
1841
1.450
0.372





VS
GTATCT
783.62
1093
1.395
0.333





VS
GTATCA
633.51
806
1.272
0.241





VS
GTCTCT
1545.10
1847
1.195
0.178





VS
GTTTCC
1387.29
1604
1.156
0.145





VS
GTCTCG
469.69
542
1.154
0.143





VS
GTCTCA
1249.12
1333
1.067
0.065





VS
GTGTCC
3513.81
3722
1.059
0.058





VS
GTGTCG
929.19
860
0.926
−0.077





VS
GTGTCT
3056.67
2784
0.911
−0.093





VS
GTATCC
900.82
763
0.847
−0.166





VS
GTAAGT
643.89
499
0.775
−0.255





VS
GTGAGC
3980.98
2901
0.729
−0.316





VS
GTGTCA
2471.14
1710
0.692
−0.368





VS
GTTAGT
991.62
640
0.645
−0.438





VS
GTATCG
238.21
138
0.579
−0.546





VS
GTTTCG
366.85
202
0.551
−0.597





VS
GTGAGT
2511.63
1371
0.546
−0.605





VS
GTAAGC
1020.58
514
0.504
−0.686





VS
GTTAGC
1571.73
551
0.351
−1.048





VT
GTCACC
2294.69
4477
1.951
0.668





VT
GTCACT
1642.76
2452
1.493
0.401





VT
GTCACG
753.80
997
1.323
0.280





VT
GTAACT
833.15
1046
1.255
0.228





VT
GTCACA
1857.64
2207
1.188
0.172





VT
GTAACA
942.13
1096
1.163
0.151





VT
GTTACT
1283.09
1208
0.941
−0.060





VT
GTGACC
4539.59
4223
0.930
−0.072





VT
GTGACG
1491.24
1318
0.884
−0.123





VT
GTGACT
3249.88
2758
0.849
−0.164





VT
GTGACA
3674.98
2947
0.802
−0.221





VT
GTTACA
1450.92
1111
0.766
−0.267





VT
GTAACC
1163.79
758
0.651
−0.429





VT
GTTACC
1792.28
969
0.541
−0.615





VT
GTAACG
382.30
191
0.500
−0.694





VT
GTTACG
588.76
183
0.311
−1.169





VV
GTTGTA
655.54
1109
1.692
0.526





VV
GTTGTT
1009.55
1701
1.685
0.522





VV
GTAGTA
425.66
698
1.640
0.495





VV
GTGGTG
6476.64
9025
1.393
0.332





VV
GTGGTC
3273.84
4256
1.300
0.262





VV
GTAGTT
655.54
800
1.220
0.199





VV
GTTGTC
1292.55
1561
1.208
0.189





VV
GTGGTA
1660.38
1777
1.070
0.068





VV
GTGGTT
2557.05
2613
1.022
0.022





VV
GTTGTG
2557.05
2261
0.884
−0.123





VV
GTAGTG
1660.38
1161
0.699
−0.358





VV
GTAGTC
839.30
553
0.659
−0.417





VV
GTCGTC
1654.87
858
0.518
−0.657





VV
GTCGTG
3273.84
1250
0.382
−0.963





VV
GTCGTA
839.30
213
0.254
−1.371





VV
GTCGTT
1292.55
288
0.223
−1.501





VW
GTCTGG
1316.29
1763
1.339
0.292





VW
GTGTGG
2604.03
2451
0.941
−0.061





VW
GTATGG
667.58
578
0.866
−0.144





VW
GTTTGG
1028.10
824
0.801
−0.221





VY
GTCTAC
1602.79
2490
1.554
0.441





VY
GTTTAT
1017.23
1438
1.414
0.346





VY
GTATAT
660.53
875
1.325
0.281





VY
GTCTAT
1302.39
1544
1.186
0.170





VY
GTGTAC
3170.80
2654
0.837
−0.178





VY
GTTTAC
1251.87
1008
0.805
−0.217





VY
GTATAC
812.88
582
0.716
−0.334





VY
GTGTAT
2576.51
1804
0.700
−0.356





WA
TGGGCA
1469.77
1535
1.044
0.043





WA
TGGGCG
690.28
695
1.007
0.007





WA
TGGGCT
1678.97
1664
0.991
−0.009





WA
TGGGCC
2552.98
2498
0.978
−0.022





WC
TGGTGC
1057.38
1066
1.008
0.008





WC
TGGTGT
890.62
882
0.990
−0.010





WD
TGGGAC
2699.37
2807
1.040
0.039





WD
TGGGAT
2389.63
2282
0.955
−0.046





WE
TGGGAG
3580.00
3650
1.020
0.019





WE
TGGGAA
2677.00
2607
0.974
−0.026





WF
TGGTTT
1639.95
1735
1.058
0.056





WF
TGGTTC
1877.05
1782
0.949
−0.052





WG
TGGGGT
955.95
1064
1.113
0.107





WG
TGGGGC
2002.00
2179
1.088
0.085





WG
TGGGGA
1476.56
1454
0.985
−0.015





WG
TGGGGG
1441.49
1179
0.818
−0.201





WH
TGGCAT
971.42
1000
1.029
0.029





WH
TGGCAC
1339.58
1311
0.979
−0.022





WI
TGGATT
1537.91
1627
1.058
0.056





WI
TGGATA
707.30
714
1.009
0.009





WI
TGGATC
1944.78
1849
0.951
−0.051





WK
TGGAAG
3491.83
3645
1.044
0.043





WK
TGGAAA
2696.17
2543
0.943
−0.058





WL
TGGCTA
683.88
798
1.167
0.154





WL
TGGCTG
3821.78
4228
1.106
0.101





WL
TGGCTT
1268.11
1334
1.052
0.051





WL
TGGCTC
1839.05
1879
1.022
0.021





WL
TGGTTG
1242.54
855
0.688
−0.374





WL
TGGTTA
739.64
501
0.677
−0.390





WM
TGGATG
2335.00
2335
1.000
0.000





WN
TGGAAT
1978.70
2005
1.013
0.013





WN
TGGAAC
2179.30
2153
0.988
−0.012





WP
TGGCCC
1302.21
1381
1.061
0.059





WP
TGGCCG
471.84
486
1.030
0.030





WP
TGGCCA
1125.64
1123
0.998
−0.002





WP
TGGCCT
1166.31
1076
0.923
−0.081





WQ
TGGCAG
2983.56
2997
1.005
0.004





WQ
TGGCAA
1068.44
1055
0.987
−0.013





WR
TGGAGG
1198.99
1665
1.389
0.328





WR
TGGAGA
1221.30
1472
1.205
0.187





WR
TGGCGG
1210.98
979
0.808
−0.213





WR
TGGCGC
1107.23
895
0.808
−0.213





WR
TGGCGT
474.05
377
0.795
−0.229





WR
TGGCGA
656.45
481
0.733
−0.311





WS
TGGAGT
1031.75
1239
1.201
0.183





WS
TGGAGC
1635.35
1956
1.196
0.179





WS
TGGTCA
1015.12
898
0.885
−0.123





WS
TGGTCC
1443.44
1271
0.881
−0.127





WS
TGGTCT
1255.65
1076
0.857
−0.154





WS
TGGTCG
381.70
323
0.846
−0.167





WT
TGGACG
598.07
674
1.127
0.120





WT
TGGACA
1473.88
1559
1.058
0.056





WT
TGGACT
1303.39
1240
0.951
−0.050





WT
TGGACC
1820.65
1723
0.946
−0.055





WV
TGGGTC
1318.64
1378
1.045
0.044





WV
TGGGTG
2608.66
2633
1.009
0.009





WV
TGGGTA
668.77
665
0.994
−0.006





WV
TGGGTT
1029.93
950
0.922
−0.081





WW
TGGTGG
1559.00
1559
1.000
0.000





WY
TGGTAC
1444.91
1520
1.052
0.051





WY
TGGTAT
1174.09
1099
0.936
−0.066





YA
TATGCA
1120.39
2249
2.007
0.697





YA
TATGCT
1279.86
2296
1.794
0.584





YA
TATGCC
1946.11
2862
1.471
0.386





YA
TACGCG
647.56
622
0.961
−0.040





YA
TATGCG
526.19
482
0.916
−0.088





YA
TACGCC
2395.00
1402
0.585
−0.535





YA
TACGCA
1378.81
512
0.371
−0.991





YA
TACGCT
1575.07
444
0.282
−1.266





YC
TACTGC
1588.07
2411
1.518
0.418





YC
TACTGT
1337.61
1587
1.186
0.171





YC
TATTGT
1086.90
659
0.606
−0.500





YC
TATTGC
1290.42
646
0.501
−0.692





YD
TATGAT
2091.17
3707
1.773
0.572





YD
TATGAC
2362.22
3731
1.579
0.457





YD
TACGAC
2907.08
1653
0.569
−0.565





YD
TACGAT
2573.52
843
0.328
−1.116





YE
TATGAA
2515.85
5225
2.077
0.731





YE
TATGAG
3364.48
4722
1.403
0.339





YE
TACGAG
4140.53
2309
0.558
−0.584





YE
TACGAA
3096.14
861
0.278
−1.280





YF
TACTTC
2766.63
3380
1.222
0.200





YF
TATTTT
1964.12
2124
1.081
0.078





YF
TACTTT
2417.16
2201
0.911
−0.094





YF
TATTTC
2248.09
1691
0.752
−0.285





YG
TATGGA
1472.35
2874
1.952
0.669





YG
TATGGT
953.23
1665
1.747
0.558





YG
TATGGG
1437.38
2129
1.481
0.393





YG
TATGGC
1996.30
2749
1.377
0.320





YG
TACGGG
1768.93
1088
0.615
−0.486





YG
TACGGC
2456.76
1484
0.604
−0.504





YG
TACGGT
1173.10
448
0.382
−0.963





YG
TACGGA
1811.96
633
0.349
−1.052





YH
TACCAC
1862.81
2378
1.277
0.244





YH
TACCAT
1350.85
1420
1.051
0.050





YH
TATCAT
1097.67
1021
0.930
−0.072





YH
TATCAC
1513.67
1006
0.665
−0.409





YI
TACATC
2684.66
3935
1.466
0.382





YI
TACATT
2122.99
2162
1.018
0.018





YI
TATATT
1725.09
1554
0.901
−0.104





YI
TACATA
976.39
846
0.866
−0.143





YI
TATATA
793.39
648
0.817
−0.202





YI
TATATC
2181.48
1339
0.614
−0.488





YK
TACAAG
3508.58
4372
1.246
0.220





YK
TACAAA
2709.10
2847
1.051
0.050





YK
TATAAA
2201.34
2262
1.028
0.027





YK
TATAAG
2850.98
1789
0.628
−0.466





YL
TACCTG
4522.42
6324
1.398
0.335





YL
TATTTA
711.20
966
1.358
0.306





YL
TACCTC
2176.20
2598
1.194
0.177





YL
TACTTG
1470.33
1701
1.157
0.146





YL
TATTTG
1194.75
1358
1.137
0.128





YL
TACCTA
809.25
876
1.082
0.079





YL
TACCTT
1500.58
1449
0.966
−0.035





YL
TATCTT
1219.33
1166
0.956
−0.045





YL
TACTTA
875.24
763
0.872
−0.137





YL
TATCTA
657.58
541
0.823
−0.195





YL
TATCTC
1768.32
1087
0.615
−0.487





YL
TATCTG
3674.80
1751
0.476
−0.741





YM
TACATG
2325.97
3055
1.313
0.273





YM
TATATG
1890.03
1161
0.614
−0.487





YN
TACAAC
2442.24
3341
1.368
0.313





YN
TACAAT
2217.44
2200
0.992
−0.008





YN
TATAAT
1801.83
1629
0.904
−0.101





YN
TATAAC
1984.50
1276
0.643
−0.442





YP
TACCCG
668.65
1004
1.502
0.406





YP
TACCCA
1595.15
1925
1.207
0.188





YP
TATCCA
1296.18
1438
1.109
0.104





YP
TACCCC
1845.38
1961
1.063
0.061





YP
TATCCT
1343.02
1379
1.027
0.026





YP
TACCCT
1652.79
1558
0.943
−0.059





YP
TATCCC
1499.51
937
0.625
−0.470





YP
TATCCG
543.32
242
0.445
−0.809





YQ
TACCAG
3987.12
5013
1.257
0.229





YQ
TATCAA
1160.22
1179
1.016
0.016





YQ
TACCAA
1427.83
1397
0.978
−0.022





YQ
TATCAG
3239.83
2226
0.687
−0.375





YR
TACCGC
1307.70
2153
1.646
0.499





YR
TACCGA
775.30
990
1.277
0.244





YR
TACAGA
1442.41
1834
1.271
0.240





YR
TACCGG
1430.23
1796
1.256
0.228





YR
TACAGG
1416.06
1671
1.180
0.166





YR
TACCGT
559.87
642
1.147
0.137





YR
TATCGA
629.99
570
0.905
−0.100





YR
TATCGT
454.94
383
0.842
−0.172





YR
TATAGA
1172.07
827
0.706
−0.349





YR
TATCGG
1162.17
629
0.541
−0.614





YR
TATAGG
1150.66
560
0.487
−0.720





YR
TATCGC
1062.60
509
0.479
−0.736





YS
TACAGC
2204.13
3590
1.629
0.488





YS
TACTCG
514.46
783
1.522
0.420





YS
TACAGT
1390.60
1887
1.357
0.305





YS
TATTCA
1111.75
1210
1.088
0.085





YS
TACTCC
1945.47
2088
1.073
0.071





YS
TATTCT
1375.18
1466
1.066
0.064





YS
TACTCA
1368.18
1188
0.868
−0.141





YS
TATTCC
1580.84
1306
0.826
−0.191





YS
TACTCT
1692.37
1173
0.693
−0.367





YS
TATAGT
1129.96
728
0.644
−0.440





YS
TATTCG
418.04
229
0.548
−0.602





YS
TATAGC
1791.02
874
0.488
−0.717





YT
TACACG
697.26
1311
1.880
0.631





YT
TACACC
2122.58
2696
1.270
0.239





YT
TACACA
1718.31
2158
1.256
0.228





YT
TACACT
1519.54
1409
0.927
−0.076





YT
TATACT
1234.74
1049
0.850
−0.163





YT
TATACA
1396.25
1049
0.751
−0.286





YT
TATACC
1724.75
1063
0.616
−0.484





YT
TATACG
566.57
245
0.432
−0.838





YV
TATGTT
986.79
1723
1.746
0.557





YV
TATGTA
640.76
1113
1.737
0.552





YV
TATGTC
1263.40
1862
1.474
0.388





YV
TATGTG
2499.39
3382
1.353
0.302





YV
TACGTG
3075.90
2279
0.741
−0.300





YV
TACGTC
1554.82
991
0.637
−0.450





YV
TACGTA
788.55
284
0.360
−1.021





YV
TACGTT
1214.40
390
0.321
−1.136





YW
TACTGG
1609.87
2212
1.374
0.318





YW
TATTGG
1308.13
706
0.540
−0.617





YY
TACTAC
2256.03
2854
1.265
0.235





YY
TATTAT
1489.60
1459
0.979
−0.021





YY
TACTAT
1833.19
1760
0.960
−0.041





YY
TATTAC
1833.19
1339
0.730
−0.314








Claims
  • 1. A modified influenza virus genome having a recoded hemagglutinin (HA) protein-encoding sequence and a recoded neuraminidase (NA) protein-encoding sequence, wherein the other influenza protein-encoding sequences are not recoded, wherein: (a) the HA protein-encoding sequence, the NA protein-encoding sequence, or both are recoded by: (i) lowering the codon pair bias of the protein-encoding sequence as compared to the parent HA protein-encoding sequence, the parent NA protein-encoding sequence, or both, wherein the codon pair bias is calculated relative to an influenza host; or(ii) lowering the codon bias of the protein-encoding sequence as compared to the parent HA protein-encoding sequence, the parent NA protein-encoding sequence, or both, wherein the codon bias is calculated relative to the influenza host; and(b) the recoded sequence encodes the same protein as the parent protein-encoding sequence.
  • 2. The modified influenza virus genome of claim 1, wherein reducing the codon pair bias comprises identifying a codon pair in the parent protein-encoding sequence having a codon pair score that can be reduced, and reducing the codon pair bias by substituting the codon pair with a codon pair that encodes the same amino acid pair and has a lower codon pair score.
  • 3. The modified influenza virus genome of claim 1, wherein reducing the codon pair bias comprises rearranging the codons of a parent protein-encoding sequence.
  • 4. The modified influenza virus genome of claim 2, wherein each of the recoded HA protein-encoding sequence and the recoded NA protein-encoding sequence have a codon pair bias less than −0.1, or less than −0.2, or less than −0.3, or less than −0.4.
  • 5. The modified influenza virus genome of claim 1, wherein the HA protein-encoding sequence, the NA protein-encoding sequence, or both are recoded by replacing one or more codons with synonymous codons that are less frequent in an influenza host, wherein the influenza host is a human.
  • 6. The modified influenza virus genome of claim 1, the HA protein-encoding sequence, the NA protein-encoding sequence, or both are further recoded by modifying the CG dinucleotide content, the TA dinucleotide content, or both.
  • 7. A modified influenza virus comprising the modified influenza virus genome of claim 1.
  • 8. The modified influenza virus of claim 7, wherein the expression of the recoded HA-encoding nucleotide sequence and expression of the recoded NA-encoding nucleotide sequence is reduced compared to the parent virus.
  • 9. A vaccine composition comprising a modified influenza virus comprising the modified influenza virus genome of claim 3 for inducing a protective immune response in a subject.
  • 10. The vaccine composition of claim 9, further comprising at least one adjuvant.
  • 11. The modified influenza virus genome of claim 1, wherein the influenza host is a human.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 14/777,204, filed Sep. 15, 2015, which is a 371 of PCT/US2014/030027, filed Mar. 15, 2014, which claims the benefit of priority to U.S. Application No. 61/794,617, filed Mar. 15, 2013, all of which are incorporated herein by reference in their entireties.

FEDERAL FUNDING

This invention was made with government support under AI015122 and AI075219 awarded the National Institutes of Health. The government has certain rights in the invention.

US Referenced Citations (14)
Number Name Date Kind
7504109 Yang et al. Mar 2009 B2
7566454 Lu et al. Jul 2009 B2
8039002 Yang et al. Oct 2011 B2
8298820 Weiner et al. Oct 2012 B2
9017694 Jin et al. Apr 2015 B2
9476032 Wimmer Oct 2016 B2
10316294 Mueller Jun 2019 B2
11371024 Collins et al. Jun 2022 B2
20080118530 Kew May 2008 A1
20100008945 Angela et al. Jan 2010 A1
20110184160 Weiner et al. Jul 2011 A1
20120269849 Wimmer et al. Oct 2012 A1
20140141042 Vitelli et al. May 2014 A1
20140286992 Galarza et al. Sep 2014 A1
Foreign Referenced Citations (3)
Number Date Country
2006042156 Apr 2006 WO
2008121992 Oct 2008 WO
2011044561 Apr 2011 WO
Non-Patent Literature Citations (21)
Entry
Belshe, R.B. et al., “Live Attenuated Versus Inactivated Influenza Vaccine in Infants and Young Children” N Engl J. Med (2007); vol. 356(7); pp. 685-696.
Bouvier, N.M. et al., The Biology of Influenza Viruses; Vaccine (2008); 26 Suppl. 4; pp. D49-53.
Cello, J. et al., “Chemical Synthesis of Poliovirus cDNA: Generation of Infectious Virus in the Absence of Natural Template”; Science (2002); vol. 297(5583); pp. 1016-1018.
Coleman, J.R., et al., “Virus Attenuation by Genome-Scale Changes in Codon Pair Bias”; Science (2008) vol. 320 (5884); pp. 1784-1787.
De Jong, J.C. et al., “Haemagglutination-Inhibiting Antibody to Influenza Virus”; Dev Biol (Basel) (2003); vol. 115; pp. 63-73.
Doma, M.K. et al., “Endonucleolytic Cleavage of Eukaryotic mRNAs with Stalls in Translation Elongation”; Nature (2006); vol. 440(7083); pp. 561-564.
Dove, B.K., et al., “A Quantitative Proteomic Analysis of Lung Epithelial (A549) Cells Infected with 2009 Pandemic Influenza A Virus Using Stable Isotope Labelling with Amino Acids in Cell Culture”; Proteomics (2012); vol. 12(9); pp. 1431-1436.
Federov, A. et al., “Regularities of Context-Dependent Condon Bias in Eukaroytic Gene”; NAR (2002); vol. 30:5:' pp. 1192-1197.
Gutman, G.A. et al., “Nonrandom Utilization of Codon Pairs in Escherichia Coli”; Proc. Natl. Acad. Sci U. S. A. (1989); vol. 86(10); pp. 3699-3703.
Moura, G. et al., “Large Scale Comparative Codon-Pair Context Analysis Unveils General Rules that Fine-Tune Evolution of mRNA Primary Structure”; PLoS One (2007); vol. 2(9); p. e847.
Simonsen, L., et al. “Impact of Influenza Vaccination on Seasonal Mortality in the U.S. Elderly Population”; Arch. Intem. Med (2005); vol. 165(3); pp. 265-272.
Smith, D.J., et al., “Mapping the Antigenic and Genetic Evolution of Influenza Virus”; Science (2004); vol. 305(5682); pp. 371-376.
Sutejo, R., et al., “Activation of Type I and III Interferon Signalling Pathways Occurs in Lung Epithelial Cells Infected with Low Pathogenic Avian Influenza Viruses”; PLoS One (2012); vol. 7(3); p. e33732.
Mueller, S. et al., “Live Attenuated Influenza VirusVaccines by Computer-Aided Rational Design”; Nat Biotechnol (2010); vol. 28(7); pp. 723-726.
Thompson, W.W. et al. “Epidemiology of Seasonal Influenza: Use of Surveillance Data and Statistical Models to Estimate the Burden of Disease”; J. Infect. Dis. (2006); 194 Suppl 2; pp. S82-91.
Wang, F.P. et al., “Codon-Pair Usage and Genome Evolution” Gene (2009); vol. 433(1-2); pp. 8-15.
Wang, Z. et al., “Live attenuated or Inactivated Influenza Vaccines and Medical Encounters for Respiratory Illnesses Among US Military Personnel”; JAMA (2009); vol. 301(9); pp. 945-953.
World Health Organzation , WHO Manual on Animal Influenza Diagnosis and Surveillance (2002); www.who.int/vaccine_research/diseases/influenza/WHO_manual_on_animaldiagnosis_and_surveillance2002 5.pdf.
Ueda, M. et al., “Maturation Efficiency of Viral Glycoproteins in the ER Impacts the Productions of Influenza A Virus” Virus Research (2008); vol. 136; pp. 91-97.
Tamura, S. et al., “Mechanisms of Brand Cross-Protection Provided by Influenza Virus and their Application to Vaccines”; Jpn J. Infec. Dis (2005); vol. 58:4; pp. 195-207.
Yang, C. et al., “Deliberate Reduction of Hemagglutinin and Neuraminidase Expression of Influenza Virus Leads to an Ultraprotective Live Vaccine in Mice”; PNAS (2013); vol. 110:23; pp. 9481-9486.
Related Publications (1)
Number Date Country
20210009962 A1 Jan 2021 US
Provisional Applications (1)
Number Date Country
61794617 Mar 2013 US
Continuations (1)
Number Date Country
Parent 14777204 US
Child 16436475 US